| Keywords
|
|
[168]
|
-omics
|
|
|
| 2025 |
|
2025 ABS0006
|
INTEGRATING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR A AND CIRCADIAN RHYTHM INSIGHTS AS NOVEL UNDERLYING MECHANISMS OF OSTEOARTHRITIS,
C. Garcia-Dominguez, U. Nogueira-Recalde, A. Copena Soutelo, P. Diaz-Rodriguez, F. J. Blanco, E. Dominguez, B. Carames
|
|
2025 ABS0007
|
DERMAL MAST CELL ACTIVATION CONTRIBUTES TO VASCULOPATHY IN SYSTEMIC SCLEROSIS,
H. Yin, W. Lin, Z. Zhao, C. Gu, C. Jia, X. Liu, L. Lu
|
|
2025 ABS0014
|
SPATIAL TRANSCRIPTOMIC INSIGHTS INTO INTERFERON AND MITOCHONDRIAL PATHWAY DYSREGULATION IN JUVENILE DERMATOMYOSITIS MUSCLE BIOPSIES,
A. E. Syntakas, M. Kartawinata, H. Nguyen, C. Papadopoulou, M. Al-Obaidi, C. Pilkington, Y. Glackin, A. Merve, O. Ogunbiyi, L. Wedderburn, M. Wilkinson
|
|
2025 ABS0023
|
GENETIC ASSOCIATIONS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SUDANESE POPULATION,
K. Patasova, N. A. Mohammed, M. A. M. Nur, E. M. Elagib, A. Elshafie, I. Gunnarsson, E. Svenungsson, J. Rönnelid, S. Elbagir, L. M. Diaz-Gallo
|
|
2025 ABS0025
|
GROWTH DIFFERENTIATION FACTOR 15 IS A SERUM BIOMARKER AND PATHOGENIC FACTOR OF PROGRESSIVE FIBROSIS IN SYSTEMIC SCLEROSIS,
V. Kakkar, S. Kim, Y. Bi, C. W. Wasson, S. Di Donato, R. Ross, M. Di Battista, E. De Lorenzis, T. Sornasse, F. Del Galdo
|
|
2025 ABS0026
|
MOLECULAR AND IMMUNE LANDSCAPE OF ACUTE, SUBACUTE, AND CHRONIC CUTANEOUS LUPUS: A COMPARATIVE ANALYSIS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0030
|
UNRAVELLING THE PARATOPE SEQUENCE OF RHEUMATOID FACTOR,
J. De Leeuw, T. Dehaemers, R. Derua, B. Michiels, D. Dillaerts, M. Cockx, G. Frans, S. Carpentier, P. Verschueren, X. Bossuyt
|
|
2025 ABS0032
|
BIOMIX INTEGRATED MULTI-OMICS ANALYSIS OF PRECISESADS DATA REVEALS KEY METABOLIC PATHWAY ALTERATIONS IN B LYMPHOCYTES, IMMUNE CELLS, AND THEIR MICROENVIRONMENT IN SJÖGREN’S DISEASE,
C. IPERI, A. Fernández-Ochoa, J. O. Pers, G. Barturen, M. Alarcon-Riquelme, R. Quirantes-Piné, I. Borrás-Linares, A. Segura-Carretero, V. Devauchelle-Pensec, D. Cornec, A. Bordron, C. Jamin
|
|
2025 ABS0033
|
SYNOVIAL PROTEIN SIGNATURES AS PREDICTIVE SERUM BIOMARKERS OF INFLAMMATION, DISEASE ACTIVITY, AND TREATMENT RESPONSE IN EARLY RHEUMATOID ARTHRITIS,
S. Corrales-Díaz Flores, C. Aranda-Valera, J. Osuna, R. Ortega-Castro, J. Calvo, M. L. Ladehesa-Pineda, I. Sanchez-Pareja, L. Muñoz-Barrera, L. Formanti Alonso, D. Ruiz-Vilchez, C. Merlo, M. Á. Aguirre-Zamorano, N. Barbarroja, T. Cerdó, R. Ortega, M. Alarcon-Riquelme, C. Perez-Sanchez, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2025 ABS0042
|
HIGHER BASAL ACTIVATION OF THE PROXIMAL KYNURENINE PATHWAY IN RHEUMATOID ARTHRITIS MONOCYTES BUT IMPAIRED INFLAMMATORY RESPONSE,
S. V. Malkewitz, S. M. Duphey, C. Makowiec, M. Yang, C. Frezza, D. Kyburz, J. Jäger, S. Dudli, O. Distler, B. Müller
|
|
2025 ABS0048
|
DIFFERENTIAL ACTIVATION OF LYSOPHOSPHATIDIC ACID REGULATED GENES IN DIFFUSE AND LIMITED CUTANEOUS SYSTEMIC SCLEROSIS,
M. Kanitkar, P. Yee, S. Rodolfi, V. H. Ong, C. Denton
|
|
2025 ABS0049
|
GENETICS AND PROTEOMICS IN AUTOANTIBODY-DEFINED AUTOANTIBODY-DEFINED SUBGROUPS OF PATIENTS WITH SLE,
A. C. Gonzalez-Sanchez, H. Idborg, A. Jonsen, A. Antovic, A. Bengtsson, A. Zickert, S. Reid, K. Chemin, L. Ronnblom, I. Gunnarsson, G. Nordmark, E. Svenungsson, D. Leonard, L. M. Diaz-Gallo
|
|
2025 ABS0077
|
MOLECULARLY DIVERSE PR3+ CELLS CHARACTERIZE LUPUS NEPHRITIS: A SPATIALLY RESOLVED MULTI-OMICS APPROACH,
A. I. Celia, C. Y. Lee, T. Li, E. Shenderov, K. Casella, A. Cortez, S. Louis, X. Yang, C. Alessandri, F. Conti, M. Petri T. Accelerating Medicines Partnership in RA/SLE Network, S. Skopelja-Gardner, A. Rosenberg, A. Fava
|
|
2025 ABS0084
|
TIME-COURSE RNA SEQUENCING ANALYSIS OF LONGITUDINAL PBMC SAMPLES TO ELUCIDATE THE FACTORS DETERMINING DIFFICULT-TO-TREAT SYSTEMIC LUPUS ERYTHEMATOSUS,
S. Sumitomo, H. Oka, T. Iwasaki, K. Ohmura
|
|
2025 ABS0090
|
IDENTIFICATION OF MOLECULAR BIOMARKERS AND IMMUNE CELL PROFILES IN ACTIVE LUPUS NEPHRITIS USING TRANSCRIPTOMIC AND BIOINFORMATICS APPROACHES,
R. Martinez-Canales, G. Figueroa-Parra, A. Montoya-Rosales, C. M. Skinner-Taylor, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0101
|
Exploring Biomarkers Across Rheumatic and Musculoskeletal Diseases Using Machine Learning on Deep Immunophenotyping and Serum Proteomics,
K. Matsumoto, M. Takeshita, K. Suzuki, Y. Kaneko
|
|
2025 ABS0110
|
INTEGRATIVE OMICS REVEALS MOLECULAR SIGNATURES DISTINGUISHING EARLY FROM ESTABLISHED RHEUMATOID ARTHRITIS AND PREDICTING CLINICAL RESPONSE,
I. Sanchez-Pareja, C. Perez-Sanchez, D. Toro-Domínguez, L. Muñoz-Barrera, T. Cerdó, E. Moreno-Caño, S. Corrales-Díaz Flores, L. Formanti Alonso, R. Ortega-Castro, J. Calvo, M. L. Ladehesa-Pineda, C. Aranda-Valera, M. C. Ábalos-Aguilera, C. Merlo-Ruiz, M. Á. Aguirre-Zamorano, M. Alarcon-Riquelme, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2025 ABS0119
|
“TARGETING PAR2 IN OSTEOBLASTS: A NOVEL APPROACH FOR MANAGING OSTEOARTHRITIS AND BONE METABOLISM”,
A. Lamprou
|
|
2025 ABS0123
|
DISTINCT MOLECULAR RESPONSES TO CD19 CAR-T CELL THERAPY VERSUS STANDARD PHARMACOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
P. Garantziotis, L. Beretta, J. Lindblom, D. Nikolopoulos, R. Grieshaber-Bouyer, G. S. Moysidou, M. Hagen, A. Wirsching, J. Taubmann, C. Bergmann, A. Bozec, G. Barturen, A. Fanouriakis, G. K. Bertsias, M. Schneider, D. Boumpas, M. Alarcon-Riquelme, G. Schett, I. Parodis
|
|
2025 ABS0127
|
TYPE I INTERFERONS DRIVE IMMUNOSENESCENCE OF NAÏVE CD4+ T-CELLS VIA METABOLIC REPROGRAMMING IN SJÖGREN´S DISEASE,
P. Javorova, E. Zuegner, A. Lackner, C. Magnes, J. Thiel, J. Fessler, M. Stradner
|
|
2025 ABS0141
|
SYSTEMATIC REVIEW AND INDEPENDENT VALIDATION OF GENETIC FACTORS OF RADIOGRAPHIC OUTCOME IN RHEUMATOID ARTHRITIS IDENTIFIES A GENOME-WIDE ASSOCIATION WITH CARD9,
S. Sharma, R. Hum, N. Nair, L. Marshall, A. Storrie, J. Bowes, A. MacGregor, M. Yates, A. Morris, S. Verstappen, A. Barton, H. W. van Steenbergen, R. Knevel, A. H. M. van der Helm – van Mil, S. Viatte
|
|
2025 ABS0153
|
WHOLE BLOOD METABOLOMICS-BASED IDENTIFICATION OF TREATMENT RESPONSE BIOMARKERS FOR METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS: DISCOVERY AND VALIDATION INSIGHTS,
C. F. Yap, N. Nair, E. Doe, S. Verstappen, K. Hyrich, A. Barton, D. Plant
|
|
2025 ABS0175
|
PROTEOMICS ANALYSIS IN SLE PATIENTS REVEALS A RECONSTITUTION OF APOPTOSIS AND TREG PATHWAYS UPON BELIMUMAB TREATMENT,
G. S. Moysidou, M. Grigoriou, P. Liakopoulos, D. Nikoleri, P. Garantziotis, S. Flouda, M. Nikoloudaki, P. Kolovos, A. Fanouriakis, G. K. Bertsias, D. Boumpas
|
|
2025 ABS0187
|
PLASMA PROTEOMIC PROFILES PREDICT INDIVIDUAL FUTURE RISK OF DEVELOPING OSTEOARTHRITIS,
Z. Kang, J. Zhang, Q. Tong, S. M. Dai
|
|
2025 ABS0195
|
IMMUNE AND TRANSCRIPTOMIC DYNAMICS IN LUPUS NEPHRITIS ASSOCIATED WITH INTERFERON α KINOID TREATMENT,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0196
|
MOLECULAR LANDSCAPE, CO-EXPRESSED PATHWAYS, AND CANDIDATE BIOMARKERS IN SYSTEMIC SCLEROSIS: AN INTEGRATIVE BIOINFORMATICS META-ANALYSIS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0197
|
CUTANEOUS GENE EXPRESSION SIGNATURES REVEAL KEY INSIGHTS INTO PULMONARY FUNCTION AND FIBROSIS IN SYSTEMIC SCLEROSIS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0198
|
MOLECULAR LANDSCAPE AND CO-EXPRESSED PATHWAYS IN RHEUMATOID ARTHRITIS COMPLICATED BY ATHEROSCLEROSIS: INSIGHTS FROM INTEGRATIVE BIOINFORMATIC TRANSCRIPTOMICS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0201
|
SINGLE-CELL SEQUENCING OF AORTIC TISSUE IN PATIENTS WITH BEHÇET’S SYNDROME,
C. Wang, N. Gao, L. Pan, T. Li
|
|
2025 ABS0203
|
GENE EXPRESSION PROFILE IS DIFFERENT BETWEEN MEN AND WOMEN IN PSORIATIC DISEASE,
P. Krug, C. Chabot, A. de Sousa Leite, M. S. Stoenoiu, L. Frédéric, A. Nzeusseu Toukap
|
|
2025 ABS0210
|
NEUROINFLAMMATION-ASSOCIATED GENES UPREGULATED IN PsA PATIENTS SUFFERING FROM SEVERE FATIGUE – A TRANSLATIONAL STUDY INCORPORATING SINGLE-CELL TRANSCRIPTOMICS,
Z. R. Stisen, M. Randahl Nielsen, S. B. Ditlev, L. E. Jessen, M. Skougaard
|
|
2025 ABS0215
|
PHENOTYPE-SPECIFIC IMMUNE SIGNATURES IN BEHÇET’S DISEASE: A TRANSCRIPTOMIC AND CYTOKINE BASED APPROACH,
R. Deniz, G. Gülfidan, C. Bes, Z. Emrence, F. Alibaz-Oner, S. Sirma Ekmekci, N. Abaci, H. Direskeneli, A. Gül, K. Y. Arga, C. Erzik
|
|
2025 ABS0221
|
GENOME-WIDE MENDELIAN RANDOMIZATION IDENTIFIES DRUGGABLE THERAPEUTIC TARGETS FOR SJÖGREN’S DISEASE: EVIDENCE FROM BAYESIAN COLOCALIZATION AND CLINICAL VALIDATION,
J. He, X. Zhou, X. Tang
|
|
2025 ABS0227
|
DECREASED GPR55 EXPRESSION LINKS B-CELL ACTIVATION AND VASCULAR REMODELLING IN ATHEROSCLEROSIS IN EARLY RHEUMATOID ARTHRITIS PATIENTS,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2025 ABS0230
|
INTEGRATIVE miRNA-mRNA PROFILING UNCOVERS MECHANISMS OF BELIMUMAB ACTION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
C. Solé-Marcé, S. Sandoval Moreno, J. Cortés-Hernández
|
|
2025 ABS0234
|
CIRCULATING LEUKOCYTE SIGNATURES IN TREATMENT-NAIVE NON-RADIOGRAPHIC VERSUS RADIOGRAPHIC AXIAL SPONDYLARTHRITIS IDENTIFIED BY MASS CYTOMETRY,
M. Kyriakidi, E. K. Vetsika, M. G. Tektonidou, P. P. Sfikakis, G. E. Fragoulis
|
|
2025 ABS0240
|
MECHANO-ACTIVATED CHONDROPROGENITORS (MACS) DERIVED FROM ARTICULAR CHONDROCYTES, WHICH DRIVE INTRINSIC CARTILAGE REPAIR,
L. Zhu, H. Muhammad, T. A. Perry, A. Ardasheva, R. A. Symons, J. J. Mcclure, K. Kania, S. M. Clark, F. Colella, L. A. Koneva, S. Khan, S. Eldridge, F. Dell’Accio, S. C. Mastbergen, M. Jansen, F. E. Watt, Y. Itoh, J. Bennett, J. Miotla-Zarebska, M. Attar, C. Chan, A. Roelofs, C. De Bari, S. Sansom, J. Riegger, T. Vincent
|
|
2025 ABS0246
|
DISSECTING PATIENT HETEROGENEITY IN OSTEOARTHRITIS: APPLICATION OF MACHINE-LEARNING APPROACHES TO HIGH-DIMENSIONAL IMMUNE CYTOMIC DATA,
A. Chia, G. Ang, A. Lajam, M. Wasser, E. Petretto, Y. Y. Leung, S. Albani
|
|
2025 ABS0248
|
METHOTREXATE TREATMENT CHANGES GENE EXPRESSION IN CD19+ B-CELLS FROM RHEUMATOID ARTHRITIS PATIENTS,
M. D. Vigeland, F. Heinicke, S. T. Flåm, S. Lillegraven, M. Mjaavatten, S. Syversen, E. Haavardsholm, B. A. Lie
|
|
2025 ABS0252
|
PREVALENCE OF IFN HIGH RHEUMATOID ARTHRITIS IN EARLY AND ESTABLISHED RA PATIENTS,
E. Csomor, A. Jayaraman, L. Stewart, F. Morton, C. Paterson, G. DeBaets, D. Muthas, J. Neisen, M. Collins, R. Sparks, P. Z. Brohawn, C. Chamberlain, A. Najm, A. Platt, I. B. McInnes, C. S. Goodyear
|
|
2025 ABS0257
|
IDENTIFICATION OF KEY OVEREXPRESSED HUB GENES IN DERMATOMYOSITIS-ASSOCIATED CANCERS AS POTENTIAL SCREENING BIOMARKERS,
R. Martinez-Canales, A. Montoya-Rosales, A. Molé, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0261
|
ALTERED TRYPTOPHAN PATHWAY METABOLISM AND ASSOCIATION WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5 POSITIVE DERMATOMYOSITIS,
H. Liu, Y. Guo, X. Dai, J. Zhang, Q. Xie
|
|
2025 ABS0273
|
NEW PATHOGENIC PATHWAYS IN ANKYLOSING SPONDYLITIS IDENTIFIED THROUGH MULTI-ANCESTRY GENOMEWIDE ASSOCIATION STUDY,
Z. Li, N. Harvey, X. Wu, J. Garrido-Mesa, H. Marzo-Ortega, D. McGonagle, A. Morgan, N. Akkoc, B. Nam, H. Yarkan Tugsal, G. Kenar Artin, G. McFarlane, G. T. Jones, P. Leo, K. Zimmerman, E. Duncan, J. Brown, M. Mahmoudi, A. Jamshidi, E. Farhadi, N. Haroon, R. Inman, M. Breban, M. M. Ward, M. H. Weisman, L. S. Gensler, D. Evans, T. Kenna, T. H. Kim, P. B. Wordsworth, J. D. Reveille, H. Xu, M. Brown
|
|
2025 ABS0280
|
UNVEILING SYNERGISTIC DRUG COMBINATIONS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES: INSIGHTS FROM THE DoCTIS CONSORTIUM USING SYSTEMS BIOLOGY APPROACHES,
A. Julià, E. Choy, M. A. López Lasanta, P. Vela Casasempere, A. Fernández Nebro, S. Castañeda, C. Marras, J. Calvo Alén, J. Tornero Molina, J. D. D. Cañete Crespillo, E. Domènech, J. P. Gisbert, J. M. Carrascosa, E. Fonseca, L. Bujanda Fernández de Pierola, V. García Sánchez, B. Siegmund, G. Girolomoni, H. Heyn, L. Jimenez, P. Santamaría, E. Angelats, R. Myers, Y. Guillén, S. H. Martínez-Mateu, S. Marsal
|
|
2025 ABS0299
|
GENETICALLY PROXIED INTERLEUKIN-13 IS ASSOCIATED WITH RISK OF GOUT INDEPENDENT OF URATE,
B. Zuckerman, K. Song, S. S. Zhao
|
|
2025 ABS0367
|
PREDICTING CLINICAL RESPONSE IN PSORIATIC ARTHRITIS THROUGH INTEGRATIVE ANALYSIS OF PROTEOMICS AND TRANSCRIPTOMICS,
M. L. M. Bentvelzen, S. el Bouhaddani, J. Spierings, H. E. Vonkeman, S. C. Mooij, L. G. Schipper, A. Herman, S. C. Mastbergen, P. M. J. Welsing
|
|
2025 ABS0477
|
HYDROXYCHLOROQUINE REDUCES AUTOANTIBBODY LEVELS IN PERSONS AT RISK FOR SYSTEMIC LUPUS ERYTHEMATOSUS,
D. Karp, P. Raj, C. Zhu, D. Liao, D. Liu, N. Olsen
|
|
2025 ABS0573
|
RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN,
V. Venerito, C. Nani, A. Manfredi, M. Fornaro, G. Lopalco, F. Iannone, C. Burattini, M. Sebastiani
|
|
2025 ABS0615
|
MOLECULAR SIGNATURE FOR PREDICTION ANTI-TNF RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS,
L. Santiago Lamelas, P. Castro Santos, E. J. deAndrés Galiana, J. L. Fernández Martínez, R. Dos-Santos Sobrín, R. Díaz Peña
|
|
2025 ABS0844
|
POLYGENIC RISK FOR RHEUMATOID ARTHRITIS AND ITS ASSOCIATION WITH ANCESTRY IN THE CHILEAN POPULATION,
L. Santiago Lamelas, P. Castro Santos, J. Duran, R. A. Verdugo, R. Díaz Peña
|
|
2025 ABS1053
|
URINARY METABOLOMIC PROFILE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS,
M. Lauriola, M. Attanasi, M. C. Cufaro, A. Porreca, V. Girlando, S. La Bella, L. De Angelis, F. Chiarelli, L. Breda
|
|
2025 ABS1088
|
MULTI-OMIC INSIGHT INTO THE BIOLOGICAL CAUSAL RELATIONSHIP BETWEEN MITOCHONDRIAL-RELATED GENES AND RHEUMATOID ARTHRITIS,
L. Hao, H. Q. Niu, J. Luo, C. Wang, X. F. Li
|
|
2025 OP0001
|
COMPARATIVE ANALYSIS OF SYNOVIAL TISSUE TOPOGRAPHY BY SINGLE CELL TRANSCRIPTOMICS AND SPATIAL TRANSCRIPTOMICS REVEALS DISCRETE AND OVERLAPPING DISEASE PATHWAYS DRIVING CHECKPOINT INHIBITOR-INDUCED AND SPONTANEOUS INFLAMMATORY ARTHRITIS,
J. D. Turner, A. K. McLean, A. Thomson, K. Williams, I. Nicorescu, L. Jones, G. Merces, A. Teodosio, B. Hunter, J. McMurray, S. Gilbert, A. Degnan, D. Scheel-Toellner, S. Jariwala, Q. An, R. Plummer, A. P. Croft, L. Pallan, B. A. Fisher, J. Coxhead, R. Hussain, M. Magid-Slav, D. McDonald, S. Siebert, A. Filby, G. Reynolds, A. E. Anderson, C. Hilkens, D. F. Tough, A. Filer, A. Pratt
|
|
2025 OP0009
|
SPATIAL TRANSCRIPTOMIC-BASED PHENOTYPING OF THE FIBROBLAST NICHES IN SYSTEMIC SCLEROSIS-ASSOCIATED PRIMARY HEART INVOLVEMENT,
A. Micu, A. E. Matei, Y. N. Li, A. C. Pecher, T. Filla, J. Henes, M. Eckstein, K. Klingel, J. Distler, A. H. Györfi
|
|
2025 OP0010
|
MAPPING SPATIALLY-RESOLVED TRANSCRIPTOMES IN SYSTEMIC SCLEROSIS,
M. Liang, Z. Li, A. Rius Rigau, W. Xie, Y. N. Li, A. E. Matei, H. Zou, R. He, J. Distler
|
|
2025 OP0012
|
SomaScan proteomic analysis of the skin across the Systemic Sclerosis (SSc) disease continuum reveals a distinct very early-specific profile vs a fibrotic profile,
O. Teenan, R. Ross, I. Steer, V. Kakkar, B. Almquist, C. Higgins, F. Del Galdo
|
|
2025 OP0013
|
Metabolic phenotyping of systemic sclerosis skin by spatial proteomics,
V. Devakumar, Y. N. Li, T. Filla, A. Rius Rigau, A. H. Györfi, B. S. Tuemerdem, R. Neelagar, C. Bergmann, M. Liang, G. Schett, J. Distler, A. E. Matei
|
|
2025 OP0014
|
CD4+ TRAIL+ T Cells with Interferon-Stimulated Gene signature Differentially Restrict Anti-Nuclear Antigen Responses in M. Sjögren and Systemic Sclerosis,
T. I. Papadimitriou, P. Singh, A van Caam, M. Vonk, I. J. M. de Vries, P van der Kraan, R. Smeets, M. Koenders, E. Aarntzen, H. Koenen, M. Huijnen, R. M. Thurlings
|
|
2025 OP0018
|
Characterizing ANCA-specific B cells in ANCA-associated Vasculitis Patients,
L. van Dam, M. Zhang, S. Parsafar, A. Horomanski, S. Rasouli, B. Levin, O. Sharpe, J. R van Leeuwen, T. Lanz, C van Kooten, Y. K. O. Teng, W. Robinson
|
|
2025 OP0080
|
Interrogating type I interferon signatures at multiple signalling levels in childhood-onset SLE reveals novel heterogeneity and associated disease endotypes,
H. Cross, J. Peng, T. McDonnell, E. Jury, C. Ciurtin, G. Robinson
|
|
2025 OP0133
|
COMPREHENSIVE ANALYSIS UNVEILS POTENTIAL MECHANISMS OF MMP9 AND RNASET2 IN RHEUMATOID ARTHRITIS THROUGH GENOME-WIDE ASSOCIATION STUDIES, MENDELIAN RANDOMIZATION, AND SINGLE-CELL TRANSCRIPTOMIC,
X. Liu, X. Gu, C. Wang
|
|
2025 OP0137
|
IMMUNE INFILTRATE PROFILING IN B CELL-ENRICHED AUTOIMMUNE MYOPATHIES,
B. Ramanathan, H. C. Shen, Z. Gerber, C. del Carmen Crespo, J. Karamchandani, E. O’Ferrall, Y. Troyanov, O. Landon-Cardinal, J. Bourré-Tessier, M. Hudson, V. Leclair, M. Labrie, H. Allard-Chamard
|
|
2025 OP0141
|
FIBROBLAST-DRIVEN Ttek ACTIVATION MAY DRIVE ACINAR CELL DYSFUNCTION IN SJÖGREN’S DISEASE, PRIOR TO LYMPHOCYTIC INFILTRATION,
T. Yang, R. Wilbrink, J. H. Terpstra, S. C. Liefers, A. Vissink, F. K. L. Spijkervet, H. Bootsma, F. G. M. Kroese, S. Pringle
|
|
2025 OP0146
|
UNVEILING BIOLOGICAL PATHWAYS IN SJOGREN’S DISEASE CLUSTERS: ADVANCING PROGNOSTIC PRECISION,
S. E Silva-Saffar, Y. Nguyen, R. Seror, J. E. Gottenberg, X. Mariette, A. Niarakis, G. Nocturne
|
|
2025 OP0151
|
UPREGULATION OF TYPE 1 INTERFERON STIMULATED GENES IN CIRCULATING INNATE IMMUNE CELLS PRECEDES THE ONSET OF SUBCLINICAL SYNOVITIS IN ANTI-CCP+ AT-RISK INDIVIDUALS WHO IMMINENTLY PROGRESS TO RHEUMATOID ARTHRITIS.,
F. Tariq, W. Ye, P. Martin, X. Sun, S. MacKay, D. Muldoon, L. Duquenne, A. Di Matteo, K. Harnden, K. Mbara, M. Menon, M. Buch, B. Fairfax, D. Newton, P. Emery, K. Mankia
|
|
2025 OP0155
|
RA RISK GENES ARE DIFFERENTIALLY EXPRESSED BETWEEN (PEAC) PATHOTYPES IN SYNOVIUM WITH A CLEAR ENRICHMENT IN THE LYMPHOID-RICH PATHOTYPE,
I. C. den Hond, M. J. T. Reinders, M. Lewis, C. Pitzalis, R. Knevel, E. B. van den Akker
|
|
2025 OP0205
|
SPATIAL OMICS ANALYSIS REVEALS DISTINCT INFLAMMATORY PATHWAYS AND CELLULAR INTERACTIONS IN KIDNEY BIOPSIES FROM LUPUS NEPHRITIS RESPONDERS AND NON-RESPONDERS,
S. Sandoval Moreno, C. Solé-Marcé, M. Passols, I. Agraz Pamplona, M. A. Gabaldón, J. Cortés-Hernández
|
|
2025 OP0230
|
SYNOVIAL FIBROBLASTS, MACROPHAGES AND DENDRITIC CELLS FORM AN INFLAMMATORY NICHE IN RHEUMATOID ARTHRITIS, BUT NOT IN PSORIATIC ARTHRITIS SYNOVIUM,
A. Khmelevskaya, M. Houtman, K. Buerki, C. Pauli, O. Distler, A. Ciurea, A. Ramming, U. Fearon, C. Ospelt, R. Micheroli
|
|
2025 OP0237
|
INTEGRATIVE METABOLOMIC AND INFLAMMATORY PROFILING IN RHEUMATOID ARTHRITIS: DISEASE ACTIVITY, THERAPEUTIC MODULATION, AND UNDERLYING HEPATIC MECHANISMS,
L. Muñoz-Barrera, C. Perez-Sanchez, R. Ortega-Castro, S. Corrales-Díaz Flores, T. Cerdó, I. Sanchez-Pareja, F. U. Pilar, J. Calvo-Gutiérrez, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Seguí Azpilcueta, C. Merlo-Ruiz, J. J. Pérez Venegas, D. Ruiz-Montesino, C. M. Romero-Barco, A. Fernández-Nebro, N. Mena-Vázquez, F. J. Godoy Navarrete, A. M. Cabezas Lucena, M. Á. Aguirre-Zamorano, N. Barbarroja, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2025 OP0243
|
SINGLE-CELL RNA SEQUENCING OF ACPA-ENRICHED B CELLS REVEALED A CD11c+ ATYPICAL B CELL GENE SIGNATURE IN RHEUMATOID ARTHRITIS,
Y. Nagafuchi, L. Slot, D. Simaite, A. M. Bakker, T. Andreani, E. B. van den Akker, T. Huizinga, C. Struebing, R. E. M. Toes, H. U. Scherer
|
|
2025 OP0244
|
INTEGRATIVE MULTI-OMICS PHENOTYPING IN BLOOD REVEALS DISTINCT IMMUNE AND METABOLIC SIGNATURES BETWEEN ACPA-NEGATIVE AND ACPA-POSITIVE RHEUMATOID ARTHRITIS,
J. Sung, B. Hur, V. Gupta, M. Oh, H. Zeng, C. S. Crowson, K. J. Warrington, E. Myasoedova, V. L. Kronzer, J. M.III Davis
|
|
2025 OP0245
|
C3a-C3aR1-MEDIATED INTERACTIONS BETWEEN FIBROBLAST-LIKE SYNOVIOCYTES AND MACROPHAGES PROMOTE THE PROGRESSION OF RHEUMATOID ARTHRITIS,
M. Cai, Z. Chen
|
|
2025 OP0246
|
SYNOVIAL TISSUE ENRICHMENT OF OXYLIPINS AND THEIR MEDIATORS PROVIDES INSIGHT INTO REMISSION MAINTENANCE IN RHEUMATOID ARTHRITIS,
S. Perniola, J. Murillo-Saich, D. Somma, C. Di Mario, B. Tolusso, D. Campobasso, M. Gessi, L. Petricca, M. R. Gigante, V. A. Pacucci, D. Bruno, M. M. Lizzio, E. Gremese, M. A. D’Agostino, M. Kurowska-Stolarska, M. Guma, S. Alivernini
|
|
2025 OP0247
|
SINGLE CELL IMMUNOPROFILE OF SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS WITH TNF-α/JAK INHIBITOR TREATMENT,
C. He, X. Xia, Z. Xue, G. Yin, H. Xu, Q. Xie
|
|
2025 OP0248
|
CELLULAR AND MOLECULAR DECONSTRUCTION OF (TENO)SYNOVIAL TISSUE ACROSS DIFFERENT RHEUMATOID ARTHRITIS PHASES AND COMPARISON WITH ADJACENT SYNOVIUM,
L. A. Coletto, D. Somma, C. Di Mario, D. Campobasso, B. Tolusso, P. Rizzuti, D. Bruno, C. Tur, P. Rubortone, B. Fresch, T. Hubert, N. Goulas, L. Petricca, M. R. Gigante, V. A. Pacucci, S. Perniola, A. Elmesmari, L. MacDonald, R. Benvenuto, M. Gessi, E. Gremese, M. A. D’ Agostino, M. M. Lizzio, M. Kurowska-Stolarska, S. Alivernini
|
|
2025 OP0251
|
A CUTTING-EDGE THREE-DIMENSIONAL STROMAL-IMMUNE MICROENVIRONMENT EMULATES INTERACTIONS BETWEEN SYNOVIAL FIBROBLASTS AND MACROPHAGES IN INFLAMMATORY ARTHROPATHIES,
A. Tiaden, S. Haener-Massimi, U. A. Walker, D. Kyburz, S. Giaglis
|
|
2025 OP0252
|
A MULTIMODAL DISSECTION OF SPATIAL TISSUE NICHES ASSOCIATED WITH SEVERITY IN CHILDHOOD ARTHRITIS,
C. Bolton, C. Mahony, E. Clay, P. I. Reis Nisa, S. Lomholt, A. Hackland, P. S. Chin, C. Smith, V. Alexiou, H. Nguyen, M. Thyagarajan, Z. Sheikh, P. Davis, S. Chippington, S. Davda, S. Compeyrot-Lacassagne, C. Foley, I. Tursevich, B. Ingledow, K. Kupiec, M. Hanlon, E. DiCarlo, S. Smith, S. Eyre, S. Kemble, G. Neag, R. Madhu, M. G. Palshikar, I. Korsunsky, G. Ce, M. Tran, C. Dendrou, C. D. Buckley, M. Coles, K. Raza, E. Gravallese, A. Filer, E. Al-Abadi, K. Wei, E. Rosser, L. Wedderburn, A. P. Croft
|
|
2025 OP0253
|
COMMON AND RARE VARIANT CONTRIBUTIONS TO FAMILIAL AGGREGATION IN SPONDYLOARTHRITIS,
F. Costantino, R. SAID, H. Mambu-Mambueni, A. Boland, J. F. Deleuze, M. Brown, H. J. Garchon, M. Breban
|
|
2025 OP0257
|
SINGLE-CELL TRANSCRIPTOMICS AND DEEP IMMUNOPHENOTYPING REVEAL MEMORY CD8+ T CELL ACTIVATING IN ANKYLOSING SPONDYLITIS,
H. Zhu, X. Ma, J. Wang, J. Liu
|
|
2025 OP0258
|
AUTOIMMUNE REACTIVE SYNOVIUM CD4+HLADR+ T EFFECTORS WITH REGULATORY RESISTANCE AND INFLAMMATORY POTENTIAL IN HUMAN ARTHRITIS,
J. Y. Leong, P. Kumar, S. H. Tay, G. Mijnheer, A. J. M. Lim, S. Hazirah, J. G. Yeo, C. Chua, P. Chen, A. Consolaro, M. Gattorno, T. Arkachaisri, F. van Wijk, A. Martini, S. Albani
|
|
2025 OP0259
|
METABOLOMIC AND MACHINE LEARNING ENHANCES PATIENT DIAGNOSIS AND STRATIFICATION IN SYSTEMIC AUTOIMMUNE DISEASES,
C. Perez-Sanchez, A. Perez-Campoamor, G. D. García-Delgado, B. Vellón-García, A. Llamas-Urbano, P. Ortiz-Buitrago, C. Merlo, M. D. C. Abalos-Aguilera, N. Barbarroja, V. Bolón-Canedo, M. Á. Aguirre-Zamorano, R. Ortega-Castro, J. Calvo-Gutiérrez, M. L. Ladehesa-Pineda, M. Alarcon-Riquelme, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2025 OP0260
|
DoCTIS: A SINGLE CELL RNA-Seq ATLAS OF DRUG RESPONSE TO TARGETED THERAPIES,
A. Julià, Y. Guillén, J. A. Patiño Galindo, S. H. Martínez-Mateu, P. Vela Casasempere, A. Fernández Nebro, C. Marras, S. Castañeda, J. Calvo Alén, J. Tornero Molina, J. D. D. Cañete Crespillo, E. Domènech, J. P. Gisbert, J. M. Carrascosa, E. Fonseca, L. Bujanda Fernández de Pierola, V. García Sánchez, B. Siegmund, G. Girolomoni, H. Heyn, L. Jimenez, P. Santamaría, E. Angelats, R. Myers, E. Choy, S. Marsal
|
|
2025 OP0261
|
SINGLE-CELL ANALYSIS IN PREGNANT WOMEN WITH SLE: IMMUNOLOGICAL FEATURES ASSOCIATED WITH ADVERSE PREGNANCY OUTCOMES,
K. Terada, Y. Tsuchida, S. Nakajima, S. Isojima, T. Isozaki, Y. Hiramatsu, H. Nakajima, S. Morimoto, T. Mimura, N. Tamura, K. Amano, Y. Kirino, S. Ohno, I. Matsumoto, S. Yasuda, Y. Kaneko, M. HARIGAI, S. Kaname, K. Itoh, H. Kameda, K. Kaneko, T. Okamura, Y. Okada, A. Murashima, K. Fujio, N. Yajima
|
|
2025 OP0262
|
INTEGRATED MULTI-OMICS ANALYSIS REVEALING SUBTYPE-SPECIFIC PATHOGENIC MECHANISMS IN IDIOPATHIC INFLAMMATORY MYOPATHIES,
S. Xie, Y. xiao, H. Luo, H. Zhu
|
|
2025 OP0263
|
DEEP IMMUNOPHENOTYPING IN PATIENTS WITH JUVENILE LOCALIZED SCLERODERMA REVEALS TWO DISTINCT IMMUNOLOGICAL ENDOPHENOTYPE,
E. Marasco, A. Aquilani, I. Caiello, F. De Benedetti, R. Nicolai
|
|
2025 OP0264
|
SPATIAL IMMUNE DIVERSITY IN LUPUS NEPHRITIS ACROSS KIDNEY ARCHITECTURE AND HISTOLOGICAL CLASSES,
E. Bettacchioli, C. Le Dantec, A. Meudec, A. Bourhis, P. Hémon, M. Le Rochais, A. A R, M. Frutoso, A. Uguen, C. Hanrotel Saliou, S. Jousse-Joulin, N. JOURDE-CHICHE, D. Cornec, S. Hillion
|
|
2025 OP0265
|
PROTEOMIC ANALYSIS IDENTIFIES NOVEL BIOMARKERS FOR THE DEVELOPMENT OF CLINICAL AUTOIMMUNITY IN ANA-POSITIVE AT-RISK INDIVIDUALS,
P. Intapiboon, L. M. Carter, J. Arnold, M. Y. Md Yusof, E. M. Vital
|
|
2025 OP0266
|
PROTEOMIC COMPARISON OF MECHANISM OF ACTION OF BIOLOGIC THERAPIES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
P. Intapiboon, L. M. Carter, J. Arnold, K. Mahmoud, M. Y. Md Yusof, E. M. Vital
|
|
2025 OP0267
|
SINGLE-CELL TRANSCRIPTOMICS OF B CELLS TOWARDS THE UNDERSTANDING OF THE MECHANISMS LEADING TO THE PRODUCTION OF ANTIPHOSPHOLIPID ANTIBODIES IN THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME,
P. Gaspar, D. Holdych, M. M. Santos, F. Ribeiro, B. Filipe, R. Vieira, A. R. Cruz-Machado, V. R. Fonseca, V. C Romão, A. R. Maceiras, L. Graca
|
|
2025 OP0268
|
EPIGENETIC MARKS OF DIFFERENT aPL-TRIGGERED SIGNALLING IN OBSTETRIC AND THROMBOTIC ANTIPHOSPHOLIPID SYNDROME,
F. Miró-Mur, A. Anunciacion-Llunell, J. Marques-Soares, M. Ockova, C. Andrada, E. Esteve-Valverde, J. Pardos-Gea, J. Alijotas-Reig
|
|
2025 OP0283
|
NOVEL DISEASE ACTIVITY INDEX FOR ADULT STILL’S DISEASE USING MACHINE LEARNING WITH THREE PROTEINS: UTILITY UNDER IL-6 SIGNAL INHIBITION,
M. Magi, H. Yoshida, H. Tamai, K. Matsumoto, K. Yoshimoto, M. Akiyama, Y. Kondo, J. Kikuchi, Y. Matsumoto, T. Soeda, Y. Kaneko
|
|
2025 OP0336
|
MODULATION OF GENETIC MARKERS OF FIBROSIS AND SKIN SCORE IN PATIENTS WITH SYSTEMIC SCLEROSIS FOLLOWING ADMINISTRATION OF TADALAFIL,
L. Minikumari Rahulan, S. Ahmed, M. K. RAI, V. Agarwal
|
|
2025 OP0349
|
Pathological mechanisms in fibromyalgia and hypermobility; a novel human model using an inflammatory challenge: insights from transcriptomics,
J. Eccles, J. Porter, M. Amato, K. Themelis, H. Critchley, S. Newbury, N. Harrison, B. Towler, K. Davies
|
|
2025 OP0368
|
METTL3 Modulates SPP1+ Macrophage Activation via MafB in pulmonary fibrosis,
R. Liang, X. Chen, S. C
|
|
2025 OP0371
|
Transcriptomic analysis of transgender adolescents undergoing gender-affirming sex hormone therapy reveals sex-specific mechanisms associated with female childhood-onset SLE,
H. Cross, H. Peckham, G. Butler, E. Rosser, E. Jury, G. Robinson, C. Ciurtin
|
|
2025 OP0377
|
Acid Reflux Triggers Type I Interferon and epithelial-mesenchymal transition in Esophageal Epithelial Cells, in vitro. A new potential microenvironment contribution to the pathogenesis of Systemic Sclerosis,
S. Zahed Mohajerani, A. Altaie, M. Minerba, C. Black, L. A. Bissell, M. Hinchcliff, J. Ladbury, R. Ross, F. Del Galdo
|
|
2025 POS0045
|
DECADES-LONG ELEVATION OF INTERFERON-A DRIVES SJÖGREN DISEASE,
D. Forbes, I. Jorgacevic, J. Tarn, K. Reid, B. Rioux, K. Thompson, K. Kleeman, J. Casement, J. Berry, P. Müller, H. Eberle-Reece, C. Haase, B. Conn, K. McDade, W. Whiteley, A. Roers, W. F. Ng, R. Behrendt, D. Hunt
|
|
2025 POS0049
|
PROTEOME ANALYSIS OF MINOR SALIVARY GLANDS REVEALS SUBGROUPS OF PATIENTS WITH DISTINCT CLINICAL PHENOTYPES IN SJÖGREN’S DISEASE,
N. Štucin, K. P. Pirkmajer, A. Hočevar, S. A. Krättli, D. M. Ferreira Francisco, B. Maurer, R. Bruggmann, P. Zigon, S. Čučnik, K. Klein
|
|
2025 POS0065
|
AN IMMUNE-MOLECULAR SIGNATURE MODULATED BY JAK INHIBITORS EX VIVO PREDICTS IN VIVO THERAPY RESPONSE AND EXHIBITS SPECIFICITY COMPARED TO ANTI-TNF TREATMENTS IN RHEUMATOID ARTHRITIS,
S. Corrales-Díaz Flores, C. Perez-Sanchez, L. Muñoz-Barrera, R. Ortega-Castro, E. Moreno-Caño, J. Calvo-Gutiérrez, C. Aranda-Valera, M. L. Ladehesa-Pineda, F. U. Pilar, I. Sanchez-Pareja, L. Formanti Alonso, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, C. Merlo, M. Á. Aguirre-Zamorano, T. Cerdó, N. Barbarroja, M. Alarcon-Riquelme, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2025 POS0066
|
METABOLIC ALTERATIONS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM METABOLOMICS ANALYSIS IN JOINT FIBROBLASTS AND SERUM,
G. K. Vasileiadis, Y. Zhang, M. Laudette, T. Fatima, A. K. H. Ekwall, R. Sureshkumar, R. F. van Vollenhoven, J. Lampa, B. Gudbjornsson, E. A. Haavardsholm, D. Nordström, G. Grondal, K. Hørslev-Petersen, K. Lend, M. Lund Hetland, M. Nurmohamed, M. Østergaard, T. Uhlig, T. Sokka-Isler, A. Rudin, J. Borén, M. Guma, C. Maglio
|
|
2025 POS0069
|
SYNOVIAL IMMUNE CELLS EXHIBIT A TYPE I IFN GENE SIGNATURE IN ACPA-NEGATIVE RHEUMATOID ARTHRITIS,
A. Argyriou, M. H.II Wadsworth, C. Krishna, C. Gerstner, B. Horuluoglu, M. Sijbranda, L. Ronnblom, M. L. Eloranta, M. Wahren-Herlenius, A. Hensvold, A. Winkler, V. Malmström, K. Chemin
|
|
2025 POS0074
|
TRANSCRIPTOMIC PROFILING OF KIDNEY BIOPSIES IMPLICATES Th17 AND IL-17 IN ANCA-ASSOCIATED GLOMERULONEPHRITIS,
I. Stojkic, A. Arazi, H. Song, P. Yan, E. Puchulu-Campanella, H. Wang, L. Fussner, B. H. Rovin, S. Parikh, S. Ardoin, D. Koboldt, S. Almaani
|
|
2025 POS0076
|
CROSS-TRAIT META-ANALYSIS REVEALS A GENETIC LINK BETWEEN INFLAMMATION AND AGING IN GIANT CELL ARTERITIS,
L. Martínez Gutiérrez, I. Rodriguez-Martin, G. Borrego-Yaniz, M. Kerick, C. Salvarani, J. Hernández-Rodríguez, M. C. Cid, M. Á. González-Gay, A. Morgan, J. Martin, L. Ortiz-Fernández, A. Márquez
|
|
2025 POS0077
|
THE ROLE OF MACROPHAGE PYROPTOSIS AND INFLAMMATORY AMPLIFICATION IN TAKAYASU ARTERITIS,
Z. Yaxin, T. Li, L. Pan
|
|
2025 POS0078
|
SPATIAL TRANSCRIPTOMICS REVEALS B CELL–DOMINATED MEDIAL INFLAMMATION AS A SPECIFIC FEATURE OF LARGE VESSEL GIANT CELL ARTERITIS,
C. Ansalone, M. Karabayas, J. Cole, E. Qian, I. Gupta, D. Vossou, S. McAllister, Y. Doncheva, S. Wright, N. Jamieson, C. S. Goodyear, N. Basu
|
|
2025 POS0079
|
SPATIAL TRANSCRIPTOMICS REVEAL THE ROLE OF MMP12 IN THE PATHOGENESIS OF GIANT CELL ARTERITIS,
S. Onishi, H. Yoshida, M. Magi, C. Kato, K. Matsumoto, K. Suzuki, M. Takeshita, J. Kuramoto, M. Yazawa, T. Kato, S. Yamada, E. Sasaki, K. Hanaoka, M. Akiyama, Y. Kondo, J. Kikuchi, Y. Kaneko
|
|
2025 POS0082
|
EXPLORING THE GENETIC BASIS OF CLINICAL HETEROGENEITY IN GIANT CELL ARTERITIS,
G. Borrego-Yaniz, V. Fuentes-Moreno, J. Hernández-Rodríguez, A. Vaglio, S. Castañeda, R. Solans-Laqué, N. Khalidi, C. Langford, S. R. Ytterberg, L. Beretta, M. Govoni, G. Emmi, M. A. Cimmino, T. Witte, T. Neumann, J. Holle, V. Schönau, G. Pugnet, [. Papo], J. Haroche, A. Mahr, L. Mouthon, Ø. Molberg, A. Diamantopoulos, A. Voskuyl, T. Daikeler, C. Berger, E. Molloy, D. Blockmans, Y. van Sleen, S. GCA Group, U. G. Consortium, V. C. Research Consortium, N. Ortego-Centeno, E. Brouwer, P. Lamprecht, S. Klapa, C. Salvarani, P. Merkel, M. C. Cid, M. Á. González-Gay, A. Morgan, J. Martin, A. Márquez
|
|
2025 POS0103
|
IMPACT OF DEUCRAVACITINIB TREATMENT ON CARDIOVASCULAR RISK–ASSOCIATED SCORES AND BIOMARKERS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 2 TRIAL,
C. Charles-Schoeman, B. Weber, L. Gao, P. J. Mease, J. S. Smolen, S. Li, C. Wu, E. Vritzali, P. Schafer, J. Liu
|
|
2025 POS0179
|
CHARACTERIZATION OF MEMORY T CELL SUBSETS DURING FLARES AND DISEASE QUIESCENCE IN LUPUS,
C. Nassar, R. Quevedo, M. Ciudad, K. Manion, C. Munoz-Grajales, M. Kim, D. Gladman, Z. Touma, T. McGaha, J. Wither
|
|
2025 POS0211
|
FIBROMYALGIA FOLLOW-UP BY FECAL AND PLASMA BIOMARKERS: A LOW-INTERVENTIONAL CLINICAL TRIAL,
E. Durán-González, J. A. Ramírez-Tejero, A. Martínez Lara, D. Cotán
|
|
2025 POS0232
|
TRANSCRIPTOMIC PROFILING OF PSORIATIC ARTHRITIS RESPONSE TO SECUKINUMAB,
N. A. Abdul Jalil, A. Barton, H. Chinoy, M. Jani, N. Nair, P. Martin, J. Bluett
|
|
2025 POS0233
|
TRANSLATIONAL REMODELLING AND AMIDE METABOLIC DYSREGULATION DIFFERENTIATE MTX RESPONDERS AND NONRESPONDERS IN PSORIATIC ARTHRITIS – A SINGLE CELL PERSPECTIVE,
M. Blom Petersen, O. Møberg, M. Randahl Nielsen, W. Zheng, A. Duvetorp, J. Gerwien, L. E. Jessen, L. E. Kristensen, M. Skougaard
|
|
2025 POS0235
|
MULTI-OMICS ANALYSIS REVEALS CELLULAR AND MOLECULAR MAP LINKED TO PHARMACOLOGICAL EFFECTS AND THERAPEUTIC EFFICACY OF IL-17A INHIBITOR IN ANKYLOSING SPONDYLITIS,
J. Xie, Y. Yu, X. Ma, X. Mou, D. Zhuo, S. Liu, Y. Shen, Y. Tang, Q. Zhu, J. Wang, J. Liu
|
|
2025 POS0237
|
CD177+ NEUTROPHILS PROMOTE ENDOTHELIAL SENESCENCE THROUGH EXTRACELLULAR TRAPS IN BEHÇET’S DISEASE,
X. Wang, X. Yu, M. Zhang, Y. Liu, H. Chen, W. Zheng
|
|
2025 POS0241
|
THE SYNOVIAL CYTOKINE MILIEU SHAPES FIBROBLAST-LIKE SYNOVIOCYTE-IMMUNE CELL INTERACTION DRIVING IMMUNE CELL ACTIVATION AND SYNOVIAL PATHOTYPE DEVELOPMENT IN RHEUMATOID ARTHRITIS,
M. Dellinger, A. Tosevska, F. Kartnig, T. Preglej, M. Brinkmann, B. Luckerbauer, L. Emilius, F. S. Iaquinta, F. Abatecola, E. Pontarini, L. Fossati-Jimack, F. Rivellese, C. Pitzalis, L. Heinz, G. Steiner, D. Aletaha, T. Karonitsch, M. Bonelli
|
|
2025 POS0245
|
IMMUNE RESPONSE OF AIRWAY EPITHELIUM TO SIMULATED VIRAL INFECTION IN IDIOPATHIC INFLAMMATORY MYOPATHIES,
A. Opinc-Rosiak, J. Sarnik, A. Heider, A. Lewandowska-Polak, U. Radzikowska, O. Brzezińska, M. Sokołowska, J. Makowska
|
|
2025 POS0246
|
SINGLE-CELL RNA SEQUENCING IDENTIFIES A PROMINENT PRO-INFLAMMATORY GENE SIGNATURE IN FIBROBLASTS OF VERY EARLY SYSTEMIC SCLEROSIS,
L. Li, E. Pachera, R. Dobrota, S. Muraru, K. Buerki, C. Mihai, M. Elhai, L. Much, A. Hofman, P. Bearzi, A. M. Hoffmann-Vold, O. Distler
|
|
2025 POS0248
|
SYSTEMIC SCLEROSIS SYNOVITIS IS LESS INVASIVE AND INFLAMMATORY THAN RHEUMATOID ARTHRITIS,
C. Geiss, M. Houtman, R. Micheroli, C. Calvo Cebrian, A. Khmelevskaya, K. Buerki, O. Distler, C. Ospelt, M. Elhai
|
|
2025 POS0249
|
SPATIAL PROTEOMIC-BASED PHENOTYPING OF FIBROBLAST SUBPOPULATIONS AND THEIR MICROENVIRONMENT IN SYSTEMIC SCLEROSIS PRIMARY HEART INVOLVEMENT,
A. Stütz, G. De Luca, A. E. Matei, Y. N. Li, V. Batani, T. Filla, A. Rius Rigau, B. S. Tuemerdem, D. C. Bruni, M. Eckstein, G. Schett, C. Basso, J. Distler, M. Matucci-Cerinic, A. H. Györfi
|
|
2025 POS0252
|
IDENTIFICATION OF FIBROBLAST POPULATIONS AND THEIR PATHOGENIC NICHES IN SYSTEMIC SCLEROSIS BY IMAGING-BASED SPATIAL TRANSCRIPTOMICS,
Y. N. Li, T. Filla, A. H. Györfi, M. Liang, V. Devakumar, A. Micu, H. Chai, C. Bergmann, A. C. Pecher, J. Henes, P. Moinzadeh, S. Al-Gburi, T. Krieg, A. Kreuter, J. Wang, G. Schett, B. Homey, S. Dietrich, J. Distler, A. E. Matei
|
|
2025 POS0253
|
DIFFERENCES IN THE EFFECT OF C4A and C4B COPY NUMBERS ON SSc SEROLOGICAL AND CLINICAL SUBTYPES,
J. Martinez-Lopez, C. Rangel-Peláez, I. Rodriguez-Martin, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, O. Distler, I. S Sc Group, S. M. Proudman, M. Nikpour A. Scleroderma Interest Group (ASIG), N. Hunzelmann, G. Moroncini, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, L. Beretta, S. Assassi, C. P. Denton, M. D. Mayes, M. Acosta-Herrera, J. Martin, M. Kerick
|
|
2025 POS0317
|
THE IMMUNE MAP OF LUPUS NEPHRITIS: A SPATIALLY-RESOLVED KIDNEY PROTEOMIC APPROACH,
C. Y. Lee, M. C. Marlin, X. Yang, V. Morkotinis, A. I. Celia, J. Buyon, R. A. Furie, D. L Kamen, J. Hodgin, C. Putterman, J. Barnas, K. C. Kalunian, P. Izmirly, B. Diamond, A. Davidson T. Accelerating Medicines Partnership in RA/SLE, J. A. James, M. Petri, J. M. Guthridge, A. Rosenberg, A. Fava
|
|
2025 POS0322
|
INVESTIGATING THE IMPACT OF DEUCRAVACITINIB TREATMENT ON CARDIOVASCULAR RISK-ASSOCIATED BIOMARKERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE PHASE 2 PAISLEY STUDY,
B. Weber, C. Charles-Schoeman, L. Gao, E. Morand, J. M. Kahlenberg, M. Garshick, J. Zrubek, I. Catlett, P. Schafer, X. Chen, C. Wu, J. Liu
|
|
2025 POS0323
|
VALIDATION AND CHARACTERIZATION OF SIX DISTINCT SLE MOLECULAR SUBTYPES USING TWO LARGE PATIENT COHORTS AND MULTI-OMICS PLATFORMS,
L. Seridi, E. Myshkin, E. Noss, D. Waterworth, M. J. Loza, S. Gao
|
|
2025 POS0632
|
ARE GENES IN T-REGULATORY CELLS ARE DIFFERENTIALLY FOLLOWING TREATMENT WITH ALLOGENEIC MESENCHYMAL STEM CELLS IN EARLY RA,
M. Breitman, C. Cameron, T. Bonfield, J. Reese, E. Barnboym, M. Haghiac, S. Lewis, H. Lazarus, N. Hussein, D. Anthony, M. Cameron, B. Richardson, N. Singer
|
|
2025 POS0690
|
IDENTIFICATION OF DISTINCT PHENOTYPES IN SYSTEMIC SCLEROSIS THROUGH CLUSTERING ALGORITHM AND PROTEOMIC ANALYSIS: DATA FROM THE PRECISESADS STUDY,
S. Dans-Caballero, C. López-Medina, C. Lopez-Pedrera, C. Perez-Sanchez, A. Escudero-Contreras, R. Ortega-Castro
|
|
2025 POS0694
|
DISSECTING THE GENETIC AND FUNCTIONAL ASSOCIATION OF CARD9 WITH AXIAL SPONDYLOARTHRITIS,
F. Costantino, E. Frison, A. C. Brown, C. Cohen, M. Jacoutot, G. Migliorini, R. SAID, G. Scozzafava, P. Bowness, P. B. Wordsworth, H. J. Garchon, S. Glatigny, M. Breban, J. C. Knight
|
|
2025 POS0696
|
REVEALING A DISTINCT INTERFERON-RESPONSE CLUSTER IN SSc BLOOD MONOCYTES,
P. Bearzi, E. Pachera, A. Hofman, L. Li, L. Much, K. Buerki, A. M. Hoffmann-Vold, M. O. Becker, R. Giacomelli, O. Distler
|
|
2025 POS0713
|
PERIPHERAL BLOOD MONONUCLEAR CELL TRANSCRIPTOMICS AND PLASMA METABOLOMICS REVEAL THE ROLE OF NEUROINFLAMMATION AND NEUROPLASTICITY IN THE BACKGROUND OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS,
L. Gunkl-Tóth, A. Pintér, G. Sütő, G. Kumánovics, J. Kun, P. Urbán, K. Takács-Lovász, R. Farkas, G. Karvaly, G. Nagy, Z. Helyes
|
|
2025 POS0716
|
DYSREGULATED LIPID AND METABOLIC PATHWAYS MAY CONTRIBUTE TO UNDERLYING DISEASE MECHANISMS IN PATIENTS WITH HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,
A. Oppong, G. Robinson, A. Holloway, R. Wilson, T. McDonnell, B. Carpenter, E. Jury, J. Manson
|
|
2025 POS0718
|
SINGLE-CELL RNA SEQUENCING HIGHLIGHTS THE ROLE OF INNATE IMMUNITY IN IDENTIFYING CANDIDATES FOR EARLY BIOLOGICS TREATMENT IN AXIAL SPONDYLOARTHRITIS,
S. Lee, A. H. Cho, Y. J. Kim, S. Kang, H. Kim, H. S. Cha, H. H. Won, J. Lee
|
|
2025 POS0725
|
EXPLORING THE MOLECULAR LINK BETWEEN SYSTEMIC INFLAMMATION, STRUCTURAL DAMAGE, AND BONE METABOLISM DYSREGULATION IN AXIAL SPONDYLOARTHRITIS,
I. Arias-de la Rosa, L. Cuesta-López, E. Martin-Salazar, M. L. Ladehesa-Pineda, M. Ruiz-Ponce, A. M. Barranco, M. Á. Puche-Larrubia, C. Perez-Sanchez, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, N. Barbarroja
|
|
2025 POS0732
|
INTEGRATED DNA METHYLOME AND TRANSCRIPTOME ANALYSIS REVEALS NOVEL PATHWAYS AND CELL TYPES IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE,
M. Cerván-Martín, F. Pegoraro, J. Martinez-Lopez, I. Rodriguez-Martin, A. Márquez, L. Ortiz-Fernández, M. Acosta-Herrera, M. Kerick, E. Andrés-León, J. Haroche, A. Vaglio, J. Martin
|
|
2025 POS0790
|
ALTERATIONS AND CLINICAL SIGNIFICANCE OF PHOSPHOLIPID-DERIVED POLYUNSATURATED FATTY ACIDS LIPIDOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
Y. J. Ha, P. Dave, D. Dikeman, Z. Wang, J. Y. Pyo, E. H. Kang, Y. J. Lee, W. Stohl, S. G. Louie
|
|
2025 POS0797
|
UNIQUE IMMUNOLOGICAL CELL PROFILES AND KEY PATHWAYS ASSOCIATED WITH ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Martinez-Canales, A. Montoya-Rosales, G. Figueroa-Parra, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS0800
|
EFFECTS OF CD19 CAR-T CELL THERAPY ON THE T CELL COMPARTMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS,
P. Garantziotis, K. Anoshkin, M. Hagen, A. Wirsching, P. G. Gavin, S. L. N. Clarke, D. Muthas, D. Close, P. Z. Brohawn, C. Chamberlain, M. Belvisi, A. Platt, N. Ferrari, G. Schett, R. Grieshaber-Bouyer
|
|
2025 POS0802
|
INTEGRATION OF INDEPENDENT scRNA-SEQ DATASETS FOR LUPUS NEPHRITIS KIDNEY BIOPSIES AND HEALTHY CONTROLS KIDNEY SAMPLES ALLOWS TO DETECT CELL-CELL COMMUNICATION PATHWAYS ENRICHED IN LUPUS NEPHRITIS,
N. Oparina, M. L. Eloranta, M. Wallgren, E. Skoglund, D. Leonard
|
|
2025 POS0805
|
SERPINS AS BIOMARKERS AND THERAPEUTIC TARGETS IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS,
R. Martinez-Canales, G. Figueroa-Parra, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS0807
|
TARGETING NEUTROPHILS AND INTERFERON TO ACHIEVE LONG-TERM REMISSION IN ACTIVE LUPUS: COMBINING CXCL5 WITH METHYLPREDNISOLONE AND CYCLOPHOSPHAMIDE THERAPY,
C. J. Pua, A. Law, D. Guo, C. T. Ng, A. Low, J. Thumboo, X. Fan
|
|
2025 POS0828
|
SERUM CERAMIDE (16:0) TO SPHINGOSINE-1-PHOSPHATE RATIO: A NOVEL INDICATOR FOR DIAGNOSING AND MONITORING DISEASE ACTIVITY IN PATIENTS WITH LUPUS NEPHRITIS,
J. W. Kim, J. Y. Jung, H. A. Kim, C. H. Suh
|
|
2025 POS0849
|
DISTINCT GUT MICROBIOME AND METABOLOME PROFILES IN KOREAN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS,
Y. Park, J. Yang, H. Son, M. J. Park, S. J. Moon, K. J. Kim, H. K. Choi, S. K. Kwok
|
|
2025 POS0854
|
TRANSCRIPTOMIC ANALYSIS REVEALS DIFFERENT GENE SIGNATURES ASSOCIATED WITH INFLAMMATION OF SMALL VESSELS SURROUNDING A NORMAL TEMPORAL ARTERY BY ANCA-ASSOCIATED VASCULITIS (AAV) COMPARED TO GIANT-CELL ARTERITIS (GCA),
N. Farran, R. Alba-Rovira, S. Naranjo-Suárez, S. Prieto-González, M. Corbera-Bellalta, J. Marco-Hernández, N. Visocnik, M. C. Cid, G. Espígol-Frigolé
|
|
2025 POS0930
|
A METABOLOMICS APPROACH TO CLASSIFY CARDIOVASCULAR DISEASE ABNORMALITY IN VERY EARLY RHEUMATOID ARTHRITIS,
A. Millar-Wilson, B. Erhayiem, G. Fent, S. Plein, N. Nair, J. Bowes, M. Buch, D. Plant
|
|
2025 POS0931
|
BRIDGING GENETICS AND EPIGENETICS FOR THERAPEUTIC TARGET DISCOVERY IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS,
E. Ezen, A. Khmelevskaya, O. Distler, C. Ospelt
|
|
2025 POS0935
|
DISSECTING THE REGULATORY LANDSCAPE OF CD4+ T-CELLS IN EARLY AND REFRACTORY RHEUMATOID ARTHRITIS,
S. Smith, S. Rossi, R. Shukla, Y. Tan, A. B. Mohammad Ariff, I. Lazar, K. Patel, C. F. Yap, N. Nair, S. Eyre, M. Buch, P. Martin, G. Orozco
|
|
2025 POS0937
|
ASSOCIATIONS BETWEEN SERUM OXYLIPIN SIGNATURES AND ATHEROSCLEROSIS DURING THE EARLIEST STAGES OF ARTHRITIS: A MULTI-OMIC STUDY,
J. Rodríguez-Carrio, R. Coras, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. M. Armando, O. Quehenberger, A. Suárez, M. Guma
|
|
2025 POS0952
|
EFFECTS OF THE ANTI-CD3/CD19 T-CELL ENGAGER BLINATUMOMAB IN SEVERE SYSTEMIC SCLEROSIS,
F. Szelinski, H. Rincon-Arevalo, C. Gebhardt, G. Magno, G. Guerra, N. Neumann, P. Durek, F. Heinrich, M. F. Mashreghi, M. Bergwelt, M. Subklewe, A. Skapenko, H. Schulze-Koops, T. Dörner
|
|
2025 POS0999
|
RE-EVALUATING THE ASSOCIATION BETWEEN TREX1 VARIANTS, LUPUS AND OLIGOPROTEIN INTERFERON SIGNATURES IN UK BIOBANK,
B. Rioux, S. McGlasson, D. Forbes, K. Reid, A. Klingseisen, W. Whiteley, D. Hunt
|
|
2025 POS1001
|
SYSTEMIC SCLEROSIS PATIENTS WITH SKIN FIBROSIS REGRESSION EXHIBIT A PRO-INFLAMMATORY CD4+ T CELL PHENOTYPE,
A. Hofman, P. Bearzi, E. Pachera, L. Li, L. Much, K. Buerki, A. M. Hoffmann-Vold, M. O. Becker, O. Distler
|
|
2025 POS1005
|
IMMUNE SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS NOT TREATED WITH IMMUNOSUPPRESSIVE THERAPY COMPARED TO HEALTHY CONTROLS AS ANALYZED BY SINGLE-CELL RNA SEQUENCING,
T. Eviatar, N. Stein, A. Tsitsiklis, G. Mbambo, C. Joyce, J. Wollman, V. Furer, A. Polachek, O. Elkayam, D. Paran
|
|
2025 POS1007
|
SINGLE-CELL ANALYSIS OF CHANGES INDUCED BY ANIFROLUMAB IN PERIPHERAL BLOOD OF PATIENTS WITH SLE,
K. Terada, Y. Tsuchida, T. S. Ushijima, Y. Suwa, K. Saegusa, S. Yamada, T. Okamura, K. Fujio
|
|
2025 POS1066
|
AN ALTERED IMMUNOMETABOLIC PROFILE CHARACTERIZES B CELLS OF PATIENTS WITH OLIGOARTICULAR- AND POLYARTICULAR- JUVENILE IDIOPATHIC ARTHRITIS,
E. Marasco, A. Aquilani, G. Tarantino, M. I. Petrone, R. Nicolai, I. Caiello, S. Barresi, S. Magni-Manzoni, F. De Benedetti
|
|
2025 POS1139
|
Unravelling transcriptomic landscapes in rheumatoid arthritis and systemic lupus erythematosus: shared and unique molecular signatures related to relevant clinical features,
T. Cerdó, I. Sanchez-Pareja, C. Perez-Sanchez, D. Toro-Domínguez, M. Á. Aguirre-Zamorano, E. Moreno-Caño, L. Muñoz-Barrera, S. Corrales-Díaz Flores, L. Formanti Alonso, R. Ortega-Castro, C. Aranda-Valera, M. L. Ladehesa-Pineda, J. Calvo-Gutiérrez, F. U. Pilar, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, C. Merlo, N. Barbarroja, A. Escudero-Contreras, M. Alarcon-Riquelme, C. Lopez-Pedrera
|
|
2025 POS1143
|
The NAD+ Metabolome Pathway is Profoundly Altered in Chronic Inflammatory Rheumatic Diseases, Modulated by anti-TNF, and Modified by NAD+ Boosters,
B. Vellón-García, G. D. García-Delgado, A. Llamas-Urbano, Y. Hanaee, P. Ortiz-Buitrago, C. Merlo, M. D. C. Abalos-Aguilera, J. M. Martínez-Moreno, M. Á. Puche-Larrubia, I. Arias-de la Rosa, M. D. López Montilla, R. Ortega-Castro, J. Calvo-Gutiérrez, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, E. Collantes-Estevez, A. Escudero-Contreras, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2025 POS1275
|
CHARACTERIZATION OF GUT MICROBIOME IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS COMPARED TO A COHORT OF HEALTHY CONTROLS,
M. Osorio-Sanjuan, C. Peralta-Ginés, E. Cañadillas, P. S. Del Río Martínez, A. Tristancho-Baró
|
|
2025 POS1354
|
MOLECULAR AND CELLULAR LANDSCAPE OF PEDIATRIC SEPTIC ARTHRITIS DRIVEN BY S. AUREUS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS1360
|
THE SECOND KICK FOR FMF PATIENTS WITH ONE MUTATION ONLY: THE TALENTED MR. INTERFERON,
E. Sag, G. Imren, L. Vande Walle, E. Arslanoğlu Aydin, D. Unal, H. Ercan Emreol, Ö. Basaran, S. Ozdel, B. Karaosmanoglu, M. Alikasifoglu, Y. Bilginer, M. Lamkanfi, E. Z. Taskiran, S. Ozen
|
|
2025 POS1361
|
EUBACTERIUM_RECTALE_GROUP IS A KEY PROTECTIVE FACTOR IN RHEUMATOID ARTHRITIS: BASED ON 16s rRNA SEQUENCING COMBINED WITH MENDELIAN ANALYSIS,
X. Liu, R. Wu, B. Li, C. Wang
|
|
2025 POS1363
|
IMMUNE LANDSCAPE OF MUSCLE-INFILTRATING CELLS IN IDIOPATHIC INFLAMMATORY MYOPATHIES: INSIGHTS FROM SINGLE-CELL TRANSCRIPTOMICS,
T. Yoshida, H. Takahashi, T. Itamiya, T. Iwasaki, N. Umezawa, H. Sasaki, K. Ninagawa, Y. Fujieda, Y. Miyazaki, Y. Kamata, M. Takeshita, M. Matsushita, T. Kawamoto, M. Maeda, A. Kubota, T. Toda, N. Tamura, Y. Kaneko, T. Takeuchi, K. Sato, S. Nakayamada, Y. Tanaka, K. Yoshida, T. Atsumi, S. Yasuda, K. Ohmura, A. Morinobu, K. Yamamoto, T. Okamura, K. Fujio
|
|
2025 POS1377
|
UNDERSTANDING CAUSAL RELATIONSHIPS BETWEEN AUTOIMMUNE DISORDERS AND CARDIOMETABOLIC DISEASES,
Y. H. Ko, D. Meena, S. Abraham, I. Tzoulaki, A. Dehghan
|
|
2025 POS1387
|
DYSREGULATED GENES AND IMMUNE CELL SHIFTS IN OSTEOARTHRITIS HIGHLIGHTING M0 MACROPHAGES, MMP9, AND MAST CELL ACTIVITY,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS1390
|
TWO POPULATIONS OF MYELOID DENDRITIC CELLS ARE FOUND IN MUSCLE OF INCLUSION BODY MYOSITIS PATIENTS AND CORRELATE WITH DISEASE ACTIVITY,
R. Kirou, I. Pinal-Fernandez, M. Casal-Dominguez, K. Pak, S. Del Orso, F. Naz, S. Islam, G. Gutierrez-Cruz, E. Naddaf, T. Liewluck, W. Stenzel, A. Selva-O’Callaghan, J. Milisenda, A. Mammen
|
|
2025 POS1394
|
CO-STIMULATORY BLOCKADE CAUSES TARGETED QUANTITATIVE CONTRACTIONS IN EXTRAFOLLICULAR B-CELL SUBSETS WITH CLINICAL IMPROVEMENT IN SEROPOSITIVE RA,
G. Silverman, W. Rigby, J. Shwetar, S. Skopelja-Gardner, A. Amarnani, K. Ruggles
|
|
2025 POS1403
|
CHARACTERIZATION OF SYSTEMIC AND LOCAL MEDIATORS DRIVING OSTEOARTHRITIS AND MULTI-ORGAN AGING,
H. Welhaven, G. Bieri, T. Pham, R. Villa, R. Selle, T. Aghayev, T. Alliston, S. Villeda, K. Collins
|
|
2025 POS1414
|
SINGLE-CELL RNA SEQUENCING REVEALS DISTINCT IMMUNE SIGNATURES IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER COMPARED TO HEALTHY CONTROLS,
L. Merlo Pich, M. Ozturk, Y. Negishi, R. Deniz, A. Ziogas, M. Mhlanga, A. Gül, M. Netea
|
|
2025 POS1423
|
ALTERATIONS IN INNATE IMMUNE POPULATIONS DURING SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE DEVELOPMENT,
C. Ucciferri, C. Nassar, S. R. Johnson, Z. Touma, Z. Ahmad, D. Bonilla, L. Hiraki, A. Bookman, T. McGaha, I. Jurisica, J. Wither
|
|
2025 POS1434
|
HEPATIC STEATOSIS AND FIBROSIS IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TOWARDS PERSONALIZED DIAGNOSTICS USING PROTEOMIC BIOMARKERS AND MACHINE LEARNING,
M. Ruiz-Ponce, L. Cuesta-López, M. D. López Montilla, M. L. Ladehesa-Pineda, A. M. Barranco, E. Martin-Salazar, C. Perez-Sanchez, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, I. Ruiz-Cáceres, D. Corona-Mata, M. Casares-Jimenez, C. Lopez-Pedrera, J. M. Martínez-Moreno, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, N. Barbarroja
|
|
2025 POS1438
|
MOLECULAR PATHWAYS ALTERED IN THE HYPERMOBILITY SPECTRUM DISORDER,
C. V. Elizondo Solis, A. P. Montemayor Zarazúa, O. Ilizaliturri Guerra, K. Silva Luna, A. C. Arana Guajardo, M. R. Garcia Pompermayer, E. Purón González, L. I. Lozano Plata, M. A. Garza Elizondo
|
|
|
[171]
|
Adaptive immunity
|
|
|
| 2025 |
|
2025 ABS0001
|
ANTIBODIES AGAINST CHITOHEPTOSE ARE ASSOCIATED WITH DISEASE ACTIVITY AND TREATMENT EFFECT IN EARLY RHEUMATOID ARTHRITIS,
M. A. Nielsen, A. Y. Metha, T. W. Kragstrup, M. Lund Hetland, M. Østergaard, K. Hørslev-Petersen, P. Junker, K. Stengaard-Pedersen, T. McKitrick, R. D. Cummings, B. Deleuran
|
|
2025 ABS0005
|
ACONITINE: A POTENTIAL TREATMENT FOR RHEUMATOID ARTHRITIS,
R. Wang, X. Hou, N. Wang, H. Li, J. He
|
|
2025 ABS0026
|
MOLECULAR AND IMMUNE LANDSCAPE OF ACUTE, SUBACUTE, AND CHRONIC CUTANEOUS LUPUS: A COMPARATIVE ANALYSIS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0028
|
CD25low Foxp3+ T CELLS IN SMALL INTESTINAL LAMINA PROPRIA CONTRIBUTE TO RHEUMATOID ARTHRITIS PATHOGENICITY BY PROMOTING CONVERSION INTO IL-17A-PRODUCING CELLS,
H. Lee, S. Lee, S. Kim, D. Yu, M. Kim, S. I. Lee, Y. H. Cheon
|
|
2025 ABS0029
|
MULTIPLEX IMMUNOPHENOTYPING OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME OR SEROPOSITIVITY WITHOUT CLINICAL SYMPTOMES,
A. Balog, B. Kari, E. Korogány, N. Gémes, D. G. Honfi, N. Cselei, G. Szebeni
|
|
2025 ABS0030
|
UNRAVELLING THE PARATOPE SEQUENCE OF RHEUMATOID FACTOR,
J. De Leeuw, T. Dehaemers, R. Derua, B. Michiels, D. Dillaerts, M. Cockx, G. Frans, S. Carpentier, P. Verschueren, X. Bossuyt
|
|
2025 ABS0032
|
BIOMIX INTEGRATED MULTI-OMICS ANALYSIS OF PRECISESADS DATA REVEALS KEY METABOLIC PATHWAY ALTERATIONS IN B LYMPHOCYTES, IMMUNE CELLS, AND THEIR MICROENVIRONMENT IN SJÖGREN’S DISEASE,
C. IPERI, A. Fernández-Ochoa, J. O. Pers, G. Barturen, M. Alarcon-Riquelme, R. Quirantes-Piné, I. Borrás-Linares, A. Segura-Carretero, V. Devauchelle-Pensec, D. Cornec, A. Bordron, C. Jamin
|
|
2025 ABS0039
|
IMPACT OF IMMUNOLOGICAL PROFILE ON ATLANTO-AXIAL JOINT INVOLVEMENT IN RHEUMATOID ARTHRITIS,
A. El Hajjaji, N. Akasbi, I. El Mezouar, T. Harzy
|
|
2025 ABS0051
|
AN IN VITRO MODEL TO CHARACTERIZE CYTOLOGICAL ALTERATIONS OF LEUKOCYTES FOUND IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS,
C. Baggio, L. Iorio, F. Davanzo, M. Tonello, P. Sfriso, A. Doria, R. Padoan, F. Oliviero
|
|
2025 ABS0057
|
EXPLORING THE CELLULAR AND MOLECULAR MECHANISMS OF IL-1Β PRODUCTION DIRECTED BY T CELLS FOR TREATING T CELL-MEDIATED AUTOIMMUNE DISEASES,
J. Zhao, Z. Liang, B. Kessler, L. Chen
|
|
2025 ABS0060
|
UNDERSTANDING DRIVERS OF LUPUS PATHOGENESIS THROUGH COMPARISON OF PRECLINICAL MODELS,
A. Glatman Zaretsky, C. Tasker, P. Abreu, C. Torres, L. H. Ben, S. MacDonnell, A. Limnander, J. Orengo
|
|
2025 ABS0061
|
CIRCULATING ANGIOGENIC T-CELL LEVELS ARE LOWER IN PATIENTS WITH SSc-ILD AND ASSOCIATED WITH SEVERAL CLINICAL CHARACTERISTICS IN SSc PATIENTS,
J. Krč, Y. Al-Adwi, B. Doornbos- van der Meer, A. J. Stel, W. Abdulahad, H. van Goor, J. Westra, D. J. Mulder
|
|
2025 ABS0084
|
TIME-COURSE RNA SEQUENCING ANALYSIS OF LONGITUDINAL PBMC SAMPLES TO ELUCIDATE THE FACTORS DETERMINING DIFFICULT-TO-TREAT SYSTEMIC LUPUS ERYTHEMATOSUS,
S. Sumitomo, H. Oka, T. Iwasaki, K. Ohmura
|
|
2025 ABS0090
|
IDENTIFICATION OF MOLECULAR BIOMARKERS AND IMMUNE CELL PROFILES IN ACTIVE LUPUS NEPHRITIS USING TRANSCRIPTOMIC AND BIOINFORMATICS APPROACHES,
R. Martinez-Canales, G. Figueroa-Parra, A. Montoya-Rosales, C. M. Skinner-Taylor, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0092
|
IMMUNE CELL PATTERNS IN RHEUMATOID ARTHRITIS AND HIGH-RISK RELATIVES,
R. Martinez-Canales, A. Montoya-Rosales, L. Perez-Barbosa, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0098
|
UTILIZING HIGH-DIMENSIONAL MASS CYTOMETRY TO DECODE COMPLEX PERIPHERAL IMMUNE SIGNATURES IN PROGRESSIVE INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS WITH POTENTIAL THERAGNOSTIC APPLICATIONS,
M. Noviani, P. Kumar, V. R. Chellamuthu, A. Lajam, A. Chia, K. Nay Yaung, M. Wasser, J. G. Yeo, A. Low, S. Albani
|
|
2025 ABS0102
|
STAT1 PROMOTES CD4+T CELLULAR SENESCENCE BY UPREGULATING MAP1S LACTYLATION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Wang, L. Chun, M. Zhang, H. Z. Dai
|
|
2025 ABS0103
|
CD5L IS A KEY PROTECTIVE ANTI-INFLAMMATORY FACTOR IN ARTHRITIS,
M. I. Bokarewa, A. Carmo, L. Oliveira, M. Erlandsson
|
|
2025 ABS0106
|
IN VITRO EXPANSION OF ACPA-POSITIVE B CELLS FROM RHEUMATOID ARTHRITIS PATIENTS AND THE EFFECTS OF TARGETING NF-?B ON DIFFERENTIATION AND SURVIVAL OF (AUTOREACTIVE) B LINEAGE CELLS,
G. Frazzei, A. Merino-Vico, J. Christiaans, J. P. Van Hamburg, R. F. van Vollenhoven, S. W. Tas
|
|
2025 ABS0124
|
UNIQUE SEROLOGICAL PROFILE OF IGM ANTI-ACETYLATED PROTEIN ANTIBODIES: INSIGHTS INTO THE INITIAL PHASES OF AUTOANTIBODY RESPONSES IN RHEUMATOID ARTHRITIS,
A. Athanasiadou, T. J. van Wesemael, L. Slot, C. van der Keur, M. Eikmans, S. Rantapää Dahlqvist, R. E. M. Toes, D. van der Woude
|
|
2025 ABS0126
|
INCREASED SLAMF7 EXPRESSION ON CD4+CD8aalow T CELLS,
L. Braune, H. R. Spatzier, H. Apel, A. M. Glimm, O. Seifert, P. Nguyen, U. Wagner, K. Rothe
|
|
2025 ABS0127
|
TYPE I INTERFERONS DRIVE IMMUNOSENESCENCE OF NAÏVE CD4+ T-CELLS VIA METABOLIC REPROGRAMMING IN SJÖGREN´S DISEASE,
P. Javorova, E. Zuegner, A. Lackner, C. Magnes, J. Thiel, J. Fessler, M. Stradner
|
|
2025 ABS0129
|
EFFICACY OF A BD2-SELECTIVE BET INHIBITOR IN ANIMAL MODELS OF RHEUMATOID ARTHRITIS BY INHIBITION OF NF-KB DRIVEN INFLAMMATORY PATHWAYS,
I. Stuart, S. Banerjee, A. Woodland, M. Bell, R. Jayaprakash
|
|
2025 ABS0141
|
SYSTEMATIC REVIEW AND INDEPENDENT VALIDATION OF GENETIC FACTORS OF RADIOGRAPHIC OUTCOME IN RHEUMATOID ARTHRITIS IDENTIFIES A GENOME-WIDE ASSOCIATION WITH CARD9,
S. Sharma, R. Hum, N. Nair, L. Marshall, A. Storrie, J. Bowes, A. MacGregor, M. Yates, A. Morris, S. Verstappen, A. Barton, H. W. van Steenbergen, R. Knevel, A. H. M. van der Helm – van Mil, S. Viatte
|
|
2025 ABS0144
|
ACTIVATION OF THE Th17/IL-17 AXIS MARKS THE TRANSITION FROM VERY EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS (VEDOSS) TO ESTABLISHED SYSTEMIC SCLEROSIS,
J. Ohmes, H. Grasshoff, S. Comduehr, R. Akbarzadeh, A. Müller, T. Gemoll, G. Riemekasten, J. Y. Humrich
|
|
2025 ABS0164
|
TAILORED SYNOVIAL FLUID ISOLATION PROTOCOL FOR A COMPREHENSIVE CELLULAR PROFILING IN INFLAMMATORY ARTHRITIS,
A. M. Tesfaye, E. Holm-Nordli, G. L. Goll, J. Røkke Osen, H. B. Hammer, A. Lossius, S. Syversen, A. Christophersen
|
|
2025 ABS0166
|
TIME-RESOLVED ANALYSIS OF IMMUNE SYSTEM DYNAMICS IN RHEUMATOID ARTHRITIS PATIENTS UNDERGOING METHOTREXATE THERAPY,
L. Göschl, T. Preglej, A. Tosevska, M. Brinkmann, D. Sieghart, P. Schatzlmaier, E. Simader, T. Krausgruber, L. Dobinkar, C. Bock, H. Stockinger, D. Aletaha, M. Bonelli
|
|
2025 ABS0179
|
UNDERSTANDING CAR-TREG PERSISTENCE AND EXPANSION PROTOCOLS OPTIMIZATION,
A. Ugolini, A. Miceli, P. Carulli, C. Bercher Brayer, M. Doglio, C. Bonini
|
|
2025 ABS0185
|
TARGETING T FOLLICULAR HELPER CELLS IN SJÖGREN’S DISEASE BY CALYCOSIN,
S. Yu, M. Wu, J. Shen, X. Lin
|
|
2025 ABS0195
|
IMMUNE AND TRANSCRIPTOMIC DYNAMICS IN LUPUS NEPHRITIS ASSOCIATED WITH INTERFERON α KINOID TREATMENT,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0208
|
THE PATHOGENESIS OF TRANSMEMBRANE ACTIVATOR, CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR (TACI) IN PRIMARY SJOGREN’S SYNDROME AND ITS INTRICATE REGULATION OF B CELLS,
H. Zhang, H. Zhang, Y. Geng, X. Zhang, Y. Wang, Z. Zhang
|
|
2025 ABS0215
|
PHENOTYPE-SPECIFIC IMMUNE SIGNATURES IN BEHÇET’S DISEASE: A TRANSCRIPTOMIC AND CYTOKINE BASED APPROACH,
R. Deniz, G. Gülfidan, C. Bes, Z. Emrence, F. Alibaz-Oner, S. Sirma Ekmekci, N. Abaci, H. Direskeneli, A. Gül, K. Y. Arga, C. Erzik
|
|
2025 ABS0227
|
DECREASED GPR55 EXPRESSION LINKS B-CELL ACTIVATION AND VASCULAR REMODELLING IN ATHEROSCLEROSIS IN EARLY RHEUMATOID ARTHRITIS PATIENTS,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2025 ABS0229
|
URINARY T-HELPER CELLS ARE A POTENTIAL BIOMARKER FOR TUBULOINTERSTITIAL NEPHRITIS IN SJÖGREN’S SYNDROME,
V. Laas, F. C. Feindt, T. Zimmermann, P. Böse, L. Ehnold, P. Klimicevs, J. Hagenstein, M. Warkotsch, T. Wiech, T. B. Huber, O. M. Steinmetz, S. Melderis
|
|
2025 ABS0231
|
ANALYSIS OF THE PROTEIN CORONA AROUND EXTRACELLULAR VESICLES IN RHEUMATOID ARTHRITIS,
P. Királyhidi, A. Försönits, J. Opra, Z. Adamecz, C. Grönwall, L. Klareskog, D. Szabó, L. Drahos, K. A. F. Nilsson, L. Gunkl-Toth, T. Visnovitz, E. Buzás, G. Nagy
|
|
2025 ABS0234
|
CIRCULATING LEUKOCYTE SIGNATURES IN TREATMENT-NAIVE NON-RADIOGRAPHIC VERSUS RADIOGRAPHIC AXIAL SPONDYLARTHRITIS IDENTIFIED BY MASS CYTOMETRY,
M. Kyriakidi, E. K. Vetsika, M. G. Tektonidou, P. P. Sfikakis, G. E. Fragoulis
|
|
2025 ABS0236
|
VARIABLES ASSOCIATED WITH RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AT A SOUTH AMERICAN HOSPITAL,
J. Hernandez, L. A. Dulcey Sarmiento, J. Gomez Ayala, V. Ochoa Castellanos, J. S. Theran Leon, V. Navas
|
|
2025 ABS0238
|
VALIDATION OF CLASI AND R-CLASI IN PATIENTS WITH SLE AT A SOUTH AMERICAN HOSPITAL,
J. Hernandez, L. A. Dulcey Sarmiento, J. Gomez Ayala, J. S. Theran Leon, V. Navas
|
|
2025 ABS0241
|
INTERFERON AND B CELL SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AT A SOUTH AMERICAN HOSPITAL,
L. A. Dulcey Sarmiento, J. Hernandez
|
|
2025 ABS0244
|
INCREASED Tph CELLS CONTRIBUTE TO THE PATHOPHYSIOLOGY OF LATE-ONSET ADULT STILL’S DISEASE,
M. Fukuchi, S. Takanashi, K. Tanaka, H. Tamai, Y. Kondo, N. Seki, K. Chiba, K. Yoshimoto, Y. Kaneko
|
|
2025 ABS0251
|
TRAINED IMMUNITY ENHANCES MONOCYTE-T-CELL PATHOGENIC CROSSTALK IN ANKYLOSING SPONDYLITIS,
J. Zhao, F. Liu, P. Bowness, L. Chen
|
|
2025 ABS0270
|
EXPRESSION OF ECTO-NUCLEOTIDASES IN LEUKOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON DISEASE ACTIVITY,
L. Rapino, S. Truglia, F. Ceccarelli, F. R. Spinelli, S. Mancuso, A. L. Stefanski, H. Rincon-Arevalo, T. Dörner, F. Conti
|
|
2025 ABS0282
|
INCREASED COLLAGEN DEPOSITION AND ALTERED IMMUNE CELL PROFILES ARE PRESENT IN EARLY AND LATE-STAGE SYSTEMIC SCLEROSIS WITH GASTROINTESTINAL INVOLVEMENT,
L. Much, E. Pachera, H. Fretheim, A. Laimbacher, K. E. Lundin, L. Aabakken, L. Li, A. Hofman, P. Bearzi, M. Scharl, Ø. Molberg, O. Distler, A. M. Hoffmann-Vold
|
|
2025 ABS0283
|
EXERCISE-INDUCED ADAPTATIONS TO AEROBIC TRAINING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND EFFECT MODIFICATION BY TYPE 1 INTERFERON ACTIVITY – A RANDOMIZED CONTROLLED SINGLE-CENTER CLINICAL TRIAL,
M. Lund Adamsen, I. Rasmussen, M. Lyngbæk, P. Hoejgaard, S. Jacobsen
|
|
2025 ABS0287
|
DISTINCT STABILITY AND SUPPRESSIVE PHENOTYPE OF SYNOVIAL VERSUS PERIPHERAL TREG IN RHEUMATOID ARTHRITIS,
T. Abaab, J. Sigaux, L. Semerano, M. C. Boissier, J. Biton, N. Bessis
|
|
2025 ABS0313
|
RESTORATION OF MITOCHONDRIAL RECYCLING DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NK CELLS WITH SMALL DOSES OF HYDROXYCHLOROQUINE,
N. Fluder, M. Humbel, C. Ribi, D. Comte
|
|
2025 ABS0500
|
CELLULAR IMMUNOGENICITY TO HERPES ZOSTER SUBUNIT VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS,
H. Källmark, B. Gullstrand, F. Kahn, E. Grenmyr, J. T. Einarsson, A. Bengtsson, M. C. Kapetanovic
|
|
2025 ABS0501
|
LONG-TERM ANTIBODY RESPONSE TO HERPES ZOSTER SUBUNIT VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS,
H. Källmark, T. Bergström, M. Johansson, J. T. Einarsson, M. C. Kapetanovic
|
|
2025 ABS0556
|
EMERGING TRENDS IN CAR-T THERAPY RESEARCH IN RHEUMATOLOGY: A BIBLIOMETRIC ANALYSIS,
B. Doskaliuk, R. Yatsyshyn, I. Stoika, K. Fedorovych
|
|
2025 ABS0750
|
FIRST USE OF NOVEL BCMA AND CD19 NANOBODY-BASED COMPOUND CAR-T THERAPY TO TARGET B-CELLS AND PLASMA CELLS IN PRECLINICAL STUDY OF AUTOIMMUNE DISEASES,
B. H. Choi, K. Zhang, H. M. Chang, V. DeStefano, J. Luo, Y. Ma, N. Hagag, A. Abdel-Razek, Y. Ma, J. He
|
|
2025 ABS0754
|
CLUSTER-BASED CLINICAL PHENOTYPES WITH TREATMENT RESPONSE PREDICTION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
O. Iaremenko, D. Koliadenko, Y. Nikolaieva, L. Petelytska, A. Gryshchenko
|
|
2025 ABS0870
|
INTIMA/MEDIA THICKNESS IN RHEUMATOID ARTHRITIS -CLINICAL AND IMMUNOLOGICAL IMPLICATIONS,
D. Elena, L. Andries, N. Ciobanu, R. Eugeniu, N. Alesea, M. Curchi, L. Groppa
|
|
2025 ABS0901
|
CLINICAL, IMMUNOLOGICAL AND METABOLOMIC RISK FACTORS ASSOCIATED WITH FIBROMYALGIA IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES,
S. Govea-Peláez, B. Alcala-Carmona, J. Balderas Miranda, Y. Reyna Juárez, M. J. Ostos-Prado, N. R. Mejía-Domínguez, G. Juárez-Vega, J. C. Paez-Franco, J. J. Torres Ruíz, D. Gómez-Martín
|
|
2025 ABS0945
|
ESTIMATION OF NEPHRON NUMBERS AND ITS CHANGE WITH INDUCTION THERAPY IN LUPUS NEPHRITIS,
J. B. Kuduva Loganathan, A. Jose, R. N, S. Parameswaran, S. Bh, R. Ananthakrishnan, A. Gopal, C. Kavadichanda, M. Mary Thabah, V. S. Negi
|
|
2025 ABS0951
|
MONOGENIC LUPUS: A COMPREHENSIVE REVIEW OF GENETIC AND CLINICAL FEATURES,
O. C. Kilinc, B. Aktas, K. Parlar, O. Kizilkaya, B. Acar, S. Ugurlu
|
|
2025 ABS1066
|
REGULATORY T CELL ALTERATIONS IN PRIMARY SJÖGREN’S SYNDROME: INSIGHTS INTO MALIGNANCY DEVELOPMENT,
A. Gao, R. Wu, C. Wang
|
|
2025 ABS1070
|
HIGH TH1 CELLS IN PRIMARY PANNICULITIS,
R. Su, H. Xue, C. Wang
|
|
2025 ABS1077
|
CLINICAL PHENOTYPING AND STRATIFICATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-NUCLEOSOME ANTIBODIES: A MACHINE LEARNING APPROACH,
A. García-Alija, B. P. Magallares, A. Hernández, G. Verdaguer, A. Calvet, A. Laiz, P. Moya, A. Casals Urquiza, C. Díaz-Torné, L. Sainz Comas, I. Castellví, S. P. Fernandez-Sanchez, J. Bernardez, H. Codes, J. L. Tandaipan, C. Pitarch, C. Marco Pascual, A. Garcia Guillen, M. À. Melchor, M. Sihuro, S. Ros, L. Úbeda, N. Fernández-Verdés, H. Corominas
|
|
2025 OP0014
|
CD4+ TRAIL+ T Cells with Interferon-Stimulated Gene signature Differentially Restrict Anti-Nuclear Antigen Responses in M. Sjögren and Systemic Sclerosis,
T. I. Papadimitriou, P. Singh, A van Caam, M. Vonk, I. J. M. de Vries, P van der Kraan, R. Smeets, M. Koenders, E. Aarntzen, H. Koenen, M. Huijnen, R. M. Thurlings
|
|
2025 OP0018
|
Characterizing ANCA-specific B cells in ANCA-associated Vasculitis Patients,
L. van Dam, M. Zhang, S. Parsafar, A. Horomanski, S. Rasouli, B. Levin, O. Sharpe, J. R van Leeuwen, T. Lanz, C van Kooten, Y. K. O. Teng, W. Robinson
|
|
2025 OP0019
|
The transcriptome profile of B cells: A useful non-invasive biomarker for the diagnosis of nephritis in IgA vasculitis,
J. C. Batista-Liz, L. C. Terron Camero, I. Fernández Rengel, M. T. Leonardo Cabello, A. C. Peñalba Citores, L. Martín-Penagos, L. Belmar-Vega, C. Gomez-Fernandez, L. Gabrie, R. Gálvez-Sánchez, L. Caminal-Montero, A. I. Turrión, D de Argila, E. Vicente-Rabaneda, B. Sevilla-Pérez, J. L. Callejas, A. Márquez, J. Martin, E. Andrés-León, S. Castañeda, R. Blanco, V. Pulito-Cueto, R. López-Mejías
|
|
2025 OP0063
|
Elevated proportion of peripheral CD161+ regulatory T cells and it’s clinical relevance in Behcet syndrome,
J. Li, W. Xia, F. Sun, X. Sun, T. Liu, Z. Li
|
|
2025 OP0074
|
Preliminary results of CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosus-an open-label, single-arm study,
C. Wu, Y. Fu, J. Liu, Y. Ye, R. Wang, G. Li, P. Li, L. Weng, L. Shen, S. Ye, Q. Fu
|
|
2025 OP0080
|
Interrogating type I interferon signatures at multiple signalling levels in childhood-onset SLE reveals novel heterogeneity and associated disease endotypes,
H. Cross, J. Peng, T. McDonnell, E. Jury, C. Ciurtin, G. Robinson
|
|
2025 OP0091
|
MARKERS OF IL-17 SIGNALLING IN THE BLOOD OF PATIENTS WITH PSORIATIC ARTHRITIS WITH INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS,
I. B. McInnes, I. Cutcutache, L. E. Jessen, M. B. Petersen, M. Randahl Nielsen, M. Skougaard, V. Svinti MacLeod, A. Skelton, A. Prickett, S. Shaw
|
|
2025 OP0133
|
COMPREHENSIVE ANALYSIS UNVEILS POTENTIAL MECHANISMS OF MMP9 AND RNASET2 IN RHEUMATOID ARTHRITIS THROUGH GENOME-WIDE ASSOCIATION STUDIES, MENDELIAN RANDOMIZATION, AND SINGLE-CELL TRANSCRIPTOMIC,
X. Liu, X. Gu, C. Wang
|
|
2025 OP0134
|
EXTRACELLULAR MATRIX DEGRADATION-DRIVEN ACCUMULATION OF CYTOTOXIC Vδ1 T-CELLS IN MODIC TYPE 1 CHANGES,
J. Devan, I. Heggli, M. Sandalova, D. Burri, P. Bitterli, N. Herger, D. Menghini, P. L. Hatt, K. R. Brender, M. Perez Vertti Valdes, C. Laux, M. Farshad, O. Distler, S. Dudli
|
|
2025 OP0136
|
TIGIT AND SLAMF7 DOUBLE-POSITIVE Tfh2 CELLS ACTIVATE NAIVE B CELLS, LEADING TO THE GENERATION OF IgG4 PRODUCING MEMORY B CELLS IN IgG4 RELATED DISEASE,
M. G. Kim, J. Yeo, M. H. Kim, S. U. Kim, H. R. Kang, S. Ban, H. S. Kwon, J. H. Moon, J. Y. Kim, E. Y. Lee
|
|
2025 OP0138
|
IL-33 EXPANDS PLASMA CELLS, DISRUPTS GERMINAL CENTERS AND INCREASES AUTOANTIBODY PRODUCTION,
A. Limnander, E. Conde, S. Asrat, A. Vecchione, K. Gayvert, P. Pedraza, C. Tasker, S. Huang, D. Yarilin, D. Birchard, L. H. Ben, W. K. Lim, A. Murphy, M. Sleeman, J. Orengo
|
|
2025 OP0141
|
FIBROBLAST-DRIVEN Ttek ACTIVATION MAY DRIVE ACINAR CELL DYSFUNCTION IN SJÖGREN’S DISEASE, PRIOR TO LYMPHOCYTIC INFILTRATION,
T. Yang, R. Wilbrink, J. H. Terpstra, S. C. Liefers, A. Vissink, F. K. L. Spijkervet, H. Bootsma, F. G. M. Kroese, S. Pringle
|
|
2025 OP0142
|
THE ANTIGEN SPECIFICITY OF CD4 T CELLS IN THE SALIVARY GLANDS OF PATIENTS WITH SJÖGREN’S DISEASE,
M. Takeshita, J. Inamo, K. Suzuki, Y. Kaneko
|
|
2025 OP0143
|
CXCL10+ FIBROBLASTS FACILITATE LYMPHOCYTIC AGGREGATION IN THE SALIVARY GLANDS OF SJÖGREN’S SYNDROME BY PROMOTING ANGIOGENESIS AND CHEMOTACTIC ACTIVITY,
Z. Tan, J. Zhou, J. Wang, Y. Zhou, X. Sun, L. Wang, Z. Zhou, C. Guo, X. Li
|
|
2025 OP0144
|
THE ROLE OF CXCL12/CXCR4 IN SJÖGREN’S DISEASE: FROM PATHOGENESIS TO POTENTIAL THERAPY,
X. Zhang, Y. Li, G. Shi, Y. Liu
|
|
2025 OP0147
|
SERUM APRIL IS ASSOCIATED WITH B-CELL ACTIVATION MARKERS, SYSTEMIC DISEASE ACTIVITY, AND LYMPHOMA RISK IN SJÖGREN DISEASE (SD): DATA FROM THE PROSPECTIVE ASSESS COHORT,
P. M. Duret, P. Schneider, L. Robin, M. Vierling, N. Meyer, V. Devauchelle-Pensec, D. Cornec, A. Saraux, J. Sibilia, R. Seror, Y. Nguyen, G. Nocturne, L. Mauvieux, L. Miguet, X. Mariette, J. E. Gottenberg
|
|
2025 OP0148
|
SALIVARY VIROME ALTERATIONS IN SJÖGREN’S DISEASE CONTRIBUTE TO IMMUNE HOMEOSTASIS DISRUPTION BY MOLECULAR MIMICRY,
X. Zhang, Y. Li, Y. Qin, C. Deng, G. Shi, Y. Liu
|
|
2025 OP0150
|
DRUG-FREE REMISSION IS CHARACTERISED BY EXPANSION OF CITRULLINATED VIMENTIN-REACTIVE IMMUNE-REGULATORY CD4+CD39+TIGIThi T CELLS IN ACPA+ RHEUMATOID ARTHRITIS,
A. E. Anderson, H. Lemos, H. Nel, S. Sorbet Santiago, J. Y. Hee, F. Rayner, A. Degnan, I. Wilson, J. Diboll, J. Sim, A. Melville, S. Siebert, I. B. McInnes, C. S. Goodyear, C. Hilkens, A. Filer, K. Raza, C. D. Buckley, H. Reid, K. F. Baker, A. Pratt, J. Rossjohn, R. Thomas, J. D. Isaacs
|
|
2025 OP0156
|
ANTI-CITRULLINE CD4+ T CELLS ARE PRESENT IN ALL HLA-DRB1*04:01+ PATIENTS WITH RHEUMATOID ARTHRITIS, ASSOCIATE WITH RESPONSE TO BIOLOGIC DRUGS AND WORSE CLINICAL OUTCOME AND SHARE KEY FEATURES WITH ANTI-VIRAL T CELLS.,
M. A. Elhafnawy, S. Valma, M. Christofi, N. Nair, L. Marshall, S. Turcinov, J. Bowes, A. B. Mohammad Ariff, A. Morgan, J. D. Isaacs, A. G. Wilson, K. Hyrich, D. Plant, W. Kwok, A. Barton, E. A. James, V. Malmström, S. Viatte
|
|
2025 OP0165
|
SAFETY AND EFFICACY OF A SINGLE DOSE OF RITUXIMAB TO MANAGE PREGNANCY-RELATED SEVERE FLARE OF SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT,
E. Capparelli, D. bompane, E. zaccara, L. Castelnovo, A. tamburello, A. Mazzone, P. Faggioli
|
|
2025 OP0168
|
CLINICAL IMPACT OF INCOMPLETE B-CELL DEPLETION IN ANCA-ASSOCIATED VASCULITIS PATIENTS RECEIVING MAINTENANCE RITUXIMAB THERAPY: A RETROSPECTIVE STUDY,
C. Ricordi, J. Liberatore, M. Beydon, P. Cohen, B. Donogué, C. Mettler, B. Thoreau, L. Mouthon, X. Puéchal, B. Terrier
|
|
2025 OP0189
|
SAFETY AND EFFICACY OF INEBILIZUMAB IN IgG4-RELATED DISEASE ACROSS VARIOUS PARTICIPANT DEMOGRAPHICS: SUBGROUP ANALYSIS FROM THE MITIGATE STUDY,
J. H. Stone, E. L. Culver, A. Khosroshahi, W. Zhang, K. Okazaki, Y. Tanaka, M. Lohr, N. Schleinitz, X. Dong, M. Rosen, S. Cheng, D. Cimbora
|
|
2025 OP0230
|
SYNOVIAL FIBROBLASTS, MACROPHAGES AND DENDRITIC CELLS FORM AN INFLAMMATORY NICHE IN RHEUMATOID ARTHRITIS, BUT NOT IN PSORIATIC ARTHRITIS SYNOVIUM,
A. Khmelevskaya, M. Houtman, K. Buerki, C. Pauli, O. Distler, A. Ciurea, A. Ramming, U. Fearon, C. Ospelt, R. Micheroli
|
|
2025 OP0243
|
SINGLE-CELL RNA SEQUENCING OF ACPA-ENRICHED B CELLS REVEALED A CD11c+ ATYPICAL B CELL GENE SIGNATURE IN RHEUMATOID ARTHRITIS,
Y. Nagafuchi, L. Slot, D. Simaite, A. M. Bakker, T. Andreani, E. B. van den Akker, T. Huizinga, C. Struebing, R. E. M. Toes, H. U. Scherer
|
|
2025 OP0248
|
CELLULAR AND MOLECULAR DECONSTRUCTION OF (TENO)SYNOVIAL TISSUE ACROSS DIFFERENT RHEUMATOID ARTHRITIS PHASES AND COMPARISON WITH ADJACENT SYNOVIUM,
L. A. Coletto, D. Somma, C. Di Mario, D. Campobasso, B. Tolusso, P. Rizzuti, D. Bruno, C. Tur, P. Rubortone, B. Fresch, T. Hubert, N. Goulas, L. Petricca, M. R. Gigante, V. A. Pacucci, S. Perniola, A. Elmesmari, L. MacDonald, R. Benvenuto, M. Gessi, E. Gremese, M. A. D’ Agostino, M. M. Lizzio, M. Kurowska-Stolarska, S. Alivernini
|
|
2025 OP0250
|
COMPREHENSIVE IMMUNOPHENOTYPING REVEALS OLIGOCLONAL EXPANSION OF AUTOREACTIVE T CELLS AND THE ROLE OF IL-6 IN THEIR DIFFERENTIATION IN RHEUMATOID ARTHRITIS,
S. Kubo, K. Kusaka, Y. FUJITA, N. Takahiro, Y. Miyazaki, K. Ishigaki, M. Kono, H. Tanaka, H. Sakai, M. Ueno, Y. Todoroki, Y. Satoh-Kanda, I. Miyagawa, S. Nakayamada, Y. Tanaka
|
|
2025 OP0255
|
SPATIAL AND QUANTITATIVE SEMIAUTOMATED IMAGE ANALYSIS OF SYNOVIAL BIOPSIES STUDIED USING A NOVEL HIGH-PLEX IMMUNOFLUORESCENCE PLATFORM,
L. A. Peñaranda-Bolaño, A. Arora, J. Murillo-Saich, E. Lo, T. George, D. Tanoeihusada, S. McArdle, M. Guma, E. Quesada Masachs
|
|
2025 OP0256
|
ENTHESEAL MSCS: DUAL ROLES IN T CELL IMMUNE SUPPRESSION AND IL-17A AMPLIFICATION,
A. Altaie, D. Carneiro, H. Owston, N. McDermott, V. Borse, T. Mcmillan, A. S. Rao, N. Adsul, A. Khan, R. Dunsmuir, J. Timothy, P. Loughenbury, D. McGonagle
|
|
2025 OP0257
|
SINGLE-CELL TRANSCRIPTOMICS AND DEEP IMMUNOPHENOTYPING REVEAL MEMORY CD8+ T CELL ACTIVATING IN ANKYLOSING SPONDYLITIS,
H. Zhu, X. Ma, J. Wang, J. Liu
|
|
2025 OP0258
|
AUTOIMMUNE REACTIVE SYNOVIUM CD4+HLADR+ T EFFECTORS WITH REGULATORY RESISTANCE AND INFLAMMATORY POTENTIAL IN HUMAN ARTHRITIS,
J. Y. Leong, P. Kumar, S. H. Tay, G. Mijnheer, A. J. M. Lim, S. Hazirah, J. G. Yeo, C. Chua, P. Chen, A. Consolaro, M. Gattorno, T. Arkachaisri, F. van Wijk, A. Martini, S. Albani
|
|
2025 OP0260
|
DoCTIS: A SINGLE CELL RNA-Seq ATLAS OF DRUG RESPONSE TO TARGETED THERAPIES,
A. Julià, Y. Guillén, J. A. Patiño Galindo, S. H. Martínez-Mateu, P. Vela Casasempere, A. Fernández Nebro, C. Marras, S. Castañeda, J. Calvo Alén, J. Tornero Molina, J. D. D. Cañete Crespillo, E. Domènech, J. P. Gisbert, J. M. Carrascosa, E. Fonseca, L. Bujanda Fernández de Pierola, V. García Sánchez, B. Siegmund, G. Girolomoni, H. Heyn, L. Jimenez, P. Santamaría, E. Angelats, R. Myers, E. Choy, S. Marsal
|
|
2025 OP0261
|
SINGLE-CELL ANALYSIS IN PREGNANT WOMEN WITH SLE: IMMUNOLOGICAL FEATURES ASSOCIATED WITH ADVERSE PREGNANCY OUTCOMES,
K. Terada, Y. Tsuchida, S. Nakajima, S. Isojima, T. Isozaki, Y. Hiramatsu, H. Nakajima, S. Morimoto, T. Mimura, N. Tamura, K. Amano, Y. Kirino, S. Ohno, I. Matsumoto, S. Yasuda, Y. Kaneko, M. HARIGAI, S. Kaname, K. Itoh, H. Kameda, K. Kaneko, T. Okamura, Y. Okada, A. Murashima, K. Fujio, N. Yajima
|
|
2025 OP0263
|
DEEP IMMUNOPHENOTYPING IN PATIENTS WITH JUVENILE LOCALIZED SCLERODERMA REVEALS TWO DISTINCT IMMUNOLOGICAL ENDOPHENOTYPE,
E. Marasco, A. Aquilani, I. Caiello, F. De Benedetti, R. Nicolai
|
|
2025 OP0267
|
SINGLE-CELL TRANSCRIPTOMICS OF B CELLS TOWARDS THE UNDERSTANDING OF THE MECHANISMS LEADING TO THE PRODUCTION OF ANTIPHOSPHOLIPID ANTIBODIES IN THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME,
P. Gaspar, D. Holdych, M. M. Santos, F. Ribeiro, B. Filipe, R. Vieira, A. R. Cruz-Machado, V. R. Fonseca, V. C Romão, A. R. Maceiras, L. Graca
|
|
2025 OP0294
|
TARGETED B-CELL THERAPY BY ANTI-CD19 CAR T CELLS INDUCES STABLE DISEASE REMISSION IN TREATMENT-REFRACTORY ANCA-ASSOCIATED VASCULITIS,
I. Minopoulou, A. Wilhelm, F. N. Albach, A. Kleyer, E. Wiebe, S. Schallenberg, A. Fleischmann, M. Frick, F. Damm, J. Gogolok, S. Serve, B. N. Locher, D. Borie, V. Casteleyn, R. Biesen, T. Dörner, E. Phitak, N. M. Drzeniek, T. Alexander, J. Zernicke, K. Movassaghi, M. L. Hütter-Krönke, E. Schrezenmeier, A. Schreiber, U. Schneider, L. Bullinger, G. Krönke, O. Penack, D. Simon
|
|
2025 OP0337
|
TRAJECTORIES OF THE EUSTAR AI, ACR CRISS AND REVISED CRISS UPON CD19.CART TREATMENT IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS,
C. Bergmann, S. Huang, J. Auth, A. Wirsching, M. Hagen, H. N. Kartalczik, R. Grieshaber-Bouyer, F. Müller, A. Mackensen, G. Schett, D. Khanna
|
|
2025 OP0365
|
Ianalumab’s dual mode of action: targeting B cells through enhanced B cell depletion and blockade of B cell-activating factor receptor signaling,
C. Wioland, C. Vedrine, C. Walter, F. Marque, T. Dannequin, M. Ceci, D. Buffet, C. Schmid, E. Degl’Innocenti, G. Robert, G. Wieczorek, D. Schubert, C. Paape, I. Isnardi
|
|
2025 OP0371
|
Transcriptomic analysis of transgender adolescents undergoing gender-affirming sex hormone therapy reveals sex-specific mechanisms associated with female childhood-onset SLE,
H. Cross, H. Peckham, G. Butler, E. Rosser, E. Jury, G. Robinson, C. Ciurtin
|
|
2025 OP0376
|
IL-17A+ HLA-DR-CCR6+ regulatory T cells: Dual role in T cell suppression and synovial inflammation in arthritis,
B. van Heeswijk, M. Bongenaar, N. Davelaar, P. H. P de Jong, R. J. E. M Dolhain, H den Braanker, E. Lubberts
|
|
2025 POS0004
|
Inhibition of Interleukin-2-Inducible T Cell Kinase with Soquelitinib demonstrates efficacy in preventing lung damage in murine models of systemic sclerosis,
G. Boleto, A. Cauvet, L. Y. Hsu, J. T. Rosenbaum, R. A. Miller, Y. Allanore
|
|
2025 POS0009
|
Early Onset and Durability of Efficacy in Inebilizumab-treated Participants with IgG4 Related Disease: Post Hoc Analyses from the Phase 3 MITIGATE Trial,
J. H. Stone, E. L. Culver, A. Khosroshahi, W. Zhang, K. Okazaki, Y. Tanaka, M. Lohr, N. Schleinitz, X. Dong, B. Hernandez, S. Cheng, D. Cimbora
|
|
2025 POS0010
|
A Novel Therapeutic Effect of VEGF Decoy Receptor Fusion Protein, VEGF-Grab, in Chronic Inflammatory Diseases,
H. Y. Lee, Y. Lee, K. G. Lee, S. H. Park, J. Kim, S. Kim, H. S. Lim, J. A. Shin, H. G. Yang, S. Lee, C. S. Cho, S. A. Yoo, S. H. Lee, W. U. Kim
|
|
2025 POS0012
|
Selective inhibition of TNFR1 signal by balinatunfib in vitro does not inhibit Treg expansion in contrast to anti-TNF biologics inhibiting TNFR1 and TNFR2 signaling,
G. Sibenhorn, M. Kohlmann, T. R. Matos, T. Leeuw
|
|
2025 POS0017
|
Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis,
S. Glavaris, A. Pearlman, J. Liu, J. Ge, Y. Xia, K. K. Kaeo, T. Awosika, C. Gliech, T. Nichakawade, N. Marco, C. Bettegowda, D. Pardoll, S. Paul, K. W. Kinzler, S. Zhou, B. Vogelstein, M. F. Konig
|
|
2025 POS0034
|
REGULATE-RA: A Phase 1 Study of CAR-T Regulatory Cells Targeting Citrullinated Proteins in Refractory Rheumatoid Arthritis: Interim Safety and Tolerability,
S. K. Baxter, L. Moreland, M. Griffith, E. Massarotti, J. A. Sparks, T. R. Katsumoto, S. Vlad, F. Aslam, J. Seifert, A. Clauw, R. Gyurko, O. Gabriel, A. Bitton, S. Fox-Bosetti, Y. Xiao, M. Jensen, M. G. Fromhold, A. L. Pace, H. Lebrec, M. L. Blake, A. R. van der Vuurst de Vries, M. L. Wang, J. N. Beilke, J. R. Arron, J. A. Bluestone
|
|
2025 POS0046
|
LSP1 DEFICIENCY INCREASES IL-17 PRODUCTION BY T CELLS AND ACCELERATES PRIMARY SJÖGREN’S SYNDROME,
J. Kim, J. G. Kim, K. G. Lee, S. H. Park, S. Kim, H. Y. Lee, C. S. Cho, W. U. Kim
|
|
2025 POS0047
|
SALIVARY GLAND IMMUNE-ORGANOIDS AS A MODEL TO INVESTIGATE SJOGREN’S DISEASE,
N. Goudarzi, L. Meudec, J. Pascaud, S. E Silva-Saffar, X. Mariette, G. Nocturne
|
|
2025 POS0049
|
PROTEOME ANALYSIS OF MINOR SALIVARY GLANDS REVEALS SUBGROUPS OF PATIENTS WITH DISTINCT CLINICAL PHENOTYPES IN SJÖGREN’S DISEASE,
N. Štucin, K. P. Pirkmajer, A. Hočevar, S. A. Krättli, D. M. Ferreira Francisco, B. Maurer, R. Bruggmann, P. Zigon, S. Čučnik, K. Klein
|
|
2025 POS0050
|
SERUM IMMUNE COMPLEXES ASSESSED USING A CELL-REPORTER ASSAY ARE ASSOCIATED WITH TYPE I INTERFERON SIGNATURE, MARKERS OF B-CELL ACTIVATION AND SYSTEMIC DISEASE ACTIVITY IN SJOGREN’S DISEASE: DATA FROM THE ASSESS PROSPECTIVE COHORT,
L. Robin, P. Kolb, C. Pouenat, H. Hengel, G. Nocturne, D. Cornec, V. Devauchelle-Pensec, V. Le Guern, C. Larroche, D. Sene, M. Couderc, E. Hachulla, P. Dieudé, O. Vittecoq, J. Morel, N. Meyer, M. Vierling, R. Voll, R. Seror, L. Mauvieux, P. M. DURET, L. Miguet, J. E. Gottenberg
|
|
2025 POS0057
|
EFFECTS OF T CELL ENGAGERS TREATMENT ON B AND T CELLS IN AUTOIMMUNE DISEASE,
L. Bucci, T. Rothe, K. Anoshkin, D. M. Nöthling, A. K. Götz, M. Eckstein, M. G. Raimondo, G. Schett, R. Grieshaber-Bouyer
|
|
2025 POS0058
|
GENERATION OF iPSC-DERIVED CAR-NK, γδ CAR-T, AND αβ CAR-T CELLS WITH POTENT ACTIVITY FOR TREATMENT OF B CELL-MEDIATED AUTOIMMUNE DISEASES,
J. Kurtz, D. Perry, D. Heinze, L. Campion, M. Mendonca, D. Chin, B. Gurung, C. Y. Kao, A. Perez, H. Levitsky, C. Cowan, G. G. Welstead
|
|
2025 POS0059
|
SELECTIVE DEPLETION OF dsDNA-SPECIFIC PLASMA CELLS WITH A DOUBLE-STRANDED POLYNUCLEOTIDE CONJUGATED TO AN ANTI-CD138 ANTIBODY IS BENEFICIAL ON LUPUS NEPHRITIS IN NZB/W MICE,
Q. Cheng, L. Khodadadi, P. Jani, J. Klotsche, T. Alexander, A. Radbruch, F. Hiepe
|
|
2025 POS0060
|
NEXT-GENERATION OFF-THE-SHELF CAR T CELLS: A NOVEL PLATFORM TO ENABLE COMPREHENSIVE ELIMINATION OF ABERRANT EFFECTOR CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES IN THE ABSENCE OF CONDITIONING CHEMOTHERAPY,
J. Goulding, J. Reiser, A. O’Connor, D. Morales-Mantilla, R. Mbofung, A. Williams, A. Gutierrez, M. Jelcic, Y. Pan, B. Groff, A. Macia, N. Brookhouser, T. Greene, S. Raman, R. Janani, B. Hancock, M. Denholtz, B. Rezner, R. Abujarour, L. Wong, V. Sandhu, T. Lee, B. Valamehr, J. Goodridge
|
|
2025 POS0069
|
SYNOVIAL IMMUNE CELLS EXHIBIT A TYPE I IFN GENE SIGNATURE IN ACPA-NEGATIVE RHEUMATOID ARTHRITIS,
A. Argyriou, M. H.II Wadsworth, C. Krishna, C. Gerstner, B. Horuluoglu, M. Sijbranda, L. Ronnblom, M. L. Eloranta, M. Wahren-Herlenius, A. Hensvold, A. Winkler, V. Malmström, K. Chemin
|
|
2025 POS0071
|
ANCA-ASSOCIATED VASCULITIS IMMUNOPATHOLOGY: INVESTIGATING CROSS REACTIVITY FOR AUTOANTIBODIES DIRECTED AGAINST PROTEINASE 3 AND Staphylococcus aureus ANTIGENS,
G. Boscato Sopetto, T. Pius, D. Missiakas, A. Hummel, M. Pizzato, M. F. Konig, M. Pandey, D. Cornec, U. Specks, G. Grandi, A. Berti
|
|
2025 POS0078
|
SPATIAL TRANSCRIPTOMICS REVEALS B CELL–DOMINATED MEDIAL INFLAMMATION AS A SPECIFIC FEATURE OF LARGE VESSEL GIANT CELL ARTERITIS,
C. Ansalone, M. Karabayas, J. Cole, E. Qian, I. Gupta, D. Vossou, S. McAllister, Y. Doncheva, S. Wright, N. Jamieson, C. S. Goodyear, N. Basu
|
|
2025 POS0080
|
MASS CYTOMETRY OF POLYMYAGIA RHEUMATICA SHOULDER BURSA BIOPSY REVEALS ACTIVATION AND PRO-INFLAMMATORY CYTOKINE EXPRESSION BY B CELLS AND PLASMACELLS,
B. Quere, S. Boukhlal, P. Hemon, P. Pochard, T. Marhadour, A. Uguen, D. Cornec, V. Devauchelle-Pensec, G. Carvajal Alegria
|
|
2025 POS0094
|
PHARMACODYNAMIC ACTIVITY OF JNJ-67484703 IN RHEUMATOID ARTHRITIS, ULCERATIVE COLITIS AND SJOGREN’S DISEASE (PARIS): RESULTS OF A PHASE II PROOF OF BIOLOGY TRIAL,
B. A. Fisher, J. van de Wiel, J. D. Turner, Y. S. Liu, T. Hosack, J. Young, S. Al-Taei, A. Baranskaya, F. Humby, J. McMurray, S. Gilbert, C. Shave, D. H. Gardner, S. Nayar, T. Cox, R. Muthinti, A. Recchioni, M. C. Maybury, P. de Pablo, S. Bowman, A. Rowe, C. D. Buckley, A. Richter, M. J. Loza, S. Marciniak, W. F. Ng, A. Pratt, S. Travis, V. Homer, A. Filer
|
|
2025 POS0179
|
CHARACTERIZATION OF MEMORY T CELL SUBSETS DURING FLARES AND DISEASE QUIESCENCE IN LUPUS,
C. Nassar, R. Quevedo, M. Ciudad, K. Manion, C. Munoz-Grajales, M. Kim, D. Gladman, Z. Touma, T. McGaha, J. Wither
|
|
2025 POS0233
|
TRANSLATIONAL REMODELLING AND AMIDE METABOLIC DYSREGULATION DIFFERENTIATE MTX RESPONDERS AND NONRESPONDERS IN PSORIATIC ARTHRITIS – A SINGLE CELL PERSPECTIVE,
M. Blom Petersen, O. Møberg, M. Randahl Nielsen, W. Zheng, A. Duvetorp, J. Gerwien, L. E. Jessen, L. E. Kristensen, M. Skougaard
|
|
2025 POS0325
|
RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT,
J. Patel, P. Emery, E. M. Vital, M. Y. Md Yusof
|
|
2025 POS0481
|
“Real World” Incidence and Characteristics of Immune Effector Cell–Associated Hemophagocytic Lymphohisticytosis: A GoCart Coalition Study on Behalf of the European Bone Marrow TraNsplantation (EBMT) Autoimmune Disease Working Party (ADWP), Cellular Therapy Working Party (CTIWP) ,
M. Doglio, R. D. Sandler, J. E. Galimard, E. Michel, P. Dreger, P. Chauvet, D. Blaise, P. Vandenberghe, C. Besley, L. López-Corral, C. Solano, F. Stolzen, F. Ciceri, H. Einsele, E. Angelucci, A. Rambaldi, I. Cutini, K. Kalwak, M. Martino, A. Ho, A. Perez-Martinez, A. Schmidt, J. Sramek, J. Mihalyova, M. Schaap, T. Alexander, J. Kuball, Z. Peric, A. Ruggeri, R. Greco
|
|
2025 POS0491
|
TITERS OF STANDARD VACCINATIONS, SERUM IMMUNOGLOBULINS AND CD19+ B-LYMPHOCYTES IN A TWO-YEAR-TIME-PERIOD AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR SYSTEMIC SCLEROSIS,
S. Endres, A. C. Pecher, R. Klein, J. Henes
|
|
2025 POS0614
|
AUTOANTIBODIES DIRECTED AGAINST THE ANGIOTENSIN II TYPE 1 RECEPTOR AND THE ENDOTHELIN-1 TYPE A RECEPTOR IN PATIENTS WITH SYSTEMIC SCLEROSIS,
K. E. van der Wouden, S. Ahmed, W. van Oostveen, E. Hoekstra, S. Liem, T. Huizinga, R. E. M. Toes, A. E. Voskuyl, G. Riemekasten, C. Fehres, M. Vonk, J. K. de Vries-Bouwstra
|
|
2025 POS0683
|
PREEXISTING ANTIBODIES AGAINST VACCINE ANTIGENS ARE PRESERVED IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SJÖGREN’S DISEASE UPON IANALUMAB TREATMENT WHILE AUTOANTIBODIES DECLINE,
T. Dörner, N. Shen, T. Grader-Beck, C. Walter, C. Wioland, C. Rauld, P. Schmutz, S. Riek, W. Hueber, C. Sips, S. Oliver, C. Lau, C. Bonal, I. Isnardi
|
|
2025 POS0695
|
SHIFT TOWARDS IgA EXPRESSION AND ABERRANT B CELL RECEPTOR SIGNALING RESPONSES IN DOUBLE NEGATIVE B CELLS FROM PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS,
R. Wilbrink, J. P. L. Spoorenberg, O. B. J. Corneth, S. Arends, E. Brouwer, F. G. M. Kroese, G. M. Verstappen
|
|
2025 POS0722
|
CHEMOKINE-ENGINEERED CAR-T CELLS FOR AUTOIMMUNITY: MULTIPLEXED mRNA TECHNOLOGY FOR IMPROVED MODE-OF-ACTION AND SAFETY,
S. Picht, L. Hemmerling, A. M. Klaas, D. Simon, A. Kleyer, M. Gossen, H. D. Volk, G. Krönke, M. Schmueck-Henneresse, N. M. Drzeniek
|
|
2025 POS0728
|
DECIPHERING SYNOVIAL FLUID IMMUNE DYSREGULATION IN RHEUMATOID ARTHRITIS THROUGH CYTOKINE PROFILING AND SINGLE-CELL TRANSCRIPTOMICS,
M. Lesturgie-Talarek, F. Carbone, V. Gonzalez, A. Schvartz, S. Hecquet, F. Oudart, M. Thomas, R. D’Alessandro, Y. Allanore, M. Ménager, J. Avouac
|
|
2025 POS0743
|
HARNESSING TOLEROGENIC DENDRITIC CELLS FOR ANTIGEN-SPECIFIC IMMUNE MODULATION IN RHEUMATOID ARTHRITIS: FINDINGS FROM THE TOLERANT TRIAL,
A. J. Stoppelenburg, N. Benne, G. Schreibelt, P. M. J. Welsing, L. Lammers, A. de Goede, T. Duiveman-de Boer, W. van Eden, P. Leufkens, I. J. M. de Vries, J. M. van Laar, F. Broere
|
|
2025 POS0797
|
UNIQUE IMMUNOLOGICAL CELL PROFILES AND KEY PATHWAYS ASSOCIATED WITH ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Martinez-Canales, A. Montoya-Rosales, G. Figueroa-Parra, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS0798
|
B CELL RECONSTITUTION IN SLE PATIENTS AFTER CAR-T CELL THERAPY IS MARKED BY A NAÏVE PHENOTYPE AND REDUCTION OF EXTRAFOLLICULAR IMMUNE RESPONSES,
D. M. Nöthling, L. Bucci, T. Rothe, K. Anoshkin, M. Hagen, A. Wirsching, J. Taubmann, P. Garantziotis, S. Völkl, F. Müller, A. Mackensen, G. Schett, R. Grieshaber-Bouyer
|
|
2025 POS0801
|
LOSS OF CD72 IMMUNE CHECKPOINT MOLECULES ON DOUBLE NEGATIVE 2 B CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND ASSOCIATION WITH DISEASE ACTIVITY AND TREATMENT,
K. Wangriatisak, W. Huang, C. de Vries, C. Grönwall, I. Gunnarsson, V. Malmström, F. Faustini
|
|
2025 POS0802
|
INTEGRATION OF INDEPENDENT scRNA-SEQ DATASETS FOR LUPUS NEPHRITIS KIDNEY BIOPSIES AND HEALTHY CONTROLS KIDNEY SAMPLES ALLOWS TO DETECT CELL-CELL COMMUNICATION PATHWAYS ENRICHED IN LUPUS NEPHRITIS,
N. Oparina, M. L. Eloranta, M. Wallgren, E. Skoglund, D. Leonard
|
|
2025 POS0856
|
ALTERED B CELL SUBPOPULATIONS IN GIANT CELL ARTERITIS,
B. Nieto-Carvalhal, I. Monjo-Henry, S. García-Carazo, E. De Miguel, M. E. Miranda-Carus
|
|
2025 POS0862
|
SPECIFIC CD4+T CELL AND CD8+T CELL SIGNATURE IN TAKAYASU ARTERITIS,
K. Xu, T. Li, L. Pan
|
|
2025 POS0876
|
EFFECT OF ANTI-CD19 CAR T CELL THERAPY IN THE BONE MARROW OF PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES,
I. Minopoulou, A. Wilhelm, F. N. Albach, A. Kleyer, E. Wiebe, A. Fleischmann, M. Frick, F. Damm, D. Borie, V. Casteleyn, R. Biesen, T. Dörner, T. Alexander, J. Zernicke, L. Hinkelmann, E. Phitak, N. M. Drzeniek, K. Movassaghi, M. L. Hütter-Krönke, E. Schrezenmeier, A. Schreiber, U. Schneider, G. Schett, L. Bullinger, G. Krönke, O. Penack, D. Simon
|
|
2025 POS0907
|
EXPOSURE TO AIR POLLUTION AND AXIAL SPONDYLOARTHRITIS FLARE: WHICH POLLUTANT AND WHICH CRITICAL WINDOWS COULD OPERATE AN EXPLORATORY CASE-CROSS-OVER ENVIRONMENTAL STUDY,
S. Pujol, F. Mauny, C. Vauchy, B. Martin, L. Fossi Djembi, C. Prati, Z. Nicod, N. Bernard, E. Toussirot
|
|
2025 POS0925
|
A POTENTIAL ROLE FOR BACTERIAL SUPERANTIGENS TO PROPAGATE AUTOANTIGEN-SPECIFIC T-CELLS IN RHEUMATOID ARTHRITIS,
A. Dubnovitsky, R. Kumar, B. Horuluoglu, S. Turcinov, L. Klareskog, V. Malmström
|
|
2025 POS0934
|
ANTI-CARBAMYLATED FIBRINOGEN RESPONSE IN RHEUMATOID ARTHRITIS IS ASSOCIATED WITH A MORE SEVERE STRUCTURAL PROGNOSIS (ESPOIR COHORT),
P. Brevet, B. Gerard, B. de Maleprade, V. Devauchelle-Pensec, T. Schaeverbeke, S. Candon, O. Boyer, T. Lequerré, M. Freret, O. Vittecoq
|
|
2025 POS0952
|
EFFECTS OF THE ANTI-CD3/CD19 T-CELL ENGAGER BLINATUMOMAB IN SEVERE SYSTEMIC SCLEROSIS,
F. Szelinski, H. Rincon-Arevalo, C. Gebhardt, G. Magno, G. Guerra, N. Neumann, P. Durek, F. Heinrich, M. F. Mashreghi, M. Bergwelt, M. Subklewe, A. Skapenko, H. Schulze-Koops, T. Dörner
|
|
2025 POS0954
|
CMV AND EBV REACTIVATION COMPARED TO LOW T HELPER AND CYTOTOXIC T CELLS WITH THE FOCUS ON THERAPY SAFETY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH SYSTEMIC SCLEROSIS,
S. Endres, A. C. Pecher, R. Klein, J. Henes
|
|
2025 POS0996
|
PRKD2 AS A CANDIDATE GENE MODULATING T CELL ACTIVATION IN FAMILIAL SYSTEMIC SCLEROSIS,
P. Maus, J. Hatoum, D. Nolf, T. Hirsch, T. Gomard, M. Vanthuyne, V. Smith, N. Limaye
|
|
2025 POS0998
|
CC312, A CD19-TARGETING, CO-STIMULATORY CD28 RECEPTOR-ACTIVATING TRI-SPECIFIC T CELL ENGAGER, FOR THE TREATMENT OF AUTOIMMUNE DISEASES,
Y. Huang, X. Zhang, C. Zhao, R. Zhang, J. Zhen, F. Pan, B. Zheng, R. Dai
|
|
2025 POS1001
|
SYSTEMIC SCLEROSIS PATIENTS WITH SKIN FIBROSIS REGRESSION EXHIBIT A PRO-INFLAMMATORY CD4+ T CELL PHENOTYPE,
A. Hofman, P. Bearzi, E. Pachera, L. Li, L. Much, K. Buerki, A. M. Hoffmann-Vold, M. O. Becker, O. Distler
|
|
2025 POS1005
|
IMMUNE SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS NOT TREATED WITH IMMUNOSUPPRESSIVE THERAPY COMPARED TO HEALTHY CONTROLS AS ANALYZED BY SINGLE-CELL RNA SEQUENCING,
T. Eviatar, N. Stein, A. Tsitsiklis, G. Mbambo, C. Joyce, J. Wollman, V. Furer, A. Polachek, O. Elkayam, D. Paran
|
|
2025 POS1007
|
SINGLE-CELL ANALYSIS OF CHANGES INDUCED BY ANIFROLUMAB IN PERIPHERAL BLOOD OF PATIENTS WITH SLE,
K. Terada, Y. Tsuchida, T. S. Ushijima, Y. Suwa, K. Saegusa, S. Yamada, T. Okamura, K. Fujio
|
|
2025 POS1054
|
METHOTREXATE WITHHOLDING INCREASES CD4+ SARS-CoV-2 SPIKE-SPECIFIC T CELL RESPONSE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AFTER COVID-19 mRNA vaccination,
N. K. H. Khoo, K. L. Teh, C. Huang, S. L. Poh, A. Chia, Y. X. Book, M. Wasser, J. G. Yeo, S. Albani, T. Arkachaisri
|
|
2025 POS1066
|
AN ALTERED IMMUNOMETABOLIC PROFILE CHARACTERIZES B CELLS OF PATIENTS WITH OLIGOARTICULAR- AND POLYARTICULAR- JUVENILE IDIOPATHIC ARTHRITIS,
E. Marasco, A. Aquilani, G. Tarantino, M. I. Petrone, R. Nicolai, I. Caiello, S. Barresi, S. Magni-Manzoni, F. De Benedetti
|
|
2025 POS1078
|
Impact of Immunosuppressive Therapies on Shingrix Vaccine Response in Immune-Mediated Inflammatory Diseases,
C. Sieiro Santos, J. Ordas Martínez, J. García Herrero, C. Álvarez Castro, A. López Robles, E. Diez Álvarez, J. M García Ruíz de Morales
|
|
2025 POS1113
|
TREATMENT OF SEVERE SYSTEMIC SCLEROSIS WITH BLINATUMOMAB, A BISPECIFIC ANTI-CD3/CD19 T CELL ENGAGER,
C. Gebhardt, F. Szelinski, H. Rincon-Arevalo, G. Magno, V. Buecklein, G. Haenel, G. Zugmaier, M. Bergwelt, M. Subklewe, T. Dörner, A. Skapenko, H. Schulze-Koops
|
|
2025 POS1122
|
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors–a review of the literature,
D. Nagra, K. Song, M. Adas, J. Odia, Z. Yang, M. Russell, K bechman, C. Wincup, A. Mahto, S. Banerjee, T. Blake, C. Rosa, G. Kasavkar, N. Gullick, J. Galloway
|
|
2025 POS1133
|
Upregulation of pro-survival receptors on antibody-secreting cells is linked to worse disease characteristics across SLE, Scleroderma and Sjögrens disease and offers potential new treatment angles,
T. D. Steinmetz, C. Hut, B Doornbos- van der Meer, H. Bootsma, J. Westra, F. G. M. Kroese, D. J. Mulder, K de Leeuw
|
|
2025 POS1134
|
The keyhole limpet hemocyanin (KLH) challenge model to establish early clinical proof-of-mechanism of investigational drugs for auto-immune diseases,
A. Meijs, M. Ronner, M. Jansen, M. Moerland, N. Klarenbeek
|
|
2025 POS1151
|
IMMUNOGENICITY AND IMMUNE ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AFTER RECEIVING SARS-COV-2 MRNA-BASED VACCINES,
P. Dhanasekaran, N. Y. Kow, A. Mak
|
|
2025 POS1157
|
CLUSTER ANALYSIS OF BEHCET SYNDROME BASED ON IMMUNE CELL SUBSETS AND CLINICAL FEATURES,
J. Li, S. Jin, F. Sun, X. Sun, T. Liu, Z. Li
|
|
2025 POS1188
|
PROSPECTIVE ANALYSIS OF IMMUNOGLOBULIN LEVELS IN PATIENTS WITH RHEUMATIC INFLAMMATORY DISEASES TREATED WITH INTERLEUKIN-6 PATHWAY INHIBITORS,
E. Perea, A. L. Jiménez-Portillo, A. Bermúdez-García, R. Caño, S. Gómez, F. Marco, M. Andrés
|
|
2025 POS1267
|
CC312, A NOVEL ENGINEERED CD19/CD3/CD28 TRI-SPECIFIC ANTIBODY, LEADS TO RAPID AND DEEP B-CELL DEPLETION AND HAS BROAD POTENTIAL FOR DEVELOPMENT IN AUTOIMMUNE DISEASES,
J. Qi, Y. Huang, R. Zhang, J. Zhen, X. Zhang, Y. wei
|
|
2025 POS1287
|
NEXT GENERATION SEQUENCING ANALYSIS IDENTIFIES HIGH FREQUENCY OF GENETIC VARIANTS POTENTIALLY LINKED TO INBORN ERRORS OF IMMUNITY IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY RHEUMATIC DISEASES,
P. Semeraro, M. Frassi, S. C. Giliani, F. Franceschini, P. Airo
|
|
2025 POS1347
|
THE IMMUNOMODULATORY ROLE OF MIF SIGNALING PATHWAY IN MDA5+ DM,
L. Ding, H. Luo, H. Zhu
|
|
2025 POS1361
|
EUBACTERIUM_RECTALE_GROUP IS A KEY PROTECTIVE FACTOR IN RHEUMATOID ARTHRITIS: BASED ON 16s rRNA SEQUENCING COMBINED WITH MENDELIAN ANALYSIS,
X. Liu, R. Wu, B. Li, C. Wang
|
|
2025 POS1363
|
IMMUNE LANDSCAPE OF MUSCLE-INFILTRATING CELLS IN IDIOPATHIC INFLAMMATORY MYOPATHIES: INSIGHTS FROM SINGLE-CELL TRANSCRIPTOMICS,
T. Yoshida, H. Takahashi, T. Itamiya, T. Iwasaki, N. Umezawa, H. Sasaki, K. Ninagawa, Y. Fujieda, Y. Miyazaki, Y. Kamata, M. Takeshita, M. Matsushita, T. Kawamoto, M. Maeda, A. Kubota, T. Toda, N. Tamura, Y. Kaneko, T. Takeuchi, K. Sato, S. Nakayamada, Y. Tanaka, K. Yoshida, T. Atsumi, S. Yasuda, K. Ohmura, A. Morinobu, K. Yamamoto, T. Okamura, K. Fujio
|
|
2025 POS1371
|
A UNIQUE CIRCULATING SOLUBLE SERUM MEDIATOR PROFILE, TREG EXPANSION AND IL-6 INDUCED STAT3 PHOSPHORYLATION IN CD4+ T CELLS ARE BIOMARKERS OF DISEASE FLARE IN RHEUMATOID ARTHRITIS,
A. E. Anderson, F. Rayner, J. Swift, D. Maunder, H. Lemos, D. J. Swan, L. Jones, G. Smith, A. Degnan, I. Wilson, J. Diboll, G. Reynolds, J. Sim, A. Melville, S. Siebert, I. B. McInnes, C. S. Goodyear, C. Hilkens, K. Raza, C. D. Buckley, K. F. Baker, A. Pratt, A. Filer, J. D. Isaacs
|
|
2025 POS1385
|
THE INTERPLAY BETWEEN CD4+ T CELLS AUTOPHAGY, METABOLISM AND FITNESS IN RHEUMATOID ARTHRITIS.,
D. Doulaptsi-Teeuwen, K. Kulakova, R. Sanaei, K. Panagiotidis, C. Kirby, C. Hughes, A. Connerton, M. Colfer, L. Durcan, E. McCarthy, M. Freeley, A. Floudas
|
|
2025 POS1387
|
DYSREGULATED GENES AND IMMUNE CELL SHIFTS IN OSTEOARTHRITIS HIGHLIGHTING M0 MACROPHAGES, MMP9, AND MAST CELL ACTIVITY,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS1392
|
PRESENCE AND CLINICAL SIGNIFICANCE OF ANTI-SMN ANTIBODIES IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES,
Y. Imai, M. Takeshita, K. Suzuki, H. Fukui, K. Furuhashi, K. Matsumoto, J. Kikuchi, K. Yoshimoto, Y. Kaneko
|
|
2025 POS1394
|
CO-STIMULATORY BLOCKADE CAUSES TARGETED QUANTITATIVE CONTRACTIONS IN EXTRAFOLLICULAR B-CELL SUBSETS WITH CLINICAL IMPROVEMENT IN SEROPOSITIVE RA,
G. Silverman, W. Rigby, J. Shwetar, S. Skopelja-Gardner, A. Amarnani, K. Ruggles
|
|
2025 POS1402
|
NEXT GENERATION CAR-NK CELL THERAPY LEVERAGES ALLOIMMUNE DEFENSE TECHNOLOGY TO PERSIST WITHOUT CONDITIONING CHEMOTHERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASE,
T. Greene, S. Peng, C. Bickers, M. Lunning, P. Lulla, V. Bachanova, A. Williams, D. Morales-Mantilla, R. Mbofung, A. Aguilar, N. Brookhouser, S. Reeder, W. Zhao, D. Patel, R. Abujarour, T. Lee, R. Clarke, B. Rezner, J. Goodridge, R. Elstrom, D. Zack, V. Sandhu, B. Valamehr, L. Wong
|
|
2025 POS1414
|
SINGLE-CELL RNA SEQUENCING REVEALS DISTINCT IMMUNE SIGNATURES IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER COMPARED TO HEALTHY CONTROLS,
L. Merlo Pich, M. Ozturk, Y. Negishi, R. Deniz, A. Ziogas, M. Mhlanga, A. Gül, M. Netea
|
|
2025 POS1418
|
TRANSLATIONAL INVESTIGATION OF EXPRESSION OF IMMUNE CHECKPOINT MOLECULES IN RHEUMATOID SYNOVITIS,
A. Ezdoglian, W. R. P. van der Heijden, M. M. Steinz, G. Jansen, C. J. van der Laken
|
|
2025 POS1424
|
THE ROLE AND DISTRIBUTION OF AGE-RELATED T HELPER CELLS IN RHEUMATOID ARTHRITIS WERE ANALYZED BASED ON SINGLE-CELL TRANSCRIPTOME SEQUENCING,
X. Liu, C. Wang
|
|
2025 POS1429
|
CHAPERONE-MEDIATED AUTOPHAGY IN SYNOVITIS DISTINGUISHES PSORIATIC ARTHRITIS FROM RHEUMATOID ARTHRITIS,
V. Venerito, S. del Vescovo, T. Caferri, G. Cazzato, F. Girolamo, F. Cacciapaglia, G. Lopalco, F. Iannone
|
|
2025 POS1432
|
MECHANISMS OF CD45RChigh T AND B CELL DEPLETION BY AN ANTI-CD45RC mAb IN EXPERIMENTAL RHEUMATOID ARTHRITIS,
C. Bergua, M. Besnard, G. Ahmil, L. H. Ouisse, N. Vimond, E. Brisebard, F. Blanchard, T. Larcher, R. Van Brempt, B. Le Goff, I. Anegon, C. Guillonneau
|
|
2025 POS1436
|
HUMAN PBMC-BASED HUMANIZED MICE EXHIBIT ASPECTS OF A MYOSITIS MODEL AND POTENTIAL FOR EVALUATING MYOSITIS THERAPEUTICS,
A. Nishidate, K. Takemoto, Y. Imura, Y. Koda
|
|
|
[46]
|
And Inclusion (DEI)
|
|
|
| 2025 |
|
2025 ABS0046
|
THE EVOLVING ROLE OF JANUS KINASE INHIBITORS (JAKI) IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): AN INTERNATIONAL DELPHI STUDY,
A. Barkaway, P. J. Mease, R. Moots, M. Ndosi, Z. Rutter-Locher, M. McLean
|
|
2025 ABS0651
|
RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM,
V. Ruiz-Esquide, D. Roig-Vilaseca, L. Mateo-Soria, S. Holgado Pérez, A. Nack, C. Perez-Garcia, H. S. Park, H. Borrell Paños, J. A. Gómez-Puerta, R. Sanmarti
|
|
2025 ABS0685
|
PERFORMING NAILFOLD CAPILLAROSCOPY UTILISING DIFFERENT WAVELENGTH LIGHT SOURCES TO INVESTIGATE OPTIMAL IMAGING OF CAPILLARIES IN DARKER SKIN TONES,
M. Parkes, S. N. Nkouontchie, L. Robogo, L. Tilson, M. Berks, G. Dinsdale, J. Manning, S. Wilkinson, S. Groves, A. Vail, C. Wagstaff, C. Taylor, A. L. Herrick, A. Murray
|
|
2025 ABS0693
|
IDENTIFYING STEREOTYPES AMONGST EARLY TRAINEES FOR PATIENTS WITH RHEUMATIC DISEASES,
K. Young, L. Hamilton, J. Liew, J. Stone
|
|
2025 ABS0802
|
MATERNITY, DISCRIMINATION, AND WORKPLACE ADJUSTMENTS AMONG FEMALE RHEUMATOLOGISTS AND PROFESSIONALS IN LATIN AMERICA: A CROSS-SECTIONAL STUDY,
D. B. Tovar-Bastidas, Y. Chichotky, A. Beltrán-Ostos, A. M. Arredondo-González, A. Lucas Ribeiro, A. Bran, D. N. Rincon-Riano, E. V. Sarabia Chavez, M. Peixoto Guimarães e Silva de Souza, S. Bonilla-Tovar, V. Rivera Terán, M. Resende, A. M. Sapag Duran, G. Vásquez
|
|
2025 ABS0988
|
LACK OF INSURANCE IS THE STRONGEST SOCIOECONOMIC FACTOR AFFECTING ADVERSE OUTCOMES IN LUPUS PATIENTS IN THE BRONX, NY,
M. Gellman, X. Xie, J. Allen, J. Shafik, K. Brennan, M. Ashrafi, A. Ramu, A. Kumthekar, N. Schwartz
|
|
2025 ABS0989
|
NO TITLE,
N. Nooh, Z. Shahnawaz, A. Budhwani, R. Turkawi, A. Filer, B. Rhodes, H. Merris, I. Sahbudin
|
|
2025 ABS1001
|
ANALYSIS OF THE ACTIVITY OF A MULTIDISCIPLINARY COMMITTEE ON SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES IN A TERTIARY CARE HOSPITAL,
E. Fernández Panadero, G. Moral García, J. L. Rodas Flores, V. Moreira Navarrete, F. J. Toyos Sáenz de Miera, J. J. Pérez Venegas
|
|
2025 ABS1038
|
USE OF A MOLECULAR SIGNAL RESPONSE CLASSIFIER INFORMS TREATMENT SELECTION AND IMPROVES OUTCOMES IN HISPANIC PATIENTS WITH RHEUMATOID ARTHRITIS,
G. Karpouzas, M. Rodriguez, V. Bui, S. Ormseth
|
|
2025 ABS1126
|
HIGH INTEREST AMONGST NON-ACADEMIC RHEUMATOLOGISTS FOR INVOLVEMENT IN CLINICAL TRIALS IN THE UNITED STATES,
M. Bacalao, G. Wright, G. Kerr, S. Dowell
|
|
2025 ABS1130
|
IMPACT OF OPHTHALMIC CONDITIONS ON HOSPITAL OUTCOMES IN PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES: A NATIONWIDE STUDY,
I. Mannstadt, Y. Wu, R. Parikh, B. Mehta
|
|
2025 ABS1168
|
PATIENTS WITH VERY EARLY PERIPHERAL PSORIATIC ARTHRITIS HAVE FEW SWOLLEN JOINTS BUT MODERATE DISEASE ACTIVITY SCORES, WITH NO DIFFERENCES NOTED BETWEEN MEN AND WOMEN: FIRST RESULTS OF THE NATIONAL APACHE COHORT, 186 PATIENTS,
L. Gossec, V. Devauchelle-Pensec, P. Richette, A. Constantin, F. Berenbaum, C. Gaujoux-Viala, P. Goupille, D. Wendling, G. Mouterde, T. Pascart, B. Razat, E. Audureau, S. Jousse-Joulin, B. Combe, P. Claudepierre
|
|
2025 ABS1196-HPR
|
HIGH REPORT OF SIDE-EFFECTS, AND ASSOCIATION OF PATIENTS’ AGE WITH TOLERANCE OF SUBCUTANEOUS METHOTREXATE – TELEPHONE SURVEY RESULTS FROM A QUALITY IMPROVEMENT PROJECT,
W. Hussan, J. Lau, G. Koli, S. Wig, S. Vasireddy
|
|
2025 ABS1229-HPR
|
ENHANCING ACCESS TO LUPUS CLINICAL TRIALS: EXPLORING BARRIERS TO LUPUS CLINICAL TRIAL PARTICIPATION AMONG US SITES SERVING LOW-INCOME AND DISADVANTAGED PATIENTS,
H. Pandyaram, C. Timon, S. Sheikh, T. Englund
|
|
2025 ABS1231-HPR
|
COMMUNITY PERSPECTIVES ON ADVANCING EQUITY IN LUPUS CLINICAL TRIALS: INSIGHTS FROM PHYSICIANS, PATIENTS, RESEARCH STAFF, AND ORGANIZATIONAL REPRESENTATIVES IN NORTH AMERICA,
T. Englund, C. Timon, K. Holben, S. Sheikh
|
|
2025 ABS1239-PARE
|
ANMAR YOUNG GROUP HELP FOR RMD PATIENTS: AN ITALIAN VOLUNTEERING EXAMPLE OF SUPPORT,
G. Mascarino, I Testa, G. Barison, B. Garrone
|
|
2025 ABS1240-PARE
|
CHILEAN NETWORK OF RHEUMATIC PATIENTS INVOLVING DIFFERENT STAKEHOLDERS TO CO-BUILD SOLUTIONS FOR OUR PATIENTS: PUBLIC FORUM TO DISCUSS PUBLIC HEALTH AND MANAGEMENT OF RMDS IN THE COUNTRY,
G. Tobar Carrizo, C. D. González Quintana, E. Rocuant, R. Atenas, C. Quijada
|
|
2025 ABS1248-PARE
|
1st SCLERODERA NATIONAL CONGRESS FOR PATIENTS IN SPAIN. DECALOGUE IDEAL MODEL CARE FOR SCLERODERMA,
M. Piñero Vegas, A. Sánchez Lorite, I. Martín Ramos
|
|
2025 ABS1251-PARE
|
IN SEARCH OF A LAW FOR THE RIGHTS OF PEOPLE WITH LUPUS IN MEXICO: IDENTIFYING DISCRIMINATION, INEQUITIES, AND COMMUNITY PATHWAYS,
E. Calleja Macedo, L. Athié
|
|
2025 ABS1258-PARE
|
FROM BENCH TO VOICE: EMBEDDING PATIENT INVOLVEMENT IN RHEUMATOLOGY RESEARCH,
S. Grealis, F. M. Quinlan, S. E. Bender, S. M. O’Connor, J. M. Kinahan Finnan, K. Sheridan, A. G. Wilson, E. Dorris
|
|
2025 ABS1259-PARE
|
INCLUDING RURAL PATIENTS IN RHEUMATOLOGY RESEARCH: EXPLORING THE TENSION BETWEEN INVOLVING PATIENTS AS CO-RESEARCHERS AND BREACHING CONFIDENTIALITY OF THEIR MEDICAL CONDITION,
M. McLucas, A. Croker, N. Perry, J. Croker
|
|
2025 OP0026
|
Health literacy associates with clinical, treatment and work status in people with inflammatory arthritis: Results from a national cohort,
M. Dey, S. Norton, A. Cope, M. Buch, R. Osborne, J. Galloway, E. Nikiphorou
|
|
2025 OP0197
|
PREMATURE MORTALITY IN RHEUMATOID ARTHRITIS: A NATIONWIDE ANALYSIS OF YPLL, ASMR, MEDIAN AGE OF DEATH, AND ODDS OF EARLY DEATH,
P. Das, S. S. P. Singamsetti, E. Yen, R. R. Singh
|
|
2025 OP0233-PARE
|
UNDERSTANDING SEXUALITY IN RHEUMATIC AND MUSCULOSKELETAL DISEASES: EXPANDING THE REUMASUTRA PROJECT TO THE GENERAL POPULATION,
J. B. J. B. Negrón, R. (Lliga Reumatològica Catalana)
|
|
2025 OP0238-PARE
|
LIVING WITH LUPUS AS A MAN – A MAJOR CHALLENGE TO IMAGE OF SELF,
Z. Karakikla-Mitsakou, R. Chotai, A. Spanou Nicolaou, C. Kyriakou Yiasoumi, E. Koskina, A. Cornet
|
|
2025 OP0350-PARE
|
Do Patient Research Partners and Researchers share the same perspective on collaborative research Assessing implementation of the EULAR recommendations for PRP involvement in the STRATA-FIT Consortium,
S. Rumpl Tunjić, D. Rodrigues, B. Maat, S. Valpereiro, N. Trehan, B. Barten, I. Pitsillidou, E. Mateus, K. Chingov, P. Studenic, P. M. J. Welsing, J. M van Laar
|
|
2025 OP0356-PARE
|
ReumaCuida: Empowering Women with RMDs in Caregiving Roles,
E. Bretones Espejo, C. Alves, S. Muntadas Castelló, M. S. García Rodríguez
|
|
2025 OP0367-HPR
|
Health literacy needs among migrant patients with inflammatory rheumatic diseases - diversity of strengths and challenges: a qualitative exploration,
L. Treacy, L. M. Alpers, S. Hakim, M. Azimi, H. A. Zangi
|
|
2025 OP0370-HPR
|
Exploring Health Literacy and eHealth Literacy Strengths and Challenges Among Danish Gout Patients: A Co-Design process for Developing a Nurse-Led Telehealth Intervention,
S. B. Vestergaard, C. Ammitzbøll, R. Osborne, C. Cheng, M. Hawkins, A de Thurah
|
|
2025 POS0060
|
NEXT-GENERATION OFF-THE-SHELF CAR T CELLS: A NOVEL PLATFORM TO ENABLE COMPREHENSIVE ELIMINATION OF ABERRANT EFFECTOR CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES IN THE ABSENCE OF CONDITIONING CHEMOTHERAPY,
J. Goulding, J. Reiser, A. O’Connor, D. Morales-Mantilla, R. Mbofung, A. Williams, A. Gutierrez, M. Jelcic, Y. Pan, B. Groff, A. Macia, N. Brookhouser, T. Greene, S. Raman, R. Janani, B. Hancock, M. Denholtz, B. Rezner, R. Abujarour, L. Wong, V. Sandhu, T. Lee, B. Valamehr, J. Goodridge
|
|
2025 POS0196-PARE
|
STEROIDS AND ME: A PRACTICAL TOOL FOR SHARED DECISION-MAKING ABOUT GLUCOCORTICOID TAPERS,
J. H. Stone, M. Stone, M. Petri, G. Papliodis, C. Cotton, M. Marinaro, J. McDowell, J. Gelfand, H. Ansari, K. Kaminishi
|
|
2025 POS0198-PARE
|
AN UNMET GENERATION: “HOW CAN WE BETTER SUPPORT PEOPLE WITH AN RMD AGED 30-45”,
P. Pennings MSc, P. Borsje MSc, J. Coehorst, H. Koning, N. Krikhaar, G. Willemsen- de Mey MSc
|
|
2025 POS0350-PARE
|
BARRIERS TO INTERVENTION UPTAKE IN THE REMOTE MONITORING OF RHEUMATOID ARTHRITIS (REMORA2) TRIAL: FINDINGS FROM QUALITATIVE INTERVIEWS,
J. Behan-Devlin, S. Moschogianis, K. Staniland, C. Sharp, S. van der Veer, W. Dixon, D. Dowding, C. Sanders
|
|
2025 POS0360-PARE
|
PARTICIPACIENTES: TRAINING FOR THE INVOLVEMENT OF RHEUMATIC PATIENTS IN RESEARCH,
L. Cano-Garcia, J. M. Martín Martín, M. J. Montesa, J. Garcia Campos, F. Cortes, V. Romero Pazos
|
|
2025 POS0407
|
GENDER SPECIFIC DIFFERENCES IN RHEUMATOLOGISTS’ REASONS TO SHIFT FROM HOSPITAL TO PRIVATE PRACTICE - FINDINGS FROM A SURVEY ACROSS EUROPE,
J. Sautner, A. Posch, C. Duftner, I. Grabner
|
|
2025 POS0474
|
Hispanic Knee Osteoarthritis Patients’ and Partners’ Perspectives Regarding Exercise,
E. Vina, L. Stauber, C. Villamil-Grest, R. Gomez, A. Hurtig, F. Razzaq, J. Dagnino, K. Bennell, C. K. Kwoh
|
|
2025 POS1014-PARE
|
AGENCY FOR RECOGNIZING THE DISEASE: LÚPICA AS A TOOL FOR (SELF-)LEARNING FOR DOCTORS AND PEOPLE WITH LUPUS,
E. Calleja Macedo, L. Athié
|
|
2025 POS1016-PARE
|
EMBEDDING A CONSUMER-DRIVEN APPROACH INTO AUSTRALIAN ARTHRITIS RESEARCH: GUIDANCE FROM A NATIONAL MULTI-STAGE CONSULTATION,
D. Liew, J. Smithers, L. Hardy, G. Banfield, S. Croxford, A. Forsyth, S. Mills
|
|
2025 POS1067
|
SIX-MONTH OUTCOMES FOLLOWING FIRST TNFi FOR JIA: THE ASSOCIATION WITH ETHNICITY AND SOCIOECONOMIC POSITION,
R. Beesley, L. Kearsley-Fleet, E. Baildam, M. W. Beresford, S. Douglas, T. Southwood The U.K. J I A Biologics Register, K. Hyrich, J. Humphreys
|
|
2025 POS1068
|
THE ASSOCIATION BETWEEN ETHNICITY, SOCIOECONOMIC POSITION AND OUTCOMES FOLLOWING INITIATION OF METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITIS,
R. Beesley, L. Kearsley-Fleet, E. Baildam, M. W. Beresford, S. Douglas, T. Southwood The U.K. J I A Biologics Register, K. Hyrich, J. Humphreys
|
|
2025 POS1105
|
GENDER DISPARITIES IN CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH SARCOID MYOCARDITIS: A RETROSPECTIVE COHORT STUDY,
B. Subedi, R. Ali, J. R. Lam, S. Abdollahi, A. Lau, I. Tan
|
|
2025 POS1123
|
Myositis Community Proposes a Framework to Guide Clinical Trials and Ensure Patient Safety during Influx of CAR-Based Therapies,
L. A. Saketkoo, K. Cheng, I de Groot, M de Visser, S. Shenoi, M. Dimachkie, G. Gilkeson, V. P. Werth, J. Day, J. Paul, K. A. Chandwar, T. Gono, L. Gupta, J. Paik, A. Valenzuela Vegara, F. Muehlensiepen, E. Naddaf, F. C. Ernste, J. Albayda, P. Basharat, H. Alexanderson, B. Shafranski, K. Highland, L. Christopher Stine, V. Venerito, L. Kobert, C. Galloway, C. V. Oddis, R. Nicolai, J. Koopman, E. Marrani, H. So, J. Andrews, C von Muhlen, A. Khojah, R. Mirza, P. Vignesh, A. Huber, E. Dourado, M. Giannini, M. Kuwana, V. Leclair, L. Chung, A. S. Zubair, J. Sanchez, C. W. Tseng, M. Lubinus, A. Meyer, D Brito de Araujo, S. Moghadam-Kia, B. Yi, B. Bader-Meunier, M. Sumaila, F. Gok, L. Andrade Ortega, P. Gordon, A. Allenzara, A. Haemel, N. Olsen, M. Shaaf, R. Gomez, J. M. de Souza, W. Gregory, A. Sharma, M. López-Corbeto, I. Ventura, N. Gonzalez, C. Papadopoulou, G bird, M. Fornaro, J. Vencovský, J. Makowska, A. Benitez, A. Fernandez, S. O’Connor, M. Groener, A. Dihkan, C. Lowe, P. Machado
|
|
2025 POS1402
|
NEXT GENERATION CAR-NK CELL THERAPY LEVERAGES ALLOIMMUNE DEFENSE TECHNOLOGY TO PERSIST WITHOUT CONDITIONING CHEMOTHERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASE,
T. Greene, S. Peng, C. Bickers, M. Lunning, P. Lulla, V. Bachanova, A. Williams, D. Morales-Mantilla, R. Mbofung, A. Aguilar, N. Brookhouser, S. Reeder, W. Zhao, D. Patel, R. Abujarour, T. Lee, R. Clarke, B. Rezner, J. Goodridge, R. Elstrom, D. Zack, V. Sandhu, B. Valamehr, L. Wong
|
|
2025 POS1415
|
IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON OUTCOMES AMONG ADULTS WITH ARTHRITIS: A LATENT CLASS ANALYSIS OF NATIONALLY REPRESENTATIVE DATA FROM THE CANADIAN LONGITUDINAL STUDY OF AGING,
M. M. Thomas, E. C. Sayre, M. Harrison, M. A. De Vera
|
|
2025 POS1416
|
GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: SHOULD MALES WITH RHEUMATOID ARTHRITIS WORRY,
T. V. Mohta, U. Chukwuemeka, P. Barve, B. Khin, S. Vuong, P. Tangirala, M. Baidya
|
|
2025 POS1417
|
RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE IN HOSPITALIZED PATIENTS: A FIVE-YEAR NATIONWIDE ANALYSIS,
T. V. Mohta, U. Chukwuemeka, P. Barve, B. Khin, S. Vuong, P. Tangirala, M. Baidya
|
|
|
[75]
|
And Physical Activity
|
|
|
| 2025 |
|
2025 ABS0147
|
EARLY IMPROVEMENTS IN QUADRICEPS MUSCLE INHIBITION AS A KEY DETERMINANT OF FUNCTIONAL RECOVERY FOLLOWING TOTAL KNEE ARTHROPLASTY,
E. Unuvar-Yuksel, S. Bozgeyik-Bagdatli, H. Guney-Deniz, O. Caglar
|
|
2025 ABS0283
|
EXERCISE-INDUCED ADAPTATIONS TO AEROBIC TRAINING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND EFFECT MODIFICATION BY TYPE 1 INTERFERON ACTIVITY – A RANDOMIZED CONTROLLED SINGLE-CENTER CLINICAL TRIAL,
M. Lund Adamsen, I. Rasmussen, M. Lyngbæk, P. Hoejgaard, S. Jacobsen
|
|
2025 ABS0334
|
ARE HEALTH STATUS AND TREATMENT BURDEN ASSOCIATED WITH NON-RESPONSE BIAS IN PATIENTS WITH CHRONIC SPINAL PAIN A PROSPECTIVE COHORT STUDY,
J. Gandløse, R. Westermann, S. Christensen, J. Vela, L. Dreyer, S. Skou, A. Olesen, L. Jønholt, T. Palsson
|
|
2025 ABS0376
|
COMPARISON OF SEDENTARY BEHAVIOUR PATTERNS IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT INTERSTITIAL LUNG DISEASE,
S. W. Tio, A. Kelleher, J. Morrow, L. Chawke, K. Quinn, H. O Leary, L. Larkin, M. Henry, G. Murphy
|
|
2025 ABS0430
|
THE NOVEL DIGITAL THERAPEUTIC AXIA IMPROVES DISEASE ACTIVITY, FUNCTIONALITY, AND QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS PATIENTS: EIGHT WEEK OUTCOME FROM A 12-WEEK RANDOMIZED CONTROLLED CROSSOVER TRIAL,
P. P. Strunz, T. Heusinger, M. Le Maire, A. Fleischer, K. S. Luetkens, P. Possler, M. Gernert, H. Labinsky, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, M. Fröhlich, M. Schmalzing
|
|
2025 ABS0623
|
ANALYSIS OF YOUTUBE VIDEOS ON TOTAL HIP AND KNEE ARTHROPLASTY REHABILITATION IN TERMS OF QUALITY AND RELIABILITY,
B. Unver, G. Cura, E. Aydin
|
|
2025 ABS0624
|
EVALUATION OF PHYSICAL FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS BY MOBILITY DISABILITY STAGE,
H. Yamamoto, M. Suzuki, T. Sugiura, Y. Saito, Y. Saito, K. Terabe, R. Sato, J. Hasegawa, Y. Ohno, T. Sato, S. Asai, S. Imagama
|
|
2025 ABS0634
|
COMPARATIVE EFFECTIVENESS OF CONVENTIONAL REHABILITATION, GLOBAL POSTURAL REEDUCATION, AND PAIN NEUROSCIENCE EDUCATION IN MANAGING CHRONIC LOW BACK PAIN,
S. Bouden, S. Ben Hamouda, L. Rouached, A. Ben Tekaya, I. Mahmoud, R. Tekaya, O. Saidane, L. Abdelmoula
|
|
2025 ABS0635
|
FACTORS ASSOCIATED WITH PHYSICAL ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. INSIGHTS FROM THE IMAS STUDY,
M. Garrido-Cumbrera, F. Sommerfleck, D. Poddubnyy, J. Correa-Fernández, J. Lowe, C. Bundy, S. Makri, S. M. Akerkar, V. Navarro-Compán
|
|
2025 ABS0711
|
PRIORITY SETTING OF PHYSICAL ACTIVITY BARRIERS AND FACILITATORS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS: A NOMINAL GROUP TECHNIQUE STUDY,
M. Ester, K. Dhiman, R. Githumbi, M. Sipley, K. Adhikari Dahal, C. E. H. Barber
|
|
2025 ABS0846
|
CONTENT ANALYSIS OF YOUTUBE VIDEOS ABOUT DE QUERVAIN’S TENOSYNOVITIS: ASSESSMENT OF QUALITY AND RELIABILITY OF INFORMATION,
U. Kalkan, B. Unver
|
|
2025 ABS0855
|
EVALUATION OF COMMON AND NOVEL RISK FACTORS FOR LOW BONE MINERAL DENSITY IN SYSTEMIC SCLEROSIS, A CASE CONTROL STUDY OF 211 PATIENTS,
K. Lillpers, M. Najibi, K. Andréasson, R. Hesselstrand, K. Åkesson, M. C. Kapetanovic
|
|
2025 ABS0890
|
ABNORMAL PHENOTYPES OF BODY COMPOSITION AND ITS ASSOCIATION WITH PHYSICAL PERFORMANCE IN PATIENTS WITH SPONDYLOARTHRITIS,
U. Kiltz, M. Bedei, I. Kononenko, I. Redeker, D. Kiefer, P. Sewerin, I. Andreica, A. L. Kernder, D. Vossen, B. Bühring, X. Baraliakos
|
|
2025 ABS0949
|
SURFACE ELECTROMYOGRAPHY (s-EMG) ANALYSIS AND MACHINE LEARNING FOR DISEASE ACTIVITY EVALUATION IN ANKYLOSING SPONDYLITIS (AS),
C. Sun, X. Wang, N. Fei, Z. Xie, L. Tu, Z. Lin
|
|
2025 ABS0967
|
THE IMPACT OF ANTI-TNF-ALPHA AND ANTI-IL-17 BIOLOGICAL DRUGS ON CHRONIC PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT FIBROMYALGIA,
M. Raimondi, S. Formisano, I. Pantano, F. Ciccia, R. Tirri
|
|
2025 ABS1043
|
INVESTIGATION OF FACTORS AFFECTING HOME EXERCISE ADHERENCE AFTER TOTAL KNEE ARTHROPLASTY,
A. Başyiğit, A. Abit Kocaman, M. Kaşikci Çavdar, M. Çalbiyik
|
|
2025 ABS1072
|
PHYSICAL ACTIVITY IN PATIENTS WITH SJÖGREN’S DISEASE: COMPLIANCE WITH WORLD HEALTH ORGANIZATION RECOMMENDATIONS AND RELATIONSHIP WITH HEALTH-RELATED QUALITY OF LIFE,
N. S. Ausma, D. Harmsen, M. Carbo, D. Paap, H. Bootsma, S. Arends
|
|
2025 ABS1170-HPR
|
EFFICACY OF MYOFASCIAL INDUCTION COMPARED WITH ITS SIMULATION ON JOINT AMPLITUDE IN PEOPLE WITH AXIAL SPONDYLARTHRITIS: A RANDOMIZED CLINICAL TRIAL,
M. A. Sánchez Vera, M. L. Alfonso Mora, D. A. Jaimes Fernández, R. Schleip, A. Pilat
|
|
2025 ABS1172-HPR
|
THE EFFICACY OF A TELEREHABILITATION-BASED CLINICAL PILATES PROGRAM ON LUMBOPELVIC MUSCLE MORPHOLOGY AND STRENGTH IN FEMALE PATIENTS WITH FIBROMYALGIA SYNDROME: A RANDOMIZED CONTROLLED TRIAL,
F. Sari, Y. MİRZA, P. D. Yilmaz, A. Kucuk
|
|
2025 ABS1177-HPR
|
OBJECTIVE ASSESSMENT OF PHYSICAL ACTIVITY IN ADULTS WITH SYSTEMIC SCLEROSIS,
E. B. Cokol, D. C. Saraç, N. B. Karaca, O. Ustun, E. A. Akatay, İ. Kurut Aysin, M. Ozmen, S. Gucenmez, S. Akar, D. Bayraktar
|
|
2025 ABS1191-HPR
|
THE INFLUENCE OF PAIN CHARACTERISTICS ON INSOMNIA, KNEE FUNCTION, AND MUSCLE STRENGTH IN PATIENTS WITH KNEE OSTEOARTHRITIS,
S. N. Aslan, S. Bozgeyik-Bagdatli, G. I. Kinikli
|
|
2025 ABS1193-HPR
|
THE TYPE AND THE EFFECT OF PHYSICAL ACTIVITY ON QOL AND DEPRESSION IN PATIENTS WITH RMDS IN GREECE: A CROSS-SECTIONAL STUDY,
D. K. Bonia, P. Siaperas, A. Fotiou
|
|
2025 ABS1194-HPR
|
INVESTIGATION OF BALANCE AND CORE ENDURANCE IN PATIENTS WITH FIBROMYALGIA SYNDROME,
S. Baglan Yentur, M. Ş. Elbasti, B. Dagdeviren, D. Cetintas
|
|
2025 ABS1202-HPR
|
INVESTIGATION OF NEUROPATHIC PAIN AND RELATED FACTORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS,
M. Ş. Elbasti
|
|
2025 ABS1208-HPR
|
INVESTIGATION OF FATIGUE AND PHYSICAL ACTIVITY LEVELS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER,
T. Civi Karaaslan, S. Ugurlu, Z. Toker Dincer, E. Tarakci
|
|
2025 ABS1210-HPR
|
COMPARISON OF PHYSICAL ACTIVITY LEVELS, GENERAL HEALTH STATUS, QUALITY OF LIFE, AND MOOD OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME WITH HEALTHY INDIVIDUALS,
M. B. Şentürk, N. Köse, A. Özçadirci, M. Ekici, L. Kiliç
|
|
2025 ABS1219-HPR
|
THE DIFFERENCE BETWEEN LUNG AGE AND REAL AGE IN PATIENTS WITH RHEUMATOID ARTHRITIS,
Z. Çelik, F. Sari, H. Apaydin, K. Yavuz, M. Pamukcu
|
|
2025 ABS1220-HPR
|
DEVELOPMENT OF THE PEDIATRIC PHYSICAL ACTIVITY TRACKING PLATFORM (PEDI@CTIVITY) AND SMARTWATCH-BASED BIG DATA ANALYSIS: A DIGITAL HEALTH APPLICATION IN SOCIETY 5.0,
N. Arman, T. Çakar, S. Güllü, N. Aktay Ayaz, A. Yekdaneh, A. Albayrak
|
|
2025 LB0002
|
THE NOVEL DIGITAL THERAPEUTIC AXIA IMPROVES DISEASE ACTIVITY, FUNCTIONALITY, AND QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS PATIENTS: RESULTS FROM A RANDOMIZED CONTROLLED CROSSOVER TRIAL (BECHTEREW-APP TRIAL),
P. P. Strunz, T. Heusinger, M. Le Maire, A. Fleischer, K. S. Luetkens, P. Possler, M. Gernert, H. Labinsky, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, M. Fröhlich, M. Schmalzing
|
|
2025 OP0007-HPR
|
EFFECTIVENESS AND COST-UTILITY OF A MULTIMODAL, PHYSIOTHERAPIST-LED, VOCATIONAL INTERVENTION FOR PEOPLE WITH RHEUMATOID ARTHRITIS OR AXIAL SPONDYLOARTHRITIS AND A REDUCED WORK ABILITY: A RANDOMIZED, CONTROLLED TRIAL,
N. Bakker, J. Knoop, W. B. van den Hout, N. Hutting, J. Engels, J. B. Staal, M. van der Leeden, A. Boonen, A. Willemze, M. Nurmohamed, M. G. J. Gademan, T. P. M. Vliet Vlieland, S. van Weely
|
|
2025 OP0117-HPR
|
EFFECTIVENESS OF THE REMOTE VIDEO-BASED SARAH EXERCISE PROGRAM IN INDIVIDUALS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED SINGLE-BLINDED STUDY,
A. Ceylan, E. Başkan, İ. İnanc, D. C. SARAÇ, A. Özkan, N. B. Karaca, D. Solmaz, S. Gucenmez, S. Akar, D. Bayraktar
|
|
2025 OP0119-HPR
|
A CANADIAN ADVANCED PHYSIOTHERAPIST PRACTITIONER (APP) SHARED-CARE MODEL OFFERS SAFE AND EFFECTIVE CARE IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS,
J. Herrington, P. Clarkin, J. Singleton, K. Beattie, M. Batthish
|
|
2025 OP0157-PARE
|
I’M NOT ME ANYMORE, I’M LIKE A ZOMBIE LOST IN PAIN’: A QUALITATIVE INQUIRY ON FIBROMYALGIA PAIN,
C. Climent-Sanz, O. Martínez-Navarro, K. Hamilton, F. Valenzuela-Pascual, D. Whibley, E. Briones-Vozmediano
|
|
2025 OP0209
|
EFFECT OF PHYSICAL THERAPY ON DISEASE ACTIVITY, FUNCTIONAL ABILITY, QUALITY OF LIFE AND PAIN IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS,
K. L. Teh, C. Huang, L. Das, Y. X. Book, S. F. Hoh, X. Gao, T. Arkachaisri
|
|
2025 OP0225
|
KNEE BRACING PLUS ADVICE, WRITTEN INFORMATION AND EXERCISE INSTRUCTION VERSUS ADVICE, WRITTEN INFORMATION AND EXERCISE INSTRUCTION ALONE IN ADULTS WITH KNEE OSTEOARTHRITIS: THE PROP OA PARALLEL-GROUP, SUPERIORITY, RANDOMISED CONTROLLED TRIAL,
M. Holden, E. Nicholls, Z. Abdali, S. Jowett, F. Birrell, B. Borrelli, M. Callaghan, D. T. Felson, N. E. Foster, N. Halliday, C. Ingram, C. Jinks, G. Peat
|
|
2025 OP0358-PARE
|
Barriers and facilitators for implementing longstanding, personalized exercise therapy in people with Rheumatoid Arthritis or Axial Spondylarthritis and severe functional limitations,
A. Iken, M. G. J. Gademan, A. Nutma, R. W. Poolman, T. P. M. Vliet Vlieland, L . van Bodegom-Vos
|
|
2025 OP0363-PARE
|
Co-Design in Action: Mobilising knowledge and lived experience to design D-MAPP, a digital self-management intervention for distal upper limb MSDs,
L. Brading, J. Rimmer, S. Mason, S. Kingsbury, P. G. Conaghan, I. Kellar
|
|
2025 OP0378-HPR
|
Effects of Mat Pilates Exercises on Physical Performance and Related Parameters in Women with Psoriatic Arthritis: A Randomized Controlled Single-Blinded Clinical Trial,
İ. İnanc, D. Solmaz, D. C. SARAÇ, E. Başkan, A. Özkan, N. B. Karaca, S. Akar, D. Bayraktar
|
|
2025 OP0379-HPR
|
Tracking Step Counts in Adolescents with Juvenile Idiopathic Arthritis and Familial Mediterranean Fever: A 3-Month m-Health Monitoring Study Using Smartwatches,
A. Albayrak, N. Arman, A. Yekdaneh, I. Donmez, Y. Acikgoz, G. Filiz, T. Cakar, N. Aktay Ayaz
|
|
2025 OP0380-HPR
|
Reduced cardiorespiratory fitness level in patients with psoriatic arthritis: a cross-sectional study using cardiopulmonary exercise testing,
M. Kaerts, T. W. Swinnen, R. Lories, K de Vlam, B. Neerinckx
|
|
2025 OP0381-HPR
|
Diurnal patterns of physical activity are associated with dimensions of fatigue in people living with Rheumatoid Arthritis,
S. Fenton, S. Elmsmari, C. O’Brien, G. S. Metsios, G. D. Kitas, J Veldhuijzen van Zanten
|
|
2025 OP0382-HPR
|
Exploration of Country-specific Barriers and facilitators for the implementation of Physical Activity according to the EULAR Physical Activity recommendations for people with Rheumatic Musculoskeletal Diseases in four European countries: the COPA project,
Ö. Öztürk, D. Ueckert, L van Bodegom-Vos, S van Weely, Ö. Feyzioğlu, K. Niedermann, T. Davergne, A. K. Rausch Osthoff
|
|
2025 OP0383-HPR
|
Sustained effects of longstanding supervised exercise therapy in rheumatoid arthritis and axial spondyloarthritis patients with severe functional limitations: long-term follow-up,
D. Ueckert, T. P. M. Vliet Vlieland, M. A. T. van Wissen, M. M. H. Teuwen, W. F. Peter, C. H. M. van den Ende, S. van Weely, M. G. J. Gademan
|
|
2025 OP0384-HPR
|
Effectiveness of interventions aiming to reduce sedentary behavior: Meta-analysis informing the updated EULAR physical activity recommendations in people with inflammatory arthritis and osteoarthritis,
A. K. Rausch Osthoff, C. Juhl, T. Thomsen, G. S. Metsios, N. Brodin, R. J. O. Ferreira, T. P. M. Vliet Vlieland, K. Niedermann
|
|
2025 POS0219
|
ARE EXERCISE AND MINDFULNESS EFFECTIVE TO IMPROVE BODY COMPOSITION IN INDIVIDUALS WITH CHRONIC PRIMARY LOW BACK PAIN THE BACKFIT PROJECT,
G. Tsiarleston, B. Donoso, M. Y. Castellote-Caballero, V. Segura-Jiménez
|
|
2025 POS0255
|
AN INDIVIDUALIZED EXERCISE PROGRAM ON CARDIORESPIRATORY FITNESS, TRUNK STRENGTH AND MOBILITY LEADS TO SIGNIFICANT BETTER OUTCOMES IN PATIENTS WITH axSpA,
S. De Mits, T. Willems, L. Danneels, P. Calders, F. van den Bosch, D. Elewaut, P. Carron
|
|
2025 POS0288
|
PHYSICAL ACTIVITY LEVEL AMONG CHILDREN WITH ARTHRITIS IN THE UNITED STATES OF AMERICA,
C. Y. Tamashiro, W. D. Soulsby
|
|
2025 POS0344-HPR
|
IS IT FEAR OR PAIN UNDERSTANDING IT’S IMPACT ON PHYSICAL PERFORMANCE AND RUMINATION IN CHILDREN WITH RHEUMATIC DISEASES,
I. Donmez, N. Arman, A. Yekdaneh, A. Albayrak, Y. Acikgoz, N. Aktay Ayaz
|
|
2025 POS0348-PARE
|
LET’S GET OUT INTO THE WILD NATURE TO EXERCISE, MAN!,
M. Thode
|
|
2025 POS0349-PARE
|
HIGH INTENSITY INTERVAL AQUATIC EXERCISE,
L. Friid Lauvålien
|
|
2025 POS0396
|
IMPACT OF DIFFERENT TYPES OF PHYSICAL ACTIVITY ON BONE HEALTH IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: A CROSS-SECTIONAL ANALYSIS FROM A PROSPECTIVE COHORT STUDY,
E. Wiebe, C. F. Liebich, D. Huscher, Z. Boyadzhieva, A. Palmowski, S. Hermann, B. Muche, G. Krönke, B. Wolfarth, F. Buttgereit
|
|
2025 POS0474
|
Hispanic Knee Osteoarthritis Patients’ and Partners’ Perspectives Regarding Exercise,
E. Vina, L. Stauber, C. Villamil-Grest, R. Gomez, A. Hurtig, F. Razzaq, J. Dagnino, K. Bennell, C. K. Kwoh
|
|
2025 POS0593
|
SIMILAR NEGATIVE EFFECTS OF FATIGUE ON PHYSICAL ACTIVITY IN PERSONS WITH RHEUMATOID ARTHRITIS AND HEALTHY CONTROLS: A PATIENT-CONTROL STUDY,
M. Cox, K. Theunissen, K. Meijer, A. Timmermans, S. Ramiro, A. Boonen, G. Plasqui
|
|
2025 POS0823
|
THE PHYSICAL INACTIVITY AND OTHER CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH PSORIATIC ARTHRITIS: DO WE REALLY “KILL TWO BIRDS WITH ONE STONE” BY MANAGING INFLAMMATION,
S. Lukovic, N. Tomonjic, M. Vujovic Sestakov, J. Mihailovic, A. Neskovic, I. Pavlovic, M. Zlatanovic, B. Barac, T. Zivanovic Radnic, P. Ostojic
|
|
2025 POS0872
|
IMPROVING HEALTH OUTCOMES AND REDUCING HEALTHCARE COSTS THROUGH DIGITAL MOVEMENT THERAPY: A RANDOMIZED TRIAL,
P. Palm von Alten Blaskowitz, N. Köhl, A. M. Liphardt, C. Bouzas, B. Coppers, P. Petit, N. Vuillerme, V. Bundle, S. Rudolf, J. Knitza, M. G. Raimondo, H. Labinsky, L. Hatscher, A. Wirsching, D. Bohr, E. Araujo, A. Ramming, A. M. Ramming, M. Kreienkamp, R. Polacsek-Ernst, G. Schett, H. Morf
|
|
2025 POS1149-PARE
|
OPTIMIZING A PHYSIOTHERAPIST-LED VOCATIONAL INTERVENTION FOR PEOPLE WITH RHEUMATOID ARTHRITIS AND AXIAL SPONDYLOARTHRITIS. A QUALITATIVE EVALUATION OF ITS PROCESS AND OUTCOMES FROM THE PATIENTS’ PERSPECTIVE,
M. Voorneveld, N. Bakker, T. P. M. Vliet Vlieland, N. Hutting, J. Knoop, S. F. E. van Weely
|
|
2025 POS1441-HPR
|
EULAR RECOMMENDATIONS FOR PHYSICAL ACTIVITY IN PEOPLE WITH INFLAMMATORY ARTHRITIS AND OSTEOARTHRITIS: 2025 UPDATE,
A. K. Rausch Osthoff, T. P. M. Vliet Vlieland, R. J. O. Ferreira, R. Amarnani, S. Battista, D. Bayraktar, V. Boyadzhieva, N. Brodin, A. Cox, T. Davergne, M. T. Duruöz, B. A. Esbensen, C. Fongen, K. P. Günther, Y. Henrotin, C. Juhl, N. Kennedy, U. Kiltz, K. Knittle, G. S. Metsios, M. Nurmohamed, V. Romero Pazos, T. W. Swinnen, T. Thomsen, L. Warburton, K. Niedermann
|
|
2025 POS1444-HPR
|
ADHERENCE TO A SELF-MANAGED DIGITALLY BASED INTERVENTION WITH HIGH-INTENSITY INTERVAL TRAINING FOR INDIVIDUALS WITH AXIAL SPONDYLOARTHRITIS,
A. Torell, E. Haglund, Å. Andersson, E. Mogard, M. C. Olsson
|
|
2025 POS1445-HPR
|
INVESTIGATION OF THE SYNERGISTIC BENEFITS OF COMBINING TOPICAL DICLOFENAC WITH STRUCTURED EXERCISE IN KNEE OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
S. Karaborklu Argut, A. Erekdağ, D. Celik, A. Kaya
|
|
2025 POS1446-HPR
|
IMPACT OF POSITIVE SCREENING OF SARCOPENIA ON PHYSICAL PERFORMANCE, COGNITIVE FUNCTIONS, AND QUALITY OF LIFE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS,
Ö. Öztürk, D. Şahin, Ö. Hakli, N. N. Uzun, M. E. Tezcan
|
|
2025 POS1448-HPR
|
EFFICIENCY OF MOBILE-BASED AI-PERSONALIZED EXERCISE PROGRAM VERSUS SUPERVISED AI-PERSONALIZED EXERCISE PROGRAM IN JUVENILE IDIOPATHIC ARTHRITIS: A PILOT STUDY,
A. Yekdaneh, N. Arman, N. Aktay Ayaz
|
|
2025 POS1458-HPR
|
EFFECTIVENESS OF A BIOPSYCHOSOCIAL-BASED EXERCISE APPROACH ON PATIENT OUTCOMES IN PRIMARY SJÖGREN’S SYNDROME: A PRELIMINARY RANDOMIZED CONTROLLED TRIAL,
N. E. Nacar, O. Tüfekçi, M. Ekici, Ş. A. Bilgen, S. Kiraz, E. Ünal
|
|
2025 POS1459-HPR
|
VALUE OF CLINICAL FIELD TESTS AS A SURROGATE FOR CARDIOPULMONARY EXERCISE TESTING TO EVALUATE CARDIORESPIRATORY FITNESS IN PATIENTS WITH PSORIATIC ARTHRITIS,
M. Kaerts, T. W. Swinnen, R. Lories, K. de Vlam, B. Neerinckx
|
|
2025 POS1460-HPR
|
EVALUATING THE IMPACT OF EXERCISE INTERVENTIONS ON PAIN, FATIGUE, QUALITY OF LIFE, DISEASE ACTIVITY, AEROBIC CAPACITY, AND DRYNESS IN PRIMARY SJÖGREN’S SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS,
N. E. Nacar, S. Karaborklu Argut, E. Ünal
|
|
2025 POS1464-HPR
|
SURVEY OF CURRENT PHYSIOTHERAPY SERVICES FOR PEOPLE WITH AXIAL SPONDYLOARTHOPATHY ATTENDING IRISH RHEUMATOLOGY DEPARTMENTS,
K. Quinn, M. Conneely, M. Bannon, H. J. Garrigle, H. O Leary
|
|
2025 POS1471-HPR
|
VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE HAND SCLERODERMA LIVED EXPERIENCE SCALE,
G. G. Pala, N. G. Tore, F. Sari, S. Bayram, İ. Vasi, A. Tufan, D. Oskay
|
|
2025 POS1476-HPR
|
GAIT DYNAMICS AND LOCOMOTOR FUNCTION IN FAMILIAL MEDITERRANEAN FEVER: A COMPARATIVE STUDY WITH HEALTHY PEERS,
A. Namli Seker, N. Arman, A. Albayrak, A. Yekdaneh, O. Akgun, N. Aktay Ayaz
|
|
2025 POS1481-HPR
|
EXPLORING THE FEASIBILITY OF USING DIGITAL TECHNOLOGIES TO MEASURE FREE-LIVING PHYSICAL ACTIVITY AND REAL-TIME SYMPTOMS IN PEOPLE LIVING WITH RHEUMATOID ARTHRITIS,
R. Baynham, J Veldhuijzen van Zanten, A. Doherty, S. Fenton
|
|
2025 POS1485-HPR
|
PHYSICAL FITNESS TRAFFIC LIGHTS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND FAMILIAL MEDITERRANEAN FEVER: A FITNESSGRAM ROADMAP,
A. Albayrak, N. Arman, A. Yekdaneh, I. Donmez, Y. Acikgoz, K. Ucar, A. Namli Seker, F. Çakmak, O. Akgun, N. Aktay Ayaz
|
|
2025 POS1488-HPR
|
MORPHOLOGICAL PROPERTIES OF LUMBOPELVIC MUSCLES AND RELATION TO PAIN AND FATIGUE IN PATIENTS WITH FIBROMYALGIA SYNDROME,
Y. Mirza, F. Sari, P. D. Yilmaz, A. Kucuk
|
|
2025 POS1496-HPR
|
LONG-TERM HIP FUNCTION AND PERFORMANCE: A COMPARATIVE STUDY OF PATIENTS UNDER 40 YEARS OF AGE UNDERGOING TOTAL HIP ARTHROPLASTY AND ASYMPTOMATIC AGE AND GENDER-MATCHED CONTROLS,
E. Turkcan, S. Bozgeyik-Bagdatli, O. Caglar
|
|
2025 POS1502-HPR
|
EFFECTS OF TELEREHABILITATION AND YOUTUBE® PLATFORM-BASED EXERCISE VIDEOS IN PATIENTS WITH AXIAL SPONDILOARTHRITIS: A RANDOMIZED CONTROLLED STUDY,
S. Baglan Yentur, İ. S. Boyrazli, M. Ş. Elbasti, S. S. Koca
|
|
2025 POS1506-HPR
|
EDUCATIONAL NEEDS IN THE MANAGEMENT OF INFLAMMATORY AND NON-INFLAMMATORY LOW BACK PAIN: PERSPECTIVES OF PHYSIOTHERAPY STUDENTS,
A. Fanuscu, O. Ulger
|
|
2025 POS1511-HPR
|
PHYSICAL FITNESS AND FUNCTIONAL CAPACITY IN CHILDREN AND ADOLESCENTS WITH JUVENILE DERMATOMYOSITIS,
A. Yilmaz, N. Arman, S. D. Arik, N. Aktay Ayaz
|
|
2025 POS1514-HPR
|
THE IMPACT OF PARENT AND PATIENT GENDER ON SATISFACTION WITH AN ADVANCED PHYSIOTHERAPIST PRACTITIONER (APP) SHARED CARE MODEL IN PEDIATRIC RHEUMATOLOGY,
J. Herrington, S. Heera, K. Beattie, M. Batthish
|
|
|
[81]
|
And genetics
|
|
|
| 2025 |
|
2025 ABS0023
|
GENETIC ASSOCIATIONS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SUDANESE POPULATION,
K. Patasova, N. A. Mohammed, M. A. M. Nur, E. M. Elagib, A. Elshafie, I. Gunnarsson, E. Svenungsson, J. Rönnelid, S. Elbagir, L. M. Diaz-Gallo
|
|
2025 ABS0041
|
BODY MASS INDEX AND RHEUMATIC JOINT DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MENDELIAN RANDOMIZATION STUDIES,
T. Fatima, F. Nord, C. Maglio
|
|
2025 ABS0044
|
GENOMIC PROFILING OF PALINDROMIC RHEUMATISM DEFINES AN AUTOINFLAMMATORY ARTHRITIS,
Y. Ma, Q. Hu
|
|
2025 ABS0047
|
MATERNAL AND NEONATAL ANTI-RO52, ANTI-RO60 AND ANTI-LA LEVELS CORRELATE WITH INTERFERON SCORES,
L. Rudolph, M. Hedlund, E. Richardsdotter Andersson, V. Ottosson, J. Tingström, F. Nordenstam, G. Bergman, S. E. Sonesson, G. E. Thorlacius, M. Wahren-Herlenius
|
|
2025 ABS0048
|
DIFFERENTIAL ACTIVATION OF LYSOPHOSPHATIDIC ACID REGULATED GENES IN DIFFUSE AND LIMITED CUTANEOUS SYSTEMIC SCLEROSIS,
M. Kanitkar, P. Yee, S. Rodolfi, V. H. Ong, C. Denton
|
|
2025 ABS0050
|
HISTONE LYSINE METHYLTRANSFERASES MLL1 AND MLL3 COOPERATIVELY REGULATE CHEMOKINE GENE EXPRESSION IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS,
K. Okamoto, Y. Araki, Y. Aizaki, H. Kajiyama, K. Yokota, Y. Funakubo Asanuma, Y. Akiyama, Y. Kadono, T. Mimura
|
|
2025 ABS0056
|
IFN-Γ DAMAGES SALIVARY GLAND EPITHELIAL CELLS BY ACTIVATING THE IRE1–JNK–AP-1 SIGNALING AXIS IN SJÖGREN’S SYNDROME,
X. Sun, Z. Zhou, L. Wang, Z. Tan, X. Li
|
|
2025 ABS0123
|
DISTINCT MOLECULAR RESPONSES TO CD19 CAR-T CELL THERAPY VERSUS STANDARD PHARMACOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
P. Garantziotis, L. Beretta, J. Lindblom, D. Nikolopoulos, R. Grieshaber-Bouyer, G. S. Moysidou, M. Hagen, A. Wirsching, J. Taubmann, C. Bergmann, A. Bozec, G. Barturen, A. Fanouriakis, G. K. Bertsias, M. Schneider, D. Boumpas, M. Alarcon-Riquelme, G. Schett, I. Parodis
|
|
2025 ABS0129
|
EFFICACY OF A BD2-SELECTIVE BET INHIBITOR IN ANIMAL MODELS OF RHEUMATOID ARTHRITIS BY INHIBITION OF NF-KB DRIVEN INFLAMMATORY PATHWAYS,
I. Stuart, S. Banerjee, A. Woodland, M. Bell, R. Jayaprakash
|
|
2025 ABS0141
|
SYSTEMATIC REVIEW AND INDEPENDENT VALIDATION OF GENETIC FACTORS OF RADIOGRAPHIC OUTCOME IN RHEUMATOID ARTHRITIS IDENTIFIES A GENOME-WIDE ASSOCIATION WITH CARD9,
S. Sharma, R. Hum, N. Nair, L. Marshall, A. Storrie, J. Bowes, A. MacGregor, M. Yates, A. Morris, S. Verstappen, A. Barton, H. W. van Steenbergen, R. Knevel, A. H. M. van der Helm – van Mil, S. Viatte
|
|
2025 ABS0149
|
THE TT GENOTYPE OF rs7574865 IN STAT4 IS ASSOCIATED WITH INCREASED COMPLICATIONS AND COMORBIDITIES IN PATIENTS INCLUDED IN PRINCESS EARLY ARTHRITIS REGISTER LONGITUDINAL STUDY (PEARL),
J. C. Sáez Martínez, M. Dueñas, M. Nikitsina, P. Floranes Elorza, A. Baeza Muriel, M. Pardines Ortiz, A. Romero Robles, E. Roy Vallejo, E. Toledano, M. Uriarte-Ecenarro, I. Llorente, A. Triguero-Martinez, M. Pavía Pascual, P. Quiroga Colina, M. Ahijón Lana, C. Valero-Martínez, R. Garcia-Vicuña, A. Ortiz, I. González-Álvaro
|
|
2025 ABS0178
|
IL1B POLYMORPHISMS IN THE PROGNOSIS OF IgAV AND THE DIFFERENTIAL DIAGNOSIS WITH IgAN,
J. C. Batista-Liz, M. Sebastián Mora-Gil, M. T. Leonardo Cabello, A. C. Peñalba Citores, L. Gabrie, R. Gálvez-Sánchez, L. Martín-Penagos, P. Collado, A. Fernández-Nebro, G. Díaz-Cordoves, L. Caminal-Montero, A. I. Turrión, E. Rubio-Romero, M. León Luque, B. Sevilla-Pérez, J. L. Callejas, F. J. Narváez Garcia, P. Floranes Elorza, E. Vicente-Rabaneda, J. M. Blanco-Madrigal, E. Galíndez-Agirregoikoa, S. Castañeda, R. Blanco, V. Pulito-Cueto, R. López-Mejías
|
|
2025 ABS0201
|
SINGLE-CELL SEQUENCING OF AORTIC TISSUE IN PATIENTS WITH BEHÇET’S SYNDROME,
C. Wang, N. Gao, L. Pan, T. Li
|
|
2025 ABS0205
|
ROLE OF TNF POLYMORPHISMS IN THE PHENOTYPIC EXPRESSION OF GIANT CELL ARTERITIS,
V. Pulito-Cueto, R. López-Mejías, J. C. Batista-Liz, J. Loricera, D. Prieto-Peña, A. Muñoz Jimenez, F. Ortiz-SanJuan, S. Romero-Juste, C. Moriano Morales, E. Galíndez-Agirregoikoa, N. Alvarez-Rivas, S. Castañeda, R. Blanco
|
|
2025 ABS0206
|
NLRP3 POLYMORPHISMS AS GENETIC BIOMARKERS FOR THE ACCURATE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASES,
V. Pulito-Cueto, J. C. Batista-Liz, B. Atienza-Mateo, D. Iturbe Fernández, V. M. Mora-Cuesta, M. Sebastián Mora-Gil, C. Aguirre Portilla, J. M. Cifrián-Martínez, R. Blanco, R. López-Mejías
|
|
2025 ABS0213
|
GENETIC ALLELES AND AUTOANTIBODIES ASSOCIATED WITH SYSTEMIC SCLEROSIS SUSCEPTIBILITY IN KAZAKH PATIENTS,
L. Zaripova, A. Baigenzhin, Z. Zhabakova, A. Boltanova, M. Solomadin, D. Makimova, L. Kozina
|
|
2025 ABS0215
|
PHENOTYPE-SPECIFIC IMMUNE SIGNATURES IN BEHÇET’S DISEASE: A TRANSCRIPTOMIC AND CYTOKINE BASED APPROACH,
R. Deniz, G. Gülfidan, C. Bes, Z. Emrence, F. Alibaz-Oner, S. Sirma Ekmekci, N. Abaci, H. Direskeneli, A. Gül, K. Y. Arga, C. Erzik
|
|
2025 ABS0225
|
CRTAC1 AS A BIOMARKER FOR OSTEOARTHRITIS: LINK TO INFLAMMATION AND microRNA REGULATION,
A. Prokopcova, J. Baloun, A. Navrátilová, K. Mocová, L. Ondrejčáková, J. Juhaszová, T. Kropackova, H. Wunsch, M. Tomčík, R. Ballay, P. Fulín, J. Gatterova, E. Kriegova, J. Gallo, J. Vencovský, L. Šenolt
|
|
2025 ABS0230
|
INTEGRATIVE miRNA-mRNA PROFILING UNCOVERS MECHANISMS OF BELIMUMAB ACTION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
C. Solé-Marcé, S. Sandoval Moreno, J. Cortés-Hernández
|
|
2025 ABS0273
|
NEW PATHOGENIC PATHWAYS IN ANKYLOSING SPONDYLITIS IDENTIFIED THROUGH MULTI-ANCESTRY GENOMEWIDE ASSOCIATION STUDY,
Z. Li, N. Harvey, X. Wu, J. Garrido-Mesa, H. Marzo-Ortega, D. McGonagle, A. Morgan, N. Akkoc, B. Nam, H. Yarkan Tugsal, G. Kenar Artin, G. McFarlane, G. T. Jones, P. Leo, K. Zimmerman, E. Duncan, J. Brown, M. Mahmoudi, A. Jamshidi, E. Farhadi, N. Haroon, R. Inman, M. Breban, M. M. Ward, M. H. Weisman, L. S. Gensler, D. Evans, T. Kenna, T. H. Kim, P. B. Wordsworth, J. D. Reveille, H. Xu, M. Brown
|
|
2025 ABS0299
|
GENETICALLY PROXIED INTERLEUKIN-13 IS ASSOCIATED WITH RISK OF GOUT INDEPENDENT OF URATE,
B. Zuckerman, K. Song, S. S. Zhao
|
|
2025 ABS0378
|
PROGRESSIVE OSSIFYING FIBRODYSPLASIA AS A VARIANT OF AXIAL SPONDYLOARTHRITIS WITH JUVENILE ONSET,
F. Litvak, V. Diomidova, N. Zhuravleva, E. Guryanova, N. Uchterova, I. Bufalova
|
|
2025 ABS0656
|
RARE VARIANTS OF PAH RISK GENES ASSOCIATE WITH A DISTINCT VASCULOPATHY PHENOTYPE AND WORSE OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION,
J. Qian, X. Yang, X. Wang, J. Zhao, D. Yufang, M. Li, W. Liu, Y. Liu, Z. Tian, Y. Wang, W. Yang, X. Zeng, Q. Wang, M. Li
|
|
2025 ABS0737
|
ASSOCIATION OF LEPR Q223R POLYMORPHISM WITH KNEE OSTEOARTHRITIS SUSCEPTIBILITY AND SEVERITY IN A UKRAINIAN FEMALE POPULATION,
L. Shvets, V. Novoseletskyi, I. Orlova, I. Shapoval, L. Perebetiuk, V. Bykov, V. Khomenko, M. Stanislavchuk
|
|
2025 ABS0948
|
COULD microRNA-146a AND microRNA-223 SERVE AS BIOMARKERS FOR PREDICTING DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS,
U. Bakay, A. Gülkesen, A. Sen, D. Erol, G. Akgol, A. Kaya, T. Izci Duran, Y. Gural
|
|
2025 ABS0951
|
MONOGENIC LUPUS: A COMPREHENSIVE REVIEW OF GENETIC AND CLINICAL FEATURES,
O. C. Kilinc, B. Aktas, K. Parlar, O. Kizilkaya, B. Acar, S. Ugurlu
|
|
2025 ABS0973
|
GENETICS, CLINICAL CHARACTERISTICS, AND MANAGEMENT OF FAMILIAL MEDITERRANEAN FEVER IN DIVERSE POPULATIONS: A COMPARATIVE STUDY OF BARI AND ISTANBUL,
N. Jaber, B. Kilic, L. Yagci, A. Ozturk, M. Khalil, A. Stella, A. Di Ciaula, S. Ugurlu, P. Portincasa
|
|
2025 ABS1088
|
MULTI-OMIC INSIGHT INTO THE BIOLOGICAL CAUSAL RELATIONSHIP BETWEEN MITOCHONDRIAL-RELATED GENES AND RHEUMATOID ARTHRITIS,
L. Hao, H. Q. Niu, J. Luo, C. Wang, X. F. Li
|
|
2025 ABS1212-HPR
|
GENETIC EVIDENCE FOR THE CAUSAL ROLE OF C-REACTIVE PROTEIN IN THE SUSCEPTIBILITY TO AUTOIMMUNE DISEASES: A COMPREHENSIVE MENDELIAN RANDOMIZATION STUDY,
W. Xie, J. Yue, X. Ma, R. Zhao, X. Hao, M. J. Chang, C. Wang
|
|
2025 OP0019
|
The transcriptome profile of B cells: A useful non-invasive biomarker for the diagnosis of nephritis in IgA vasculitis,
J. C. Batista-Liz, L. C. Terron Camero, I. Fernández Rengel, M. T. Leonardo Cabello, A. C. Peñalba Citores, L. Martín-Penagos, L. Belmar-Vega, C. Gomez-Fernandez, L. Gabrie, R. Gálvez-Sánchez, L. Caminal-Montero, A. I. Turrión, D de Argila, E. Vicente-Rabaneda, B. Sevilla-Pérez, J. L. Callejas, A. Márquez, J. Martin, E. Andrés-León, S. Castañeda, R. Blanco, V. Pulito-Cueto, R. López-Mejías
|
|
2025 OP0059
|
Increased Risk of Relapse and Altered Proinflammatory Signaling in Giant Cell Arteritis Patients with Mosaic Loss of the Y Chromosome,
S. M. Petzinna, S. M. Kirch, M. S. Adamson, D. Xi, C. J. Bauer, L. Kreis, P. Karakostas, R. Behrendt, S. Zimmer, R. N. Jamin, V. S. Schäfer
|
|
2025 OP0073
|
Integrating Genetic Characteristics and Clinical Prediction model to Refine Prognosis Prediction and Risk Stratification for Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension,
D. Yufang, J. Qian, X. Yang, M. Li, Q. Wang, J. Zhao, X. Zeng
|
|
2025 OP0124
|
ZNF687 REGULATES OSTEOCLASTOGENESIS AND DRIVES PAGET’S DISEASE OF BONE THROUGH MYELOID LINEAGE POPULATIONS,
S. Russo, F. Gianfrancesco
|
|
2025 OP0130
|
EXPERIMENTAL STUDY OF TARGETING PAD4 TO INHIBIT THE FORMATION OF NEUTROPHIL EXTRACELLULAR TRAP NETWORK FOR THE TREATMENT OF GOUT,
Y. Wang, D. Man, H. Li
|
|
2025 OP0133
|
COMPREHENSIVE ANALYSIS UNVEILS POTENTIAL MECHANISMS OF MMP9 AND RNASET2 IN RHEUMATOID ARTHRITIS THROUGH GENOME-WIDE ASSOCIATION STUDIES, MENDELIAN RANDOMIZATION, AND SINGLE-CELL TRANSCRIPTOMIC,
X. Liu, X. Gu, C. Wang
|
|
2025 OP0145
|
TRANSCRIPTOMIC STRATIFICATION PREDICTS RESPONSE TO RITUXIMAB, ABATACEPT OR THE ASSOCIATION OF HYDROXYCHLOROQUINE AND LEFLUNOMIDE IN 3 RANDOMIZED CONTROLLED CLINICAL TRIALS IN SJÖGREN’S DISEASE,
B. Chevet, V. Devauchelle-Pensec, E. Pontarini, V. Baloche, M. Bombardieri, S. Bowman, M. Barnes, A. Sreih, J. Liu, S. Kelly, A. Christodoulou, P. Moingeon, L. Laigle, P. Soret, C. Le Dantec, J. O. Pers, M. Alarcon-Riquelme, G. Barturen, X. Mariette, J. van Roon, R. Seror, G. Nocturne, D. Cornec, N. Foulquier
|
|
2025 OP0155
|
RA RISK GENES ARE DIFFERENTIALLY EXPRESSED BETWEEN (PEAC) PATHOTYPES IN SYNOVIUM WITH A CLEAR ENRICHMENT IN THE LYMPHOID-RICH PATHOTYPE,
I. C. den Hond, M. J. T. Reinders, M. Lewis, C. Pitzalis, R. Knevel, E. B. van den Akker
|
|
2025 OP0156
|
ANTI-CITRULLINE CD4+ T CELLS ARE PRESENT IN ALL HLA-DRB1*04:01+ PATIENTS WITH RHEUMATOID ARTHRITIS, ASSOCIATE WITH RESPONSE TO BIOLOGIC DRUGS AND WORSE CLINICAL OUTCOME AND SHARE KEY FEATURES WITH ANTI-VIRAL T CELLS.,
M. A. Elhafnawy, S. Valma, M. Christofi, N. Nair, L. Marshall, S. Turcinov, J. Bowes, A. B. Mohammad Ariff, A. Morgan, J. D. Isaacs, A. G. Wilson, K. Hyrich, D. Plant, W. Kwok, A. Barton, E. A. James, V. Malmström, S. Viatte
|
|
2025 OP0160
|
THE MAGIC OF VEXAS: A CASE OF OVERLAP BETWEEN BECHET’S DISEASE AND VEXAS SYNDROME,
E. Touma, S. Brikman, A. Bieber
|
|
2025 OP0180
|
ACUTE PSORIATIC DACTYLITIS: THE ROLE OF HLA GENETIC SUSCEPTIBILITY MARKERS AND CLINICAL ASSOCIATIONS,
F. Kharouf, V. Carrizo Abarza, P. Mehta, S. Gao, D. Ganatra, D. Periera, R. Cook, D. Poddubnyy, D. D. Gladman, V. Chandran
|
|
2025 OP0205
|
SPATIAL OMICS ANALYSIS REVEALS DISTINCT INFLAMMATORY PATHWAYS AND CELLULAR INTERACTIONS IN KIDNEY BIOPSIES FROM LUPUS NEPHRITIS RESPONDERS AND NON-RESPONDERS,
S. Sandoval Moreno, C. Solé-Marcé, M. Passols, I. Agraz Pamplona, M. A. Gabaldón, J. Cortés-Hernández
|
|
2025 OP0246
|
SYNOVIAL TISSUE ENRICHMENT OF OXYLIPINS AND THEIR MEDIATORS PROVIDES INSIGHT INTO REMISSION MAINTENANCE IN RHEUMATOID ARTHRITIS,
S. Perniola, J. Murillo-Saich, D. Somma, C. Di Mario, B. Tolusso, D. Campobasso, M. Gessi, L. Petricca, M. R. Gigante, V. A. Pacucci, D. Bruno, M. M. Lizzio, E. Gremese, M. A. D’Agostino, M. Kurowska-Stolarska, M. Guma, S. Alivernini
|
|
2025 OP0253
|
COMMON AND RARE VARIANT CONTRIBUTIONS TO FAMILIAL AGGREGATION IN SPONDYLOARTHRITIS,
F. Costantino, R. SAID, H. Mambu-Mambueni, A. Boland, J. F. Deleuze, M. Brown, H. J. Garchon, M. Breban
|
|
2025 OP0267
|
SINGLE-CELL TRANSCRIPTOMICS OF B CELLS TOWARDS THE UNDERSTANDING OF THE MECHANISMS LEADING TO THE PRODUCTION OF ANTIPHOSPHOLIPID ANTIBODIES IN THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME,
P. Gaspar, D. Holdych, M. M. Santos, F. Ribeiro, B. Filipe, R. Vieira, A. R. Cruz-Machado, V. R. Fonseca, V. C Romão, A. R. Maceiras, L. Graca
|
|
2025 OP0268
|
EPIGENETIC MARKS OF DIFFERENT aPL-TRIGGERED SIGNALLING IN OBSTETRIC AND THROMBOTIC ANTIPHOSPHOLIPID SYNDROME,
F. Miró-Mur, A. Anunciacion-Llunell, J. Marques-Soares, M. Ockova, C. Andrada, E. Esteve-Valverde, J. Pardos-Gea, J. Alijotas-Reig
|
|
2025 OP0269
|
TROPHOBLAST SENESCENCE AS A THERAPEUTIC TARGET IN ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED PREGNANCY LOSS,
M. Wang, Y. Liu, X. Meng, W. Zhu, Y. Pan
|
|
2025 OP0284
|
LANDSCAPE GENETIC ANALYSIS OF ADULT-ONSET STILL’S DISEASE IDENTIFIES RISK LOCI FOR PERSONALIZED MEDICINE,
Y. Xiao, Q. Hu
|
|
2025 OP0371
|
Transcriptomic analysis of transgender adolescents undergoing gender-affirming sex hormone therapy reveals sex-specific mechanisms associated with female childhood-onset SLE,
H. Cross, H. Peckham, G. Butler, E. Rosser, E. Jury, G. Robinson, C. Ciurtin
|
|
2025 POS0064
|
DEVELOPMENT OF A BLOOD-BASED CELL-FREE DNA THERAPY SELECTION TEST TO PREDICT BIOLOGIC AND TARGETED SYNTHETIC DMARDS RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS (PRIMA-102),
P. C. Taylor, K. Lai, S. Fransen, G. Lam, D. Chernoff, D. Abdueva, J. Carlson, J. R. Curtis
|
|
2025 POS0068
|
POLYGENIC RISK SCORES IMPROVE RISK ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS,
H. K. Aaramaa, P. Isomäki, A. Kerola, A. Palomäki, K. Eklund, F. N/A, N. Mars
|
|
2025 POS0076
|
CROSS-TRAIT META-ANALYSIS REVEALS A GENETIC LINK BETWEEN INFLAMMATION AND AGING IN GIANT CELL ARTERITIS,
L. Martínez Gutiérrez, I. Rodriguez-Martin, G. Borrego-Yaniz, M. Kerick, C. Salvarani, J. Hernández-Rodríguez, M. C. Cid, M. Á. González-Gay, A. Morgan, J. Martin, L. Ortiz-Fernández, A. Márquez
|
|
2025 POS0082
|
EXPLORING THE GENETIC BASIS OF CLINICAL HETEROGENEITY IN GIANT CELL ARTERITIS,
G. Borrego-Yaniz, V. Fuentes-Moreno, J. Hernández-Rodríguez, A. Vaglio, S. Castañeda, R. Solans-Laqué, N. Khalidi, C. Langford, S. R. Ytterberg, L. Beretta, M. Govoni, G. Emmi, M. A. Cimmino, T. Witte, T. Neumann, J. Holle, V. Schönau, G. Pugnet, [. Papo], J. Haroche, A. Mahr, L. Mouthon, Ø. Molberg, A. Diamantopoulos, A. Voskuyl, T. Daikeler, C. Berger, E. Molloy, D. Blockmans, Y. van Sleen, S. GCA Group, U. G. Consortium, V. C. Research Consortium, N. Ortego-Centeno, E. Brouwer, P. Lamprecht, S. Klapa, C. Salvarani, P. Merkel, M. C. Cid, M. Á. González-Gay, A. Morgan, J. Martin, A. Márquez
|
|
2025 POS0085
|
UNMASKING A GENETIC PREDISPOSITION: A CASE OF REFRACTORY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS/MACROPHAGE ACTIVATION SYNDROME IN A PATIENT WITH NEURODEVELOPMENTAL DELAY,
I. Bazigh, N. Eshak, V. Nagaraja
|
|
2025 POS0091
|
WHOLE EXOME SEQUENCING AS A DIAGNOSTIC TOOL FOR IMMUNOLOGIC DISORDERS. POTENTIAL CLINICAL IMPLICATIONS OF A PATHOGENETIC VARIANT IN CD64 GENE,
A. Pilato, M. Vomero, C. Lintas, L. Navarini, A. Azzarà, C. Tabolacci, M. Biffoni, D. Currado, A. Marino, O. Berardicurti, F. Gurrieri, R. Giacomelli
|
|
2025 POS0224
|
LEUKOCYTE TELOMERE LENGTH IN WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASES AND ITS RELATIONSHIP WITH PREGNANCY,
C. M. Skinner-Taylor, A. B. Fiscal-Carvajal, G. Calvo-Anguiano, J. Arenas Estala, M. Ibarra-Ramirez, M. Castellón Román, M. A. Ponce-Santillan, A. M. Ortiz-Rios, M. E. Corral-Trujillo, L. Perez-Barbosa, T. Guzman-Perez, L. E. Martinez-Garza, G. A. López-Uriarte, D. A. Galarza-Delgado
|
|
2025 POS0239
|
INVESTIGATING DUX4 RE-EXPRESSION IN FIBROBLAST-LIKE SYNOVIOCYTES: CELLULAR INSIGHTS FROM TISSUE-DERIVED AND SYNOVIAL FLUID-DERIVED CELLS,
E. Luyten, P. Ruytinx, F. M. C. Meynen, J. Lenaerts, J. Lenaerts, K. Thevissen, P. Remans, J. Heyligen, D. de Seny, C. Ospelt, V. Somers
|
|
2025 POS0442
|
PRIMARY HLH IS A SIGNIFICANT CAUSE OF HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN YOUNG ADULTS: FINDINGS FROM A SINGLE-CENTRE COHORT STUDY,
A. Holloway, B. Carpenter, S. Clark, A. Jones, S. Gohil, A. S. Carr, A. Laurence, J. Manson
|
|
2025 POS0452
|
Beyond MUC5B: Associations of an idiopathic pulmonary fibrosis polygenic risk scores with rheumatoid arthritis-associated interstitial lung disease,
G. McDermott, X. Wang, J. Cui, M. L. Paudel, P. A. Juge, P. Dieudé, M. Moll, S. Kalra, M. Cho, J. A. Sparks
|
|
2025 POS0591
|
NOVEL PREDICTION MODEL FOR RAPID STRUCTURAL PROGRESSION PHENOTYPE IN KNEE OSTEOARTHRITIS PATIENTS USING MACHINE LEARNING,
M. F. Gonzalez-Hernandez, I. Rego-Perez, I. Rodríguez-Valle, J. Vázquez-García, V. Balboa-Barreiro, S. Relaño-Fernandez, M. C. de Andres, L. Lourido, V. Calamia, R. Paz González, P. Quaranta, P. Fernández Puente, N. Veronese, C. Ruiz-Romero, N. Oreiro, F. J. Blanco
|
|
2025 POS0694
|
DISSECTING THE GENETIC AND FUNCTIONAL ASSOCIATION OF CARD9 WITH AXIAL SPONDYLOARTHRITIS,
F. Costantino, E. Frison, A. C. Brown, C. Cohen, M. Jacoutot, G. Migliorini, R. SAID, G. Scozzafava, P. Bowness, P. B. Wordsworth, H. J. Garchon, S. Glatigny, M. Breban, J. C. Knight
|
|
2025 POS0706
|
EPIGENETIC MODULATION OF CIRCADIAN CLOCK GENES IN AXIAL SPONDYLOARTHRITIS: NEW PERSPECTIVES AND CLINICAL IMPLICATIONS,
H. Koyuncu, Z. B. Celik, A. K. Cengiz
|
|
2025 POS0792
|
THE ASSOCIATION OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS,
C. Y. Wu, W. L. Fan, L. C. Hsieh, J. L. Huang
|
|
2025 POS0800
|
EFFECTS OF CD19 CAR-T CELL THERAPY ON THE T CELL COMPARTMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS,
P. Garantziotis, K. Anoshkin, M. Hagen, A. Wirsching, P. G. Gavin, S. L. N. Clarke, D. Muthas, D. Close, P. Z. Brohawn, C. Chamberlain, M. Belvisi, A. Platt, N. Ferrari, G. Schett, R. Grieshaber-Bouyer
|
|
2025 POS0863
|
DIFFERENTIAL NEUTROPHIL TRANSCRIPTOME PROFILING IN PATIENTS WITH NEWLY DIAGNOSED VERSUS RELAPSING GRANULOMATOSIS WITH POLYANGIITIS OR MICROSCOPIC POLYANGIITIS,
C. G. Gialouri, A. Banos, S. Moustafa, D. Valakos, D. Vassilopoulos
|
|
2025 POS0931
|
BRIDGING GENETICS AND EPIGENETICS FOR THERAPEUTIC TARGET DISCOVERY IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS,
E. Ezen, A. Khmelevskaya, O. Distler, C. Ospelt
|
|
2025 POS0996
|
PRKD2 AS A CANDIDATE GENE MODULATING T CELL ACTIVATION IN FAMILIAL SYSTEMIC SCLEROSIS,
P. Maus, J. Hatoum, D. Nolf, T. Hirsch, T. Gomard, M. Vanthuyne, V. Smith, N. Limaye
|
|
2025 POS0999
|
RE-EVALUATING THE ASSOCIATION BETWEEN TREX1 VARIANTS, LUPUS AND OLIGOPROTEIN INTERFERON SIGNATURES IN UK BIOBANK,
B. Rioux, S. McGlasson, D. Forbes, K. Reid, A. Klingseisen, W. Whiteley, D. Hunt
|
|
2025 POS1065
|
NONLINEARITY AND SEX DIFFERENCES IN THE PERFORMANCE OF A POLYGENIC RISK SCORE FOR JUVENILE IDIOPATHIC ARTHRITIS,
K. Løkås Haftorn, H. Khoshfekr Rudsari, P. P. Jaholkowski, V. Ø. Dåstøl, S. Valen Hestetun, O. A. Andreassen, C. R. Weinberg, H. Sanner
|
|
2025 POS1076
|
Can Variants of Unknown Significance (VUS) be associated with a specific clinical phenotype in autoinflammatory diseases,
S. Bindoli, A. Fu, S. Moz, A. Doria, P. Sfriso, P. Galozzi
|
|
2025 POS1085
|
VALIDATION OF HUMAN PHENOTYPE ONTOLOGY AND DEVELOPMENT OF AN ARTIFICIAL-INTELLIGENCE BASED DIAGNOSTIC TOOL FOR AUTOINFLAMMATORY DISEASES USING THE EUROFEVER REGISTRY,
C. Matucci-Cerinic, G. Fiorito, M. Vergani, G. Cavalca, R. Caorsi, M. E van Gijn, L. Pape, G. Boursier, P. Uva, M. Gattorno
|
|
2025 POS1137
|
Genetically proxied glucose-lowering drug target and risk of immune mediated inflammatory disease: a drug target mendelian randomization study,
Y. Jin, J. Wu, D. Wu
|
|
2025 POS1168
|
MACHINE LEARNING-BASED PREDICTION FOR GOUT USING PRS AND CLINICAL VARIABLES: A KOREAN COHORT STUDY,
D. H. Kwak, H. Kim, S. S. Choi, K. W. MOON
|
|
2025 POS1215
|
INVESTIGATING THE GENETICS OF DEPRESSION AND ANXIETY IN A MULTI-ANCESTRAL COHORT OF CHILDREN AND ADOLESCENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
I. Das, A. Tran, N. Gold, C. Burton, J. Crosbie, J. Cao, D. Dominguez, S. Kronenberg, D. M. Levy, L. Ng, A. Toulany, H. K. R. Tran, G. Zai, A. Knight, L. Hiraki
|
|
2025 POS1287
|
NEXT GENERATION SEQUENCING ANALYSIS IDENTIFIES HIGH FREQUENCY OF GENETIC VARIANTS POTENTIALLY LINKED TO INBORN ERRORS OF IMMUNITY IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY RHEUMATIC DISEASES,
P. Semeraro, M. Frassi, S. C. Giliani, F. Franceschini, P. Airo
|
|
2025 POS1368
|
TOPICAL ADMINISTRATION OF miRNA LIPOPLEXES IMPROVES SKIN LESIONS IN MRL/lpr MICE WITH CUTANEOUS LUPUS ERYTHEMATOSUS,
J. Cortés-Hernández, S. Sandoval Moreno, C. Solé-Marcé
|
|
2025 POS1370
|
TOWARDS REVOLUTIONIZING RHEUMATOID ARTHRITIS CARE USING GENETIC INFORMATION VIA A NOVEL EXOMIC TRANSFORMER,
S. Ayanian, C. Osborne, G. Venkatesh, V. Pondenkandath, B. Kanakiya, M. Blasi, C. Molnar, M. Redlon, N. Vassilieva, E. Klee, K. Lazaridis, E. Myasoedova
|
|
2025 POS1404
|
PREDICTING FLARES USING TRANSCRIPTIONAL SIGNATURES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Beretta, G. Barturen, T. Witte, I. Rodriguez Pintó, R. Cervera Segura, R. Ortega-Castro, F. Hiepe, L. Kovács, B. Virág, R. Faria, B. Vigone, M. Alarcon-Riquelme, I. Parodis
|
|
2025 POS1422
|
NUCLEAR AND MITOCHONDRIAL CELL-FREE DNA AS A POTENTIAL BIOMARKER OF MUSCLE DAMAGE IN IDIOPATHIC INFLAMMATORY MYOPATHIES,
K. Svobodová, S. Oreska, L. Vernerová, D. Dlouhá, H. Wunsch, K. Pavelka, J. Vencovský, L. Šenolt, M. Vrablik, J. A. Hubáček, M. Tomčík
|
|
2025 POS1424
|
THE ROLE AND DISTRIBUTION OF AGE-RELATED T HELPER CELLS IN RHEUMATOID ARTHRITIS WERE ANALYZED BASED ON SINGLE-CELL TRANSCRIPTOME SEQUENCING,
X. Liu, C. Wang
|
|
2025 POS1425
|
MEDIATORS OF OSTEOPETROSIS IN miR-146a DEFICIENT MICE,
E. Simader, V. Saferding, T. Sokolich, M. Boldin, S. Hayer, B. Niederreiter, D. Aletaha, S. Blüml
|
|
2025 POS1440
|
PLASMA LEVELS OF miR-133a-3p AND miR-1-3p AS POTENTIAL BIOMARKERS OF MUSCLE INVOLVEMENT INITIAL TREATMENT RESPONSE IN IDIOPATHIC INFLAMMATORY MYOPATHIES,
K. Svobodová, S. Oreska, L. Vernerová, D. Dlouhá, H. Wunsch, K. Pavelka, J. Vencovský, L. Šenolt, M. Vrablik, J. A. Hubáček, M. Tomčík
|
|
|
[75]
|
And measuring health
|
|
|
| 2025 |
|
2025 ABS0034
|
APPLICATION OF CLUSTERING TECHNIQUES FOR PATIENT STRATIFICATION IN RHEUMATIC DISEASES,
A. García-Alija, B. P. Magallares, H. S. Park, G. Verdaguer, A. Laiz, P. Moya, A. Casals Urquiza, C. Díaz-Torné, L. Sainz Comas, I. Castellví, S. P. Fernandez-Sanchez, J. Bernardez, H. Codes, J. L. Tandaipan, C. Pitarch, C. Marco Pascual, A. Garcia Guillen, N. Fernández-Verdés, L. Úbeda, M. À. Melchor, M. Sihuro, S. Ros, H. Corominas
|
|
2025 ABS0079
|
TELEWORKING VS. ON-SITE WORK: INSIGHTS INTO THE PREVALENCE AND SEVERITY OF MUSCULOSKELETAL DISORDERS,
S. Bouden, M. Dhifallah, L. Rouached, A. Ben Tekaya, I. Mahmoud, R. Tekaya, O. Saidane, L. Abdelmoula
|
|
2025 ABS0306
|
READINESS AND UNMET NEEDS IN TELEMEDICINE FOR RHEUMATOID ARTHRITIS MANAGEMENT: A MIXED METHODS STUDY AMONG PATIENTS, CAREGIVERS, AND HEALTHCARE PROFESSIONALS,
P. Dhanasekaran, B. Lim Po-Yuen, H. Ahmad, S. H. Chong, M. Lahiri, A. Santosa, G. G. Teng, P. Cheung, S. Lim, M. Ma
|
|
2025 ABS0413
|
LET’S ASK THE PATIENT: DISEASE PREDICTION BASED ON FREE-TEXT SYMPTOM DESCRIPTIONS,
I. Pérez - Sancristóbal, N. Steinz, L. Qin, T. D. Maarseveen, F. Zegers, B. Bislawska Axnäs, L. Rodriguez Rodriguez, R. Knevel
|
|
2025 ABS0415
|
ESTIMATION OF DAS28-ESR SCORE FROM A SINGLE ACCELEROMETER SIGNAL USING BAYESIAN REGULARIZED NEURAL NETWORKS,
P. Mielnik, A. Myhre Hjelle, A. Traseth, M. Fojcik, K. Tokarz
|
|
2025 ABS0430
|
THE NOVEL DIGITAL THERAPEUTIC AXIA IMPROVES DISEASE ACTIVITY, FUNCTIONALITY, AND QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS PATIENTS: EIGHT WEEK OUTCOME FROM A 12-WEEK RANDOMIZED CONTROLLED CROSSOVER TRIAL,
P. P. Strunz, T. Heusinger, M. Le Maire, A. Fleischer, K. S. Luetkens, P. Possler, M. Gernert, H. Labinsky, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, M. Fröhlich, M. Schmalzing
|
|
2025 ABS0450
|
WEARABLE-BASED ACCELEROMETRY FEATURES AS A POTENTIAL DIGITAL BIOMARKER FOR IDENTIFYING FIBROMYALGIA PATIENTS THROUGH STATIC BALANCE ASSESSMENT IN DUAL-TASK CONDITIONS,
Z. Veličković, N. Trajković, M. Novičić, N. Šuljagić, M. Janković, G. Radunovic
|
|
2025 ABS0559
|
WEARABLE-BASED ACCELEROMETRY FEATURES AS A POTENTIAL DIGITAL BIOMARKER FOR IDENTIFYING FIBROMYALGIA PATIENTS THROUGH GAIT ASSESSMENT IN DUAL-TASK CONDITIONS,
Z. Veličković, N. Trajković, M. Novičić, N. Šuljagić, M. Janković, G. Radunovic
|
|
2025 ABS0647
|
WEB-BASED SELF-GUIDED COGNITIVE BEHAVIORAL THERAPY FOR INFLAMMATORY RHEUMATIC DISEASES: A RANDOMIZED CLINICAL TRIAL,
J. Knitza, J. Kraus, M. Krusche, I. Haase, P. Klemm, A. Hueber, A. Pfeil, U. Drott, S. Kuhn, P. Klein
|
|
2025 ABS0795
|
OUTCOMES ONE YEAR AFTER IMPLEMENTING A REMOTE MULTIDISCIPLINARY HEALTHCARE APPROACH FOR RHEUMATOID ARTHRITIS,
G. S. Rodríguez-Vargas, R. Casanova Libreros, J. Chavez-Chavez, M. Rojas-Fierro, P. Santos-Moreno, J. A. Rubio-Rubio, D. P. Rivera-Triana, R. A. Castiblanco Montañez, S. M. Hernández-Zambrano, L. Villarreal, A. Rojas-Villarraga
|
|
2025 ABS0808
|
E-HEALTH LITERACY IN PATIENTS WITH RHEUMATOID ARTHRITIS,
A. Fazaa, S. Ben Hamouda, S. Miladi, Y. Makhlouf, H. Boussaa, K. Ben Abdelghani, A. Laatar
|
|
2025 ABS0829
|
THE RISE OF RHEUMATIC AND MUSCULOSKELETAL TELEREHABILITATION INTERVENTIONS AND FALL OF THEORETICAL GROUNDING: A SCOPING REVIEW,
P. Rouse, T. Ingram, R. Barnett, R. Sengupta
|
|
2025 ABS0835
|
DOES LONGITUDINAL PATIENT-REPORTED DISEASE ACTIVITY VARY BY GENDER AND AGE IN PATIENTS WITH RHEUMATOID ARTHRITIS,
I. Biliavska, E. Lenguerrand, J. Tobias, P. Hamann
|
|
2025 ABS0853
|
INTRODUCING THE MULTIDIMENSIONAL PAIN INVENTORY AS A COMPREHENSIVE TOOL FOR ASSESSING PAIN IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS,
D. Kiefer, Y. Sonkaya, D. Krause, M. Voglau, B. Mintrop, I. Redeker, X. Baraliakos, U. Kiltz
|
|
2025 ABS0864
|
EVALUATING THE USABILITY OF AN ARTIFICIAL INTELLIGENCE-BASED CHAT APPLICATION FOR SHARED DECISION-MAKING IN RHEUMATOID ARTHRITIS PATIENTS,
S. R. Choi, S. B. Lee, H. R. Park, H. R. Ko, Y. S. Jung, E. Nam, S. Yoon, S. K. Cho, Y. K. Sung
|
|
2025 ABS0866
|
CAN WE EXPLAIN HOW IMAGE-BASED AI MODELS COME TO THEIR MEDICAL DECISIONS IN RHEUMATIC DISEASES A LITERATURE REVIEW AND OWN CRITICAL APPRAISAL,
J. Nicolaes, T. Hügle
|
|
2025 ABS0912
|
EVALUATING ChatGPT’s PERFORMANCE IN DIAGNOSING LOW BACK PAIN: A COMPARISON WITH CLINICIANS AND IMPACT OF PROMPTED SPECIALTIES,
A. Nack, X. Michelena, P. Maymo Paituvi, C. Calomarde-Gómez, D. Lobo, A. García-Alija, R. Ugena-García, M. Aparicio-Espinar, P. Vidal-Montal, D. Benavent
|
|
2025 ABS0922
|
AUTOMATED EXTRACTION OF PATIENT-REPORTED PAIN OUTCOMES IN OSTEOARTHRITIS USING PROMPT ENGINEERING OF LARGE LANGUAGE MODELS,
J. Doshi, S. Batter, Y. Wu, A. Santilli, S. S. Kannayiram, S. M. Goodman, B. Mehta
|
|
2025 ABS1032
|
TWO DECADES OF RHEUMATOLOGY RESEARCH (2000-2023): A DYNAMIC TOPIC MODELING PERSPECTIVE,
A. Madrid García, D. Freites, B. Merino, I. Pérez - Sancristóbal, L. Rodriguez Rodriguez
|
|
2025 ABS1079
|
WEARABLE-DERIVED PHYSICAL ACTIVITY TRENDS FOLLOWING TREATMENT WITH SECUKINUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: A SECONDARY ANALYSIS OF THE OPEN-LABEL ARM OF THE ASLeap STUDY,
D. McGagh, L. Grinnell-Merrick, A. Winseck, T. E. Nichols, A. Doherty, L. C. Coates
|
|
2025 ABS1146
|
SELF-ASSESSMENT OF JOINTS IN RHEUMATOID ARTHRITIS: ROLE IN TREATMENT MONITORING,
S. L. Sathiyaseelan, D. Agarwal, S. Kansurkar, K. Krishna, V. Bhatt
|
|
2025 ABS1172-HPR
|
THE EFFICACY OF A TELEREHABILITATION-BASED CLINICAL PILATES PROGRAM ON LUMBOPELVIC MUSCLE MORPHOLOGY AND STRENGTH IN FEMALE PATIENTS WITH FIBROMYALGIA SYNDROME: A RANDOMIZED CONTROLLED TRIAL,
F. Sari, Y. MİRZA, P. D. Yilmaz, A. Kucuk
|
|
2025 ABS1176-HPR
|
FIVE YEARS OF THE DIGITAL RHEUMATOLOGY NETWORK: ACHIEVEMENTS, INSIGHTS, AND FUTURE DIRECTIONS,
T. Hügle, L. Gupta, A. Chan, B. van den Bemt, V. Venerito, J. Richter, M. Blanchard, J. M. van Laar, M. Krusche, D. Hans, J. Knitza
|
|
2025 ABS1179-HPR
|
WHICH PHYSIOTHERAPY METHOD IS MORE EFFECTIVE FOR HAND REHABILITATION IN PATIENTS WITH SYSTEMIC SCLEROSIS: TELEREHABILITATION OR HOME-BASED EXERCISE,
N. G. TORE, S. Bayram, G. G. PALA, İ. Vasi, D. Oskay
|
|
2025 ABS1185-HPR
|
EFFECTIVENESS OF REMOTE MONITORING OF PATIENTS WITH CHRONIC LOW BACK PAIN FOLLOWING FUNCTIONAL RESTORATION PROGRAM OF THE SPINE ON ADHERENCE WITH THE SELF-REHABILITATION PROGRAMME – A MULTICENTRE RETROSPECTIVE STUDY,
T. Davergne, L. Mroueh
|
|
2025 ABS1220-HPR
|
DEVELOPMENT OF THE PEDIATRIC PHYSICAL ACTIVITY TRACKING PLATFORM (PEDI@CTIVITY) AND SMARTWATCH-BASED BIG DATA ANALYSIS: A DIGITAL HEALTH APPLICATION IN SOCIETY 5.0,
N. Arman, T. Çakar, S. Güllü, N. Aktay Ayaz, A. Yekdaneh, A. Albayrak
|
|
2025 ABS1226-HPR
|
PATIENTS’ REFLECTIONS ON THEIR OWN ACCESS TO ELECTRONIC HEALTH RECORDS IN PSORIASIS AND PSORIATIC ARTHRITIS SPECIALIST CARE,
S. Pettersson, A. K. Rickardsdotter Olofsson, M. Hägglund
|
|
2025 ABS1240-PARE
|
CHILEAN NETWORK OF RHEUMATIC PATIENTS INVOLVING DIFFERENT STAKEHOLDERS TO CO-BUILD SOLUTIONS FOR OUR PATIENTS: PUBLIC FORUM TO DISCUSS PUBLIC HEALTH AND MANAGEMENT OF RMDS IN THE COUNTRY,
G. Tobar Carrizo, C. D. González Quintana, E. Rocuant, R. Atenas, C. Quijada
|
|
2025 ABS1252-PARE
|
ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY HELATH CARE: A BIBLIOGRAPHIC ANALYSIS,
F. Cosan
|
|
2025 ABS1256-PARE
|
ENHANCING EFFICIENCY AND STAFF WELL-BEING: TRANSITIONING RHEUMATOLOGY ADVICE LINE TO A DIGITAL PLATFORM,
L. Sammut, A. Atkins, C. Beevor
|
|
2025 ABS1260-PARE
|
HEALTH LITERACY ONLINE SURVEY,
S. Dordevic, M. Kosanovic, M. Lapčević, I. Moldovan
|
|
2025 OP0036
|
Artificial Intelligence Reinforced Social Robotics in Patient Communication for Patients with Rheumatic Diseases,
D. van Gorssel, M. Hegeman, D. Gerritsen, J. W van ‘t Klooster, H. E. Vonkeman
|
|
2025 OP0050
|
Clinical Validation of Large Language Models for Osteoporosis Risk Assessment: A Case-Based Analayis,
P. Vij, S del Vescovo, C. Casteleyn, I. Coskun Benlidayi, M. Jasim, T. Adizie, H. Sapkota, S. Venkatachalam, V. Venerito, L. Gupta
|
|
2025 OP0111
|
Digital Biomarkers in Rheumatoid Arthritis: Single-Camera Motion Capture Meets Computer Vision. External validation of the Mefisto study,
V. Venerito, T Manigold, M. Capodiferro, D Markham, M Blanchard, F Iannone, T Hügle
|
|
2025 OP0116-HPR
|
EXAMINING RHEUMATOID ARTHRITIS CARE AND eHEALTH SUPPORT IN TWO SWISS CENTRES: A CONTEXTUAL ANALYSIS TO DEVELOP THE SQUEEZE CARE MODEL FOR DMARDS ADHERENCE AND IMPLEMENTATION STRATEGIES,
C. Wettengl, S. Calado, S. Brand, M. L. Daly, S. De Geest, E. Deman, D. Kyburz, C. Manolaraki, J. Ribaut, I. von Mühlenen, A. Kocher
|
|
2025 OP0117-HPR
|
EFFECTIVENESS OF THE REMOTE VIDEO-BASED SARAH EXERCISE PROGRAM IN INDIVIDUALS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED SINGLE-BLINDED STUDY,
A. Ceylan, E. Başkan, İ. İnanc, D. C. SARAÇ, A. Özkan, N. B. Karaca, D. Solmaz, S. Gucenmez, S. Akar, D. Bayraktar
|
|
2025 OP0278
|
EFFICACY OF IMMERSIVE VIRTUAL REALITY-BASED BIOFEEDBACK ON CHRONIC PAIN AND DAILY LIFE IMPACT IN FIBROMYALGIA: A PILOT RANDOMIZED CONTROLLED TRIAL,
L. Quartuccio, S. Longhino, M. Serafini, S. Cacioppo, L. Chittaro
|
|
2025 OP0303
|
COST-EFFECTIVENESS OF NURSE-LED HOME MONITORING OF SERUM URIC ACID VALUES FOR GOUT PATIENTS IN SECONDARY CARE: A MODELLING STUDY,
J. van der Ven, M. Flendrie, F van Dijck, M. H. M. Wientjes, N van Herwaarden, P. L. Riches, B van den Bemt, L. M. Verhoef
|
|
2025 OP0355-PARE
|
Digital dawn: Here comes the sun The RMD Patients perspective,
G. Bendzuck
|
|
2025 OP0363-PARE
|
Co-Design in Action: Mobilising knowledge and lived experience to design D-MAPP, a digital self-management intervention for distal upper limb MSDs,
L. Brading, J. Rimmer, S. Mason, S. Kingsbury, P. G. Conaghan, I. Kellar
|
|
2025 OP0364-PARE
|
Leveraging machine learning to identify predictors of digital health technologies among rheumatic patients using German nationwide survey data,
F. Muehlensiepen, P. Petit, S. May, N. Vuillerme
|
|
2025 OP0370-HPR
|
Exploring Health Literacy and eHealth Literacy Strengths and Challenges Among Danish Gout Patients: A Co-Design process for Developing a Nurse-Led Telehealth Intervention,
S. B. Vestergaard, C. Ammitzbøll, R. Osborne, C. Cheng, M. Hawkins, A de Thurah
|
|
2025 OP0373-PARE
|
EQUITY OF ACCESS TO CARE AND UNIFORMITY ACROSS THE NATIONAL TERRITORY, THE CASE OF RHEUMATOID ARTHRITIS AND PSORIASIC ARTHRITIS,
S. Tonolo, S. Severoni, M. Galeazzi, P. Comite, A. Verducci
|
|
2025 OP0379-HPR
|
Tracking Step Counts in Adolescents with Juvenile Idiopathic Arthritis and Familial Mediterranean Fever: A 3-Month m-Health Monitoring Study Using Smartwatches,
A. Albayrak, N. Arman, A. Yekdaneh, I. Donmez, Y. Acikgoz, G. Filiz, T. Cakar, N. Aktay Ayaz
|
|
2025 POS0099
|
PREDICTORS OF PROLONGED USE OF A SELF-OBSERVATION App IN INFLAMMATORY RHEUMATIC DISEASES: FINDINGS FROM THE SCQM REGISTRY,
J. Brändli, C. E. Raptis, M. Riek, A. Scherer, A. Grabowski, A. Finckh, I. von Mühlenen, B. Moeller, A. Rubbert-Roth, T. Hügle, R. Micheroli
|
|
2025 POS0122
|
DIGITAL BEHAVIORAL THERAPY IMPROVES AXIAL SPONDYLOARTHRITIS OUTCOMES IN PATIENTS WITH PERSISTENT PAIN: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL,
D. Kiefer, Y. Sonkaya, D. Krause, M. Voglau, B. Mintrop, I. Redeker, X. Baraliakos, U. Kiltz
|
|
2025 POS0169
|
PREDICTION OF DISEASE ACTIVITY STATE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS BY UTILIZING WRIST-WORN WEARABLE DEVICES,
T. Niwano, T. Yamaguchi, D. Kawata, Y. Takeshita, S. Takagi, S. Oba, H. Sasaki, A. Yamamoto, N. Umezawa, T. Saito, H. Hasegawa, N. Kimura, H. Iwai, K. Mochizuki, T. Fukami, K. Izumi, K. Minato, R. Koike, S. Yasuda, T. Hosoya
|
|
2025 POS0217
|
IMPACT OF ONBOARDING ON ADOPTION AND ENGAGEMENT WITH A NEW SELF-MONITORING AND MANAGEMENT APP FOR PATIENTS WITH CHRONIC MUSCULOSKELETAL PAIN,
C. Koller, M. Blanchard, J. Mettler, T. Pretat, P. Hermann, P. Ming Azevedo, T. Hügle
|
|
2025 POS0336-HPR
|
CO-DESIGN AND EARLY EVALUATION OF A REMOTE MONITORING MOBILE APP BASED ON SELF-IMAGING FOR PATIENTS WITH INFLAMMATORY ARTHRITIS: FOCUS GROUP INSIGHTS,
L. Russo, M. Blanchard, J. Maglione, P. Hermann, C. Koller, T. Hügle
|
|
2025 POS0338-HPR
|
A USER-CENTERED MULTIMODAL ELECTRONIC HEALTH RECORD SIDECAR APPLICATION TO MONITOR INFLAMMATORY ARTHRITIS: DEVELOPMENT AND IMPLEMENTATION IN CLINICAL PRACTICE,
L. Russo, M. Blanchard, J. Maglione, P. Hermann, C. Koller, T. Hügle
|
|
2025 POS0342-HPR
|
CHANGING HABITS WITH THE HAPPY HANDS APP: A QUALITATIVE STUDY OF PARTICIPANTS’ EXPERIENCES WITH AN E-SELF-MANAGEMENT INTERVENTION,
K. A. Fjeldstad, I. Kjeken, E. Rasmussen, L. Olden, S. B. Nyheim, T. Blanck, R. M. Killingmo, A. T. Tveter
|
|
2025 POS0350-PARE
|
BARRIERS TO INTERVENTION UPTAKE IN THE REMOTE MONITORING OF RHEUMATOID ARTHRITIS (REMORA2) TRIAL: FINDINGS FROM QUALITATIVE INTERVIEWS,
J. Behan-Devlin, S. Moschogianis, K. Staniland, C. Sharp, S. van der Veer, W. Dixon, D. Dowding, C. Sanders
|
|
2025 POS0417-HPR
|
COMPARISON OF TELEREHABILITATION VS. FACE-TO-FACE CLINICAL PILATES-BASED EXERCISE TRAINING IN AXIAL SPONDYLOARTHRITIS: AN INTERIM ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL INCLUDING SIX-MONTH FOLLOW-UP,
N. B. Karaca, G. I. Kinikli, C. Boström, S. Buran, O. Tüfekçi, L. Kiliç, E. Ünal, Ş. A. Bilgen
|
|
2025 POS0427
|
DEVELOPMENT AND VALIDATION OF AN ACCURATE PRO-BASED DISEASE ACTIVITY SCORE TO ENABLE REMOTE MONITORING IN RHEUMATOID ARTHRITIS,
A. E. M. Looijen, P. M. J. Welsing, S. A. Bergstra, A. H. M. van der Helm – van Mil, P. H. P. de Jong
|
|
2025 POS0448
|
PEDIATRIC RHEUMATOLOGY ON SOCIAL MEDIA: EXPERTS DRIVE ACCURACY, PUBLIC DRIVES ENGAGEMENT – A COMPARATIVE ANALYSIS,
S. La Bella, M. Attanasi, A. Di Ludovico, F. Mainieri, F. Lauriola, L. Silvestrini, F. Ciarelli, J. Osmelli, V. Girlando, M. Rinaldi, F. Chiarelli, S. Ozen, M. Gattorno, L. Breda
|
|
2025 POS0490
|
CHALLENGES IN IMPLEMENTING EVIDENCE-BASED HEALTH INTERVENTIONS IN THE EUROPEAN UNION: THE ROLE OF THE CONTEXTUAL ANALYSIS IN THE SQUEEZE PROJECT,
E. Loza, S. Calado, K. Chingov, S. De Geest, A. Kocher, T. Oton, J. Ribaut, C. Wettengl, L. Carmona
|
|
2025 POS0601
|
DATA-DRIVEN METRICS FOR EVALUATING RHEUMATOID ARTHRITIS THERAPY RESPONSE,
A. Wong, S. Guardiano, V. Akmaev, L. Zhang
|
|
2025 POS0738
|
REMOTE CLINICAL MANAGEMENT OF PATIENTS WITH LUPUS: CAN WE PREDICT STABLE DISEASE,
M. Aguilar-Coll, R. Baslas, J. David, F. J. Narváez Garcia, R. Luqmani
|
|
2025 POS0748
|
CAN ROBOTIC ULTRASONOGRAPHY REPLACE STANDARD ULTRASONOGRAPHY IN RHEUMATOID ARTHRITIS – RESULTS FROM THE CONTROLLED ARTHUR TRIAL,
M. Ammitzbøll-Danielsen, M. Østergaard, H. P. L. Tam, L. Terslev
|
|
2025 POS0881
|
BEYOND INFLAMMATION: MENTAL HEALTH AS A KEY DRIVER OF ANTI-TNF THERAPY EFFECTIVENESS IN SPONDYLOARTHRITIS. DATA FROM REGISPONSER AND RESPONDIA REGISTRIES,
D. Castro Corredor, L. Á. Calvo Pascual, E. Collantes-Estevez, C. López-Medina
|
|
2025 POS0883
|
OPTIMIZING RHEUMATOLOGY CONSULTATIONS WITH ARTIFICIAL INTELLIGENCE: INSIGHTS FROM THE ReumAI PILOT STUDY,
A. Gómez-Centeno, M. Sabaris-Vilas, F. Garcia-Sancho, J. Segura-Sanchez
|
|
2025 POS0911
|
A NEW HORIZON IN THE CARE OF RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS: EFFECTIVENESS OF THE MIXED CARE MODEL WITH THE USE OF IMIDOC,
J. M. Iniesta-Chamorro, M. Novella-Navarro, D. Benavent, H. Borrell Paños, X. Michelena, J. Bachiller-Corral, V. García García, E. Espartal, L. Lojo, E. Calvo-Aranda, L. Berbel Arcobe, J. Rodriguez-Gago, G. Bonilla, I. Monjo-Henry, V. Navarro-Compán, J. Arroyo-Palomo, C. M. Gomez-Gonzalez, M. Díaz-Almirón, E. De Miguel-Mendieta, E. J. Gómez, A. Balsa, C. Plasencia-Rodríguez
|
|
2025 POS1070
|
Comparative Analysis of Large Language Models and Symptom Checkers for Rare Rheumatic Disease Identification,
P. Kremer, H. Schiebisch, F. Lechner, I. Haase, L. Cirkel, S. Kuhn, M. Krusche, J. Knitza
|
|
2025 POS1085
|
VALIDATION OF HUMAN PHENOTYPE ONTOLOGY AND DEVELOPMENT OF AN ARTIFICIAL-INTELLIGENCE BASED DIAGNOSTIC TOOL FOR AUTOINFLAMMATORY DISEASES USING THE EUROFEVER REGISTRY,
C. Matucci-Cerinic, G. Fiorito, M. Vergani, G. Cavalca, R. Caorsi, M. E van Gijn, L. Pape, G. Boursier, P. Uva, M. Gattorno
|
|
2025 POS1091
|
Development and Validation of ‘Rheumatic ‘ - A Digital Symptom Checker for Confirmation and Prediction of Rheumatic Diseases: A Large-Scale Prospective Study,
L. Qin, D. Selani, F. Zegers, J. Desai, B. Bislawska Axnäs, C Baatenburg de Jong, H. K. Glas, L. M. Verhoef, C. Aulin, L. Rodriguez Rodriguez, J. Askling, R. Bos, Y. Goekoop-Ruiterman, A van Tubergen, T. Huizinga, E. Steyerberg, L. Klareskog, M. J. T. Reinders, S. Le Cessie, E. B van den Akker, R. Knevel
|
|
2025 POS1112
|
IMPLEMENTATION AND BARRIERS TO USE OF DIGITAL TECHNOLOGIES IN RHEUMATOLOGY PRACTICE: PRELIMINARY RESULTS FROM A SCOPING SURVEY FROM THE EULAR DIGITAL HEALTH & TECHNOLOGY STUDY GROUP,
D. McGagh, K. F. Baker, L. C. Coates, M. Gordon, H. Grasshoff, B. Grimm, C. Hinchliffe, T. Hügle, H. Hunter, N. Kennedy, S. Compeyrot-Lacassagne, V. Macrae, M. B. Lauvsnes, P. Livermore, J. Richter, S. Del Din, W. F. Ng
|
|
2025 POS1114
|
UNDERSTANDING NON-ADHERENCE IN PSORIATIC ARTHRITIS: FACTORS AND BELIEFS AFFECTING PATIENT COMPLIANCE,
A. Özkan, E. Çiçek, S. Gurleyen, K. Yucel, H. Kocaayan, İ. Kurut Aysin, S. Akar, D. Solmaz
|
|
2025 POS1198
|
REMONIT GOUT FEASIBILITY STUDY: A SELF-MANAGEMENT APP IN A TREAT-TO-TARGET GOUT CARE APPROACH,
J. Stjärne, F. Aanesen, S. Søhus, H. B. Hammer, T. Uhlig, E. Kristianslund, A. T. Tveter, N. Dalbeth, A. Abhishek, I. J. Berg, N. Osteras
|
|
2025 POS1227
|
PATIENT SATISFACTION OF PATIENT INITIATED FOLLOW-UP IN A SURVEY OF 864 PATIENTS WITH INFLAMMATORY JOINT DISEASES IN NORWAY,
I. Sagberg, M. Hoff
|
|
2025 POS1229
|
ADHERENCE TO DIGITAL HEALTH APPLICATION AND ITS ASSOCIATION WITH DISEASE DURATION, AGE, AND GENDER IN PATIENTS WITH INFLAMMATORY ARTHRITIS,
D. Fedkov, A. Khalil, C. Peine, F. Lang, J. Knitza, J. Leipe
|
|
2025 POS1271
|
ENHANCING PATIENT CARE AND CLINICAL CAPACITY IN INFLAMMATORY ARTHRITIS WITH AN INTEGRATED ELECTRONIC PATIENT-REPORTED OUTCOME SYSTEM,
A. Chan, K. Rigler, N. Zabbey, M. Hussain, A. Hubbard
|
|
2025 POS1442-HPR
|
EULAR RECOMMENDATIONS FOR PATIENT EDUCATION IN PEOPLE WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASE: 2025 UPDATE,
J. Veldhuijzen van Zanten, K. Woodward, A. van Tubergen, A. de Thurah, S. E. Bennett, P. Böhm, L. Carmona, T. Davergne, A. Domjan, M. Doumen, K. El Aoufy, B. A. Esbensen, F. Fayet, J. Knitza, A. Kocher, G. S. Metsios, A. Opinc-Rosiak, Y. Prior, L. Raunsbæk Knudsen, J. Rodríguez-Carrio, H. Smucrova, S. Stones, T. W. Swinnen, J. E. Vriezekolk, C. Beauvais
|
|
2025 POS1448-HPR
|
EFFICIENCY OF MOBILE-BASED AI-PERSONALIZED EXERCISE PROGRAM VERSUS SUPERVISED AI-PERSONALIZED EXERCISE PROGRAM IN JUVENILE IDIOPATHIC ARTHRITIS: A PILOT STUDY,
A. Yekdaneh, N. Arman, N. Aktay Ayaz
|
|
2025 POS1481-HPR
|
EXPLORING THE FEASIBILITY OF USING DIGITAL TECHNOLOGIES TO MEASURE FREE-LIVING PHYSICAL ACTIVITY AND REAL-TIME SYMPTOMS IN PEOPLE LIVING WITH RHEUMATOID ARTHRITIS,
R. Baynham, J Veldhuijzen van Zanten, A. Doherty, S. Fenton
|
|
2025 POS1490-HPR
|
CAN KNEE OSTEOARTHRITIS BE PREDICTED USING MACHINE LEARNING WITH PEDOBAROGRAPHIC DATA,
N. B. Cigercioglu, Y. Y. Pilavci, H. Guney-Deniz
|
|
|
[84]
|
Animal Models
|
|
|
| 2025 |
|
2025 ABS0005
|
ACONITINE: A POTENTIAL TREATMENT FOR RHEUMATOID ARTHRITIS,
R. Wang, X. Hou, N. Wang, H. Li, J. He
|
|
2025 ABS0009
|
THE ERß AGONIST, WT-IV-012, SUPRESSES THE INFLAMMATORY RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
B. Zeno, S. Bruckner, C. Bennett, W. Jarjour
|
|
2025 ABS0055
|
NINTEDANIB PREVENTS THE DEVELOPMENT OF LUNG FIBROSIS IN A NOVEL HUMAN PDGFRa-TRANSGENIC MOUSE,
C. Paolini, S. Agarbati, F. Orlando, D. Benfaremo, M. Furlani, G. Bigossi, M. Malavolta, S. Svegliati Baroni, A. Funaro, A. Giuliani, G. Moroncini
|
|
2025 ABS0060
|
UNDERSTANDING DRIVERS OF LUPUS PATHOGENESIS THROUGH COMPARISON OF PRECLINICAL MODELS,
A. Glatman Zaretsky, C. Tasker, P. Abreu, C. Torres, L. H. Ben, S. MacDonnell, A. Limnander, J. Orengo
|
|
2025 ABS0085
|
TARGETING INTEGRIN avß3 WITH [18F]FLUCICLATIDE FOR IN VIVO NON-INVASIVE MOLECULAR IMAGING OF SYNOVIAL ANGIOGENESIS IN A PRECLINICAL ARTHRITIS MODEL,
F. Khodadust, M. M. Steinz, E. Philippon, A. D. Windhorst, G. Jansen, S. W. Tas, C. J. van der Laken
|
|
2025 ABS0102
|
STAT1 PROMOTES CD4+T CELLULAR SENESCENCE BY UPREGULATING MAP1S LACTYLATION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Wang, L. Chun, M. Zhang, H. Z. Dai
|
|
2025 ABS0117
|
INHIBITION OF YAP AND CCL2 ADDITIVELY REDUCES ARTHRITIS SEVERITY IN THE RAT ADJUVANT-INDUCED ARTHRITIS MODEL,
E. Dalix, A. Cifuentes, G. Courbon, S. Mundweiler, M. Paul, H. Marotte
|
|
2025 ABS0128
|
GENERATION OF PLURIPOTENT STEM CELL-DERIVED SALIVARY GLAND PROGENITOR CELLS FOR TRANSPLANTATION IN SJÖGREN’S DISEASE,
A. Soto-Gamez, J. H. Terpstra, C. Tesa, H. Bootsma, F. G. M. Kroese, R. Coppes, S. Pringle
|
|
2025 ABS0129
|
EFFICACY OF A BD2-SELECTIVE BET INHIBITOR IN ANIMAL MODELS OF RHEUMATOID ARTHRITIS BY INHIBITION OF NF-KB DRIVEN INFLAMMATORY PATHWAYS,
I. Stuart, S. Banerjee, A. Woodland, M. Bell, R. Jayaprakash
|
|
2025 ABS0130
|
MMP-9-INDUCED SYNDECAN-4 SHEDDING REFLECTS THE DEGREE OF INFLAMMATION IN SJÖGREN’S SYNDROME,
S. J. Lee, J. A. Jang, E. J. Lee, G. W. Kim, E. J. Nam
|
|
2025 ABS0139
|
PLACE OF IL17A ON HEPATIC INFLAMMATION AND FIBROSIS IN ADJUVANT INDUCED ARTHRITIS AND IMPACT OF AN EARLY TREATMENT BY SECUKINUMAB,
A. Dollinger, F. Meyer, H. Martin, C. Demougeot, W. V. Delphine, F. Verhoeven
|
|
2025 ABS0148
|
PAR2 DELETION IN THE OSTEOBLAST LINEAGE AFFORDS LONG-TERM CARTILAGE PROTECTION IN EXPERIMENTAL OSTEOARTHRITIS,
C. Huesa, S. McGrath, L. Dunning, M. L. Vieri, K. McCulloch, K. A. McIntosh, J. Cole, R. Plevin, D. Rowan, R. van ‘t Hof, W. R. Ferrell, J. Lockhart, C. S. Goodyear
|
|
2025 ABS0150
|
ANTI-TL1A ANTIBODY REDUCES DISEASE SYMPTOMS AND PATHOLOGICAL CHANGES IN RAT COLLAGEN-INDUCED ARTHRITIS,
M. Siegel, E. Lewis, D. Giles, J. LaFountaine, J. R. Friedman, A. Spencer
|
|
2025 ABS0180
|
TNF-SPECIFIC AFFIBODY: A NOVEL PET/CT CANDIDATE TRACER FOR IMAGING RHEUMATOID ARTHRITIS,
E. Philippon, M. M. Steinz, F. Khodadust, T. van de Watering, O. Wegrzyniak, J. Löfblom, O. Eriksson, S. W. Tas, C. J. van der Laken
|
|
2025 ABS0185
|
TARGETING T FOLLICULAR HELPER CELLS IN SJÖGREN’S DISEASE BY CALYCOSIN,
S. Yu, M. Wu, J. Shen, X. Lin
|
|
2025 ABS0186
|
LECTIN HISTOCHEMISTRY OF THE LIGAMENTUM CAPITIS FEMORIS IN THE INTACT HIP JOINT DURING THE POSTNATAL PERIOD,
A. Fedotchenko
|
|
2025 ABS0200
|
KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO,
J. Wang
|
|
2025 ABS0214
|
VITAMIN D3 AND α-TOCOPHEROL ACETATE MITIGATE DAMAGE TO ALVEOLOCYTES II TYPE IN AN EXPERIMENTAL MODEL OF SYSTEMIC SCLEROSIS,
V. Fedenko, B. Doskaliuk, L. Zaiats, R. Yatsyshyn
|
|
2025 ABS0222
|
ARTICULAR CARTILAGE REGENERATION IN OSTEOARTHRITIS USING A COMBINED CONCEPT OF CHONDROSPHEROID AND BIOADHESIVE FIXATION,
J. Y. Ko, G. I. Im
|
|
2025 ABS0223
|
PROFILING OF MT-3534, A HUMANIZED MONOCLONAL ANTIBODY TARGETING PAD4, AS A CANDIDATE DRUG FOR THE TREATMENT OF RA,
H. Niki, A. Nishizawa, Y. Ono, M. Yamazaki, S. Takanashi, K. Yoshimoto, M. Akiyama, T. Takeuchi, Y. Kaneko
|
|
2025 ABS0258
|
PALMITOYLATION PROTECTS NOD2 FROM p62-MEDIATED AUTOPHAGY-LYSOSOME DEGRADATION TO INHIBIT OSTEOARTHRITIS PROGRESSION,
C. Li, J. Chen, T. Liu, Y. Yu, W. Ko, C. Pan, S. Li, Y. Ding
|
|
2025 ABS0265
|
ARTHROSCOPICALLY INJECTABLE HUMAN COLLAGEN-HYALURONIC ACID SCAFFOLDS FOR EFFECTIVE CARTILAGE REGENERATION,
S. Y. Jung
|
|
2025 ABS0267
|
COATING OF MENISCUS AND CARTILAGE OF OSTEOARTHRITIC RATS AND RABBITS FOLLOWING INTRAARTICULAR INJECTION OF MM-II, A DISPERSION OF EMPTY LARGE MULTILAMELLAR LIPOSOMES,
R. Wechsler, R. Rotem
|
|
2025 ABS0268
|
LOCAL AND SYSTEMIC EFFECTS FOLLOWING REPEATED INTRAARTICULAR INJECTION IN RABBIT OF MM-II, A NOVEL DISPERSION OF LARGE, EMPTY, MULTILAMELLAR LIPOSOMES,
G. Sarfati, R. Wechsler, S. Akhtar
|
|
2025 ABS0269
|
LPA1/3 DUAL ANTAGONIST AMELIORATED SYSTEMIC SCLEROSIS MORE EFFECTIVE THAN LPA1 SELECTIVE ANTAGONIST VIA SUPPRESSING LPA3 PATHWAY IN SKIN,
T. Naruse, L. Okumura, H. Kajiyama, Y. Nagashima, T. Sugawara, S. Ito, T. Takahashi, H. Kakinuma
|
|
2025 ABS0280
|
UNVEILING SYNERGISTIC DRUG COMBINATIONS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES: INSIGHTS FROM THE DoCTIS CONSORTIUM USING SYSTEMS BIOLOGY APPROACHES,
A. Julià, E. Choy, M. A. López Lasanta, P. Vela Casasempere, A. Fernández Nebro, S. Castañeda, C. Marras, J. Calvo Alén, J. Tornero Molina, J. D. D. Cañete Crespillo, E. Domènech, J. P. Gisbert, J. M. Carrascosa, E. Fonseca, L. Bujanda Fernández de Pierola, V. García Sánchez, B. Siegmund, G. Girolomoni, H. Heyn, L. Jimenez, P. Santamaría, E. Angelats, R. Myers, Y. Guillén, S. H. Martínez-Mateu, S. Marsal
|
|
2025 ABS0281
|
ACLT + pMMx SURGERY SUCCESSFULLY INDUCES POST-TRAUMATIC OSTEOARTHRITIS IN SHEEP,
J. Uerlings, J. Grisart, F. Hontoir, H. Choi, D. K. Kim, J. M. Jang, H. J. Ha, J. M. Vandeweerd, M. Uebelhoer
|
|
2025 ABS0287
|
DISTINCT STABILITY AND SUPPRESSIVE PHENOTYPE OF SYNOVIAL VERSUS PERIPHERAL TREG IN RHEUMATOID ARTHRITIS,
T. Abaab, J. Sigaux, L. Semerano, M. C. Boissier, J. Biton, N. Bessis
|
|
2025 ABS0583
|
REVOLUTIONIZING RHEUMATOID ARTHRITIS TREATMENT: MSCS AND THEIR IMPACT ON T CELL DYNAMICS,
X. wang, A. Liu, J. he, X. liu, Q. wang, L. Yang
|
|
2025 OP0124
|
ZNF687 REGULATES OSTEOCLASTOGENESIS AND DRIVES PAGET’S DISEASE OF BONE THROUGH MYELOID LINEAGE POPULATIONS,
S. Russo, F. Gianfrancesco
|
|
2025 OP0125
|
TARGETING NLRP3 INFLAMMASOME ACTIVATION AND INFLAMMATION IN GOUT WITH NEK7 MOLECULAR GLUE DEGRADERS: A NOVEL THERAPEUTIC STRATEGY,
D. Wible, Q. Chen, S. Nguyen, M. Schillo, V. Verdine, K. Gosala, A. Trouilloud, H. Farine, V. Strande, D. Bonenfant, C. King, K. Meier, C. Komishane, M. Cabanski, A. Kostikova, L. McAllister, E. Krishnan, F. Janku, M. Walter, E. Liardo, A. Paterson, A. Iracheta-Vellve
|
|
2025 OP0130
|
EXPERIMENTAL STUDY OF TARGETING PAD4 TO INHIBIT THE FORMATION OF NEUTROPHIL EXTRACELLULAR TRAP NETWORK FOR THE TREATMENT OF GOUT,
Y. Wang, D. Man, H. Li
|
|
2025 OP0131
|
MULTITARGETED BIOLOGICAL ACTIONS OF POLYDATIN IN PREVENTING PSEUDOGOUT ACUTE ATTACK,
C. Baggio, P. Galozzi, A. C. Damasco, V. Lazzarin, G. Ravagnan, P. Sfriso, R. Ramonda, L. Punzi, G. Pennelli, A. Doria, R. Luisetto, F. Oliviero
|
|
2025 OP0138
|
IL-33 EXPANDS PLASMA CELLS, DISRUPTS GERMINAL CENTERS AND INCREASES AUTOANTIBODY PRODUCTION,
A. Limnander, E. Conde, S. Asrat, A. Vecchione, K. Gayvert, P. Pedraza, C. Tasker, S. Huang, D. Yarilin, D. Birchard, L. H. Ben, W. K. Lim, A. Murphy, M. Sleeman, J. Orengo
|
|
2025 OP0139
|
DYSFERLIN AUTOANTIBODIES COMPROMISE SARCOLEMMAL REPAIR CAPACITY AND CONTRIBUTE TO THE PATHOGENESIS OF IDIOPATHIC IMMUNE MYOPATHIES,
H. Bulgart, K. Banford, S. Bruckner, N. Young, B. Paleo, K. McElhanon, B. Zeno, C. V. Oddis, R. Aggarwal, W. Jarjour, N. Weisleder
|
|
2025 OP0144
|
THE ROLE OF CXCL12/CXCR4 IN SJÖGREN’S DISEASE: FROM PATHOGENESIS TO POTENTIAL THERAPY,
X. Zhang, Y. Li, G. Shi, Y. Liu
|
|
2025 OP0148
|
SALIVARY VIROME ALTERATIONS IN SJÖGREN’S DISEASE CONTRIBUTE TO IMMUNE HOMEOSTASIS DISRUPTION BY MOLECULAR MIMICRY,
X. Zhang, Y. Li, Y. Qin, C. Deng, G. Shi, Y. Liu
|
|
2025 OP0153
|
PATHOGENIC ROLE OF MUCOSAL-ASSOCIATED INVARIANT T CELLS IN RHEUMATOID ARTHRITIS,
M. Lesturgie-Talarek, V. Gonzalez, A. Cauvet, F. Oudart, N. Senot, L. Beaudoin, Y. Allanore, A. Lehuen, J. Avouac
|
|
2025 OP0154
|
BUTYRATE IMPROVING THE INTESTINAL BARRIER VIA PROMOTING THE PROLIFERATION OF INTESTINAL STEM CELLS AND THEREBY ALLEVIATES THE ADVANCEMENT OF RHEUMATOID ARTHRITIS,
R. Wang, N. Wang, X. Zhang, D. Lu, J. He
|
|
2025 OP0245
|
C3a-C3aR1-MEDIATED INTERACTIONS BETWEEN FIBROBLAST-LIKE SYNOVIOCYTES AND MACROPHAGES PROMOTE THE PROGRESSION OF RHEUMATOID ARTHRITIS,
M. Cai, Z. Chen
|
|
2025 OP0276
|
GUT DYSBIOSIS AND VAGUS NERVE: A PATHWAY TO CHRONIC PAIN IN RHEUMATOID ARTHRITIS,
A. Pous, R. AUDO, M. Galoppin, J. Morel, C. Rivat, J. THIREAU, E. Bourinet, C. Immediato Daien
|
|
2025 OP0365
|
Ianalumab’s dual mode of action: targeting B cells through enhanced B cell depletion and blockade of B cell-activating factor receptor signaling,
C. Wioland, C. Vedrine, C. Walter, F. Marque, T. Dannequin, M. Ceci, D. Buffet, C. Schmid, E. Degl’Innocenti, G. Robert, G. Wieczorek, D. Schubert, C. Paape, I. Isnardi
|
|
2025 OP0366
|
ABCC6-deficient mice as a spontaneous model of osteoarthritis (OA) and calcific tendinopathy (CT),
E. Faure, D. Obiri-Yeboah, Q. Li, T. Chirayath, N. Busso, S. Nasi
|
|
2025 OP0368
|
METTL3 Modulates SPP1+ Macrophage Activation via MafB in pulmonary fibrosis,
R. Liang, X. Chen, S. C
|
|
2025 POS0003
|
Specific targeting of the 5-hydroxytryptamine 2B receptor (5-HT2BR) demonstrates antifibrotic effects in murine models and ex vivo models of scleroderma skin,
T. Trinh-Minh, C. Tran-Manh, A. H. Györfi, N. Dickel, C. Liebel, X. Zhou, J. Wang, M. Kunz, H. Arozenius, L. Pettersson, S. Lindgren, C. Wenglén, J. Distler
|
|
2025 POS0004
|
Inhibition of Interleukin-2-Inducible T Cell Kinase with Soquelitinib demonstrates efficacy in preventing lung damage in murine models of systemic sclerosis,
G. Boleto, A. Cauvet, L. Y. Hsu, J. T. Rosenbaum, R. A. Miller, Y. Allanore
|
|
2025 POS0014
|
Repository corticotropin injection (RCI) attenuates inflammatory response in a pre-clinical murine collagen induced arthritis model,
M. Corr, A. Place, G. Hsueh, N. Lane
|
|
2025 POS0035
|
Experimental study of mesenchymal stem cell-derived exosomes packaging Sflt-1 for the treatment of rheumatoid arthritis-related interstitial lung disease,
X. Ma, H. Li
|
|
2025 POS0045
|
DECADES-LONG ELEVATION OF INTERFERON-A DRIVES SJÖGREN DISEASE,
D. Forbes, I. Jorgacevic, J. Tarn, K. Reid, B. Rioux, K. Thompson, K. Kleeman, J. Casement, J. Berry, P. Müller, H. Eberle-Reece, C. Haase, B. Conn, K. McDade, W. Whiteley, A. Roers, W. F. Ng, R. Behrendt, D. Hunt
|
|
2025 POS0046
|
LSP1 DEFICIENCY INCREASES IL-17 PRODUCTION BY T CELLS AND ACCELERATES PRIMARY SJÖGREN’S SYNDROME,
J. Kim, J. G. Kim, K. G. Lee, S. H. Park, S. Kim, H. Y. Lee, C. S. Cho, W. U. Kim
|
|
2025 POS0058
|
GENERATION OF iPSC-DERIVED CAR-NK, γδ CAR-T, AND αβ CAR-T CELLS WITH POTENT ACTIVITY FOR TREATMENT OF B CELL-MEDIATED AUTOIMMUNE DISEASES,
J. Kurtz, D. Perry, D. Heinze, L. Campion, M. Mendonca, D. Chin, B. Gurung, C. Y. Kao, A. Perez, H. Levitsky, C. Cowan, G. G. Welstead
|
|
2025 POS0059
|
SELECTIVE DEPLETION OF dsDNA-SPECIFIC PLASMA CELLS WITH A DOUBLE-STRANDED POLYNUCLEOTIDE CONJUGATED TO AN ANTI-CD138 ANTIBODY IS BENEFICIAL ON LUPUS NEPHRITIS IN NZB/W MICE,
Q. Cheng, L. Khodadadi, P. Jani, J. Klotsche, T. Alexander, A. Radbruch, F. Hiepe
|
|
2025 POS0071
|
ANCA-ASSOCIATED VASCULITIS IMMUNOPATHOLOGY: INVESTIGATING CROSS REACTIVITY FOR AUTOANTIBODIES DIRECTED AGAINST PROTEINASE 3 AND Staphylococcus aureus ANTIGENS,
G. Boscato Sopetto, T. Pius, D. Missiakas, A. Hummel, M. Pizzato, M. F. Konig, M. Pandey, D. Cornec, U. Specks, G. Grandi, A. Berti
|
|
2025 POS0229
|
SYSTEMIC AND TISSUE-SPECIFIC MOLECULAR PROFILING OF APREMILAST IN HEPATIC STEATOSIS: A POTENTIAL THERAPEUTIC FOR MASLD IN PsA,
M. Ruiz-Ponce, L. Cuesta-López, S. Rodriguez-Cuenca, M. Campbell, A. M. Barranco, E. Martin-Salazar, L. Romero-Zurita, C. Perez-Sanchez, P. Ortiz-Buitrago, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, I. Arias-de la Rosa, A. Vidal-Puig, N. Barbarroja
|
|
2025 POS0230
|
TYK2 INHIBITION SUPPRESSES NEUTROPHIL ACTIVATION AND NETosis IN SPONDYLOARTHRITIS: INSIGHTS FROM ANIMAL MODELS AND HUMAN SAMPLES,
M. Katsushima, H. Sun, Y. Fujisawa, K. Fukumoto, R. Watanabe, S. Yamada, K. Habiro, N. Sugiyama, M. Hashimoto
|
|
2025 POS0238
|
SCLEROSTIN FROM MARROW ADIPOGENIC PRECURSORS IS ESSENTIAL FOR BONE AND JOINT HOMEOSTASIS IN MICE,
T. He, Y. Mei, G. Xiao
|
|
2025 POS0243
|
MITOCHONDRIAL DYSFUNCTION ACTIVATES THE cGAS-STING PATHWAY, CONTRIBUTING TO INTERFERON PRODUCTION IN SYSTEMIC SCLEROSIS,
G. Forte, V. Liakouli, A. Salzillo, M. Angeli, D. Mauro, A. Ciancio, B. De Marino, I. Panarese, M. Faenza, R. Giacomelli, A. Ramming, F. Ciccia
|
|
2025 POS0367
|
ALDH2 AMELIORATES ACUTE GOUTY ARTHRITIS THROUGH INHIBITING NLRP3 INFLAMMASOME AND PYROPTOSIS BY Nrf2/ROS PATHWAY,
T. Shuting, H. Wu
|
|
2025 POS0697
|
EGL-003: AN OPTIMIZED IL-2 MUTEIN DESIGNED TO EXPAND REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES,
C. Orvain, M. Dubois, C. Janot-Sardet, E. Russo, E. Lheriteau, K. Bailly, P. Soulard, C. Muller, P. Caudana, M. Tkach, I. Mamedov, Y. Courbebaisse, J. Denizeau, A. Meola, F. Rey, P. Guardado-Calvo, A. Lladser, C. Sedlik, R. Winter, E. Piaggio, J. Bach, B. Vanhove, F. Kotsias
|
|
2025 POS0700
|
PPM1A DEFICIENCY IN MACROPHAGES INCREASES IL-1ß SECRETION IN ANKYLOSING SPONDYLITIS,
H. J. Min, Y. J. Lee, E. Y. Kim, E. Lee, D. Jung, T. H. Kim, Y. G. Kim, E. J. Chang
|
|
2025 POS0806
|
PLASMA MEMBRANE ANTIBODIES IN THE PATHOGENESIS OF LUPUS MYOCARDITIS,
S. Bruckner, B. Zeno, H. Bulgart, K. Banford, G. Giarrano, S. Ardoin, N. Weisleder, W. Jarjour
|
|
2025 POS0927
|
PMN-MDSCS PROMOTE RA INFLAMMATION PROGRESSION BY INDUCING THE PROLIFERATION AND DIFFERENTIATION OF ABCS THROUGH THE BAFF-MEDIATED ERK1/2 PATHWAY,
H. Hong, X. Tang, H. Zhang
|
|
2025 POS0998
|
CC312, A CD19-TARGETING, CO-STIMULATORY CD28 RECEPTOR-ACTIVATING TRI-SPECIFIC T CELL ENGAGER, FOR THE TREATMENT OF AUTOIMMUNE DISEASES,
Y. Huang, X. Zhang, C. Zhao, R. Zhang, J. Zhen, F. Pan, B. Zheng, R. Dai
|
|
2025 POS1013
|
Retinoic acid-related orphan receptor-a as an upstream regulator of Hippo signaling and a therapeutic target in fibrotic tissue remodeling,
C. Tran-Manh, R. Kagwiria, R. Liang, T. Trinh-Minh, C. Liebel, X. Zhou, J. Distler
|
|
2025 POS1140
|
120 Cross-species cellular mapping and humanization of Fc receptors to advance antibody modeling,
K. F. A. Van Damme, D. Sichien, K Van der Borght, J. Van Moorleghem, E. De Leeuw, D. Elewaut, A. Morel, E. Vivier, F. Sonego, K. Thiam, S. Voet, B. Balbino, B. Lambrecht
|
|
2025 POS1141
|
CND106, a novel BCMA-directed T-cell engager (TCE), has a differentiated safety profile and potential for development in autoantibody-driven autoimmune diseases,
P. Tan, L. Bao, Q. Yin, C. Li, S. Jehangir Shavaksha, H. M. Prince, J. Haddon, P. Morcos, J. Rearden, P. Wung, M. Zhang, Q. Deng, Q. Lu, C. Jiang, F. Ren, D. Wu, X. Wu, G. Naren, Y. Zhu, J. Q. Mi
|
|
2025 POS1346
|
APPLICATIONS FOR SLE PATIENT-DERIVED PBMC-INDUCED MOUSE MODEL IN PRECLINICAL PHARMACOLOGICAL STUDIES,
J. Liang, F. Li, Y. Zhang, R. Zhang, R. Dai, Y. Huang
|
|
2025 POS1350
|
LACTOBACILLUS RHAMNOSUS PROSCI-109 ALLEVIATES COLLAGEN-INDUCED ARTHRITIS IN RATS WITH PERIODONTITIS BY RESTORING ORAL-GUT-JOINT HOMEOSTASIS AND IMMUNITY,
H. Li, H. Li
|
|
2025 POS1355
|
CLEARANCE KINETICS AND CARTILAGE RETENTION OF MM-II, A DISPERSION OF LARGE EMPTY LIPOSOMES, IN RAT KNEES,
R. Wechsler, R. Rotem
|
|
2025 POS1365
|
IN VITRO AND IN VIVO EVIDENCE OF THE STEROID-SPARING POTENTIAL OF AFIMETORAN, AN EQUIPOTENT TOLL-LIKE RECEPTOR 7/8 DUAL ANTAGONIST,
S. Dudhgaonkar, S. Subramani, P. Chopra, A. Rudra, S. Palachandra, N. Bhatt, V. Pabbala, S. Selvam, M. Shaik, A. Anand, B. King, K. Chadwick, A. Dyckman, Q. Zhao, F. Baribaud, R. Janardana, V. Shobha
|
|
2025 POS1368
|
TOPICAL ADMINISTRATION OF miRNA LIPOPLEXES IMPROVES SKIN LESIONS IN MRL/lpr MICE WITH CUTANEOUS LUPUS ERYTHEMATOSUS,
J. Cortés-Hernández, S. Sandoval Moreno, C. Solé-Marcé
|
|
2025 POS1373
|
THE INTEGRIN INHIBITOR CILENGITIDE TARGETS CCN1-MEDIATED ANGIOGENESIS AND REDUCES DISEASE SEVERITY IN A PRECLINICAL RHEUMATOID ARTHRITIS MODEL,
J. Avouac, M. Lesturgie-Talarek, V. Gonzalez, A. Cauvet, F. Tilotta, L. Lau, Y. Allanore
|
|
2025 POS1374
|
DIPYRIDAMOLE PREVENTS THE METABOLIC SWITCH CAUSED BY RHEUMATOID ARTHRITIS IN MUSCLE BY PURINERGIC SYSTEM MODULATION,
M. Fresnadillo, M. Marco-Bonilla, M. De la Riva, G. Herrero-Beaumont, R. Largo, A. Mediero
|
|
2025 POS1380
|
RECOMBINANT MONOCLONAL ANTIBODY R69-4 PROTECTS AGAINST ARTHRITIS IN HLA-DRB1*0401 KNOCK-IN HUMANIZED MICE,
Z. Xu, R. Kumar Pandey, L. Romero Castillo, A. Moreno-Giro, R. Holmdahl
|
|
2025 POS1399
|
THE AVAILABILITY OF SERINE IS CRITICAL FOR OSTEOCLAST DIFFERENTIATION,
M. Kieler, M. Hofmann, G. Heller, G. Schabbauer, S. Blüml
|
|
2025 POS1409
|
EFFICACY OF A NOVEL CXCR7 AGONIST IN COLLAGEN-INDUCED ARTHRITIS (CIA) MOUSE MODEL,
Y. Kim, Y. Lee, E. H. Chae
|
|
2025 POS1413
|
NOVEL TREATMENT WITH DIPYRIDAMOLE COUNTERACTS THE SARCOPENIC FOOTPRINT IN EXPERIMENTAL RA VIA INCREASE OF ADENOSINE LEVELS AND A2A/A2BR ACTIVATION,
M. Marco-Bonilla, M. Fresnadillo, G. Herrero-Beaumont, R. Largo, A. Mediero
|
|
2025 POS1418
|
TRANSLATIONAL INVESTIGATION OF EXPRESSION OF IMMUNE CHECKPOINT MOLECULES IN RHEUMATOID SYNOVITIS,
A. Ezdoglian, W. R. P. van der Heijden, M. M. Steinz, G. Jansen, C. J. van der Laken
|
|
2025 POS1421
|
ACTIVATED PLATELETS PROMOTE PULMONARY FIBROSIS VIA DEFA1 IN PATIENTS WITH SJOGREN’S DISEASE,
X. Zhang, C. Deng, G. Shi, Y. Liu
|
|
2025 POS1425
|
MEDIATORS OF OSTEOPETROSIS IN miR-146a DEFICIENT MICE,
E. Simader, V. Saferding, T. Sokolich, M. Boldin, S. Hayer, B. Niederreiter, D. Aletaha, S. Blüml
|
|
2025 POS1427
|
ALTERED MITOCHONDRIAL BIOENERGETICS IN HYPOPHOSPHATASIA AND THE INFLUENCE OF EFZIMFOTASE ALFA,
D. Devore, J. Ruanova, W. Voegtli, D. Dunn, J. Decker, M. Tarnopolsky, M. Mazzantini, V. De Tata, M. Concetta Scavuzzo, F. Conti, A. Petryk, M. L. Brandi
|
|
2025 POS1432
|
MECHANISMS OF CD45RChigh T AND B CELL DEPLETION BY AN ANTI-CD45RC mAb IN EXPERIMENTAL RHEUMATOID ARTHRITIS,
C. Bergua, M. Besnard, G. Ahmil, L. H. Ouisse, N. Vimond, E. Brisebard, F. Blanchard, T. Larcher, R. Van Brempt, B. Le Goff, I. Anegon, C. Guillonneau
|
|
2025 POS1436
|
HUMAN PBMC-BASED HUMANIZED MICE EXHIBIT ASPECTS OF A MYOSITIS MODEL AND POTENTIAL FOR EVALUATING MYOSITIS THERAPEUTICS,
A. Nishidate, K. Takemoto, Y. Imura, Y. Koda
|
|
2025 POS1439
|
POLOXAMERS 188 & 182 ARE EFFECTIVE IN REPAIRING THE MEMBRANE RESEALING DEFECT IN MYOSITIS,
S. Bruckner, B. Zeno, N. Young, G. Giarrano, A. Tucker, H. Bulgart, K. Banford, B. Paleo, R. Aggarwal, C. V. Oddis, P. Clemens, D. Ascherman, N. Weisleder, W. Jarjour
|
|
|
[46]
|
Anti-Inflammatory Agents
|
|
|
| 2025 |
|
2025 ABS0059
|
THE PERSPECTIVES OF EUROPEAN RHEUMATOLOGISTS ON THE POTENTIAL FUTURE OF JANUS KINASE INHIBITOR (JAKI) USE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): A DELPHI STUDY,
A. Barkaway, P. J. Mease, R. Moots, M. Ndosi, Z. Rutter-Locher, J. Galloway, J. Avouac, A. Finckh, Y. Yehudina, M. McLean
|
|
2025 ABS0073
|
EARLY-ONSET VS. LATE-ONSET SPONDYLOARTHRITIS: WHAT SPECIFICITIES,
S. Daoui, N. Akasbi, K. Tahir, I. El Mezouar, T. Harzy
|
|
2025 ABS0074
|
RENAL INVOLVEMENT IN RHEUMATOID ARTHRITIS: FREQUENCY, MECHANISMS, AND CLINICAL CONSEQUENCES,
A. Jerbi, Z. Gassara, I. Mnif, A. Feki, S. Ben Jemaa, M. H. Kallel, H. Fourati, S. Baklouti
|
|
2025 ABS0076
|
THERAPEUTIC INERTIA IN JUVENILE IDIOPATHIC ARTHRITIS: BARRIERS TO EFFECTIVE MANAGEMENT AND PATHWAYS FOR IMPROVEMENT,
Y. ben slama, R. Grassa, N. Ben chekaya, M. Ghali, R. Bouazra, M. Bekey, J. mahbouba, S. zrour, I. Bejia
|
|
2025 ABS0115
|
ASSOCIATION OF IL-6 LEVELS WITH THE RISK OF DEVELOPING IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS WITH CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS,
I. Les Bujanda, D. de Haedo Sánchez, V. Arrazubi Arrula, M. Martínez-Kareaga, A. Campillo-Calatayud, A. Moreno Paul, I. de Elejoste Echebarria, I. Pérez-Francisco, M. Cabero Zamorano, J. I. Elejalde
|
|
2025 ABS0185
|
TARGETING T FOLLICULAR HELPER CELLS IN SJÖGREN’S DISEASE BY CALYCOSIN,
S. Yu, M. Wu, J. Shen, X. Lin
|
|
2025 ABS0236
|
VARIABLES ASSOCIATED WITH RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AT A SOUTH AMERICAN HOSPITAL,
J. Hernandez, L. A. Dulcey Sarmiento, J. Gomez Ayala, V. Ochoa Castellanos, J. S. Theran Leon, V. Navas
|
|
2025 ABS0238
|
VALIDATION OF CLASI AND R-CLASI IN PATIENTS WITH SLE AT A SOUTH AMERICAN HOSPITAL,
J. Hernandez, L. A. Dulcey Sarmiento, J. Gomez Ayala, J. S. Theran Leon, V. Navas
|
|
2025 ABS0241
|
INTERFERON AND B CELL SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AT A SOUTH AMERICAN HOSPITAL,
L. A. Dulcey Sarmiento, J. Hernandez
|
|
2025 ABS0247
|
HUMAN PRIMARY MONOCYTES CELL DEATH AND IL-1ß PRODUCTION IS DIFFERENTLY REGULATED IN FMF PATIENTS COMPARED TO HEALTHY CONTROLS,
C. R. E. Kievit, C. I. van der Made, C. M. Mulders-Manders, F. L. van de Veerdonk
|
|
2025 ABS0277
|
DISCOVERY AND CHARACTERIZATION OF SIM0711, A POTENT AND SELECTIVE IRAK4 PROTAC WITH ENHANCED EFFICACY AND SAFETY,
P. Gu, M. Wang, M. Zhou, Q. Liang, Y. Yan, L. Sun, Y. Chen, X. Wang, X. Zhao, F. Tang, S. Zhu
|
|
2025 ABS0293
|
JOINT GROUPS INVOLVED IN EARLY OLIGOARTICULAR PSORIATIC ARTHRITIS AND THE IMPACT OF APREMILAST TREATMENT: DATA FROM FOREMOST,
A. Zabotti, J. F. Merola, U. Mrowietz, P. J. Mease, L. Gossec, M. Kishimoto, M. Brunori, L. Teng, D. D. Gladman, L. C. Coates
|
|
2025 ABS0319
|
CANNABIS-BASED PRODUCTS FOR PAIN MANAGEMENT IN RHEUMATIC DISEASES: HIGH PATIENT-REPORTED EFFICACY AND OPENNESS TO THERAPY DESPITE LOW PRESCRIPTION RATES IN GERMANY AFTER LEGALIZATION OF NON-MEDICAL CANNABIS,
G. Corte, K. Tascilar, A. Kroker, I. Minopoulou, A. Kleyer, D. Simon, G. Schett, F. Fagni
|
|
2025 ABS0379
|
MONOCLONAL ANTI-TUMOR NECROSIS FACTOR-ALPHA ANTIBODIES FOR VASCULAR BEHÇET’S SYNDROME: A META-ANALYSIS,
J. Wu, Y. Liu, Y. Ao, X. Wang, W. Zheng
|
|
2025 ABS0438
|
ASSOCIATIONS AND RISK FACTORS FOR FREQUENT ORAL ANALGESIC USE IN LOWER LIMB OSTEOARTHRITIS,
I. Atukorala, M. Rajapaksha, I. Atapattu, C. Dassanayake, A. Pathmeswaran, J. Bowden, M. De Silva, G. Kasthuriratna, U. Saravanamuttu, I. Kulasinghe, D. Hunter
|
|
2025 ABS0472
|
PREDICTIVE FACTORS OF SELF-MEDICATION MISUSE IN PATIENTS WITH KNEE OSTEORTHRITIS,
H. Chaouachi, D. Ben Nessib, L. Kharrat, F. Majdoub, H. Ferjani, D. Kaffel, K. Maatallah, W. Hamdi
|
|
2025 ABS0544
|
DISEASE KNOWLEDGE, MANAGEMENT PRACTICES, AND AWARENESS OF DISEASE AND DRUG-RELATED SIDE EFFECTS AMONG RHEUMATOID ARTHRITIS PATIENTS IN A TERTIARY CARE CENTER IN SRI LANKA: DEVELOPMENT AND TESTING OF A CULTURALLY TAILORED QUESTIONNAIRE FOR SINHALA AND TAMIL-SPEAKING POPULATIONS,
F. N. Nasim, U. Dissanayake
|
|
2025 ABS0609
|
CLINICAL AND LABORATORY CHARACTERISTICS OF EARLY-ONSET GOUT: A RETROSPECTIVE COHORT STUDY,
B. Bitik, E. Uskudar, A. Alemdaroglu, Y. Karginer, E. Erk, A. Yavuz Derman, A. E. Yucel
|
|
2025 ABS0670
|
DIFFERENTIAL EFFICACY OF INDUCTION TREATMENTS FOR LUPUS NEPHRITIS AT ONSET AND RELAPSES: AN OBSERVATIONAL STUDY,
G. A. Ramirez, G. D. Gallina, C. Calabrese, S. Nannipieri, R. Ceniccola, M. Calatroni, F. Reggiani, G. Benanti, E. Bozzolo, L. Moroni, M. Matucci-Cerinic, G. Moroni, L. Dagna
|
|
2025 ABS0857
|
PHARMACODYNAMIC EFFECTS OF OBINUTUZUMAB ON B CELLS AND SEROLOGICAL MARKERS IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: RESULTS FROM THE PHASE III REGENCY STUDY,
R. A. Furie, I. Parodis, R. Jones, L. Lightstone, O. Hwang, A. Au-Yeung, I. Hassan, H. A. Mao, W. F.III Pendergraft, J. P. Garg, H. Raghu, B. H. Rovin
|
|
2025 ABS0968
|
CENTRAL NERVOUS SYSTEM VASCULITIS ASSOCIATED WITH UNDERLYING RHEUMATIC CONDITIONS IN CHILDREN: A SINGLE CENTER EXPERIENCE,
Y. Bayindir, D. Unal, S. Sener, Z. Balik, O. Ozdogan, Y. Bilginer, E. Aliyev, V. Cam, İ. H. Oncel, E. Sag, Ö. Basaran, E. D. Batu, K. Karli Oguz, B. Anlar, S. Ozen
|
|
2025 ABS1031
|
BASELINE FEATURES AND OUTCOMES AMONG PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS OR MICROSCOPIC POLYANGIITIS ON AVACOPAN IN A COMMUNITY PRACTICE-BASED RESEARCH NETWORK IN THE U.S.,
B. Jaros, E. Holladay, A. Mudano, Y. Su, F. Xie, S. Daigle, J. R. Curtis, E. Ibiloye, D. Trimpe, S. Oh, Z. S. Wallace, A. B. Dua
|
|
2025 ABS1052
|
REAL-WORLD SAFETY AND EFFECTIVENESS OF MEPOLIZUMAB FOR PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN JAPAN: A SUBGROUP ANALYSIS OF THE MARS STUDY,
T. Ishii, H. Kunishige, M. Yoshida, E. Hayashi, M. Komatsubara, R. Alfonso-Cristancho, P. Howarth
|
|
2025 ABS1133
|
INDICATIONS, EFFICACY, AND SAFETY OF CANAKINUMAB: REAL LIFE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CLINIC,
R. Deniz, O. Altun, S. Karabulut Gök, C. Tansu Yavuz, H. K. Yerişenoğlu Demir, F. Deniz, R. Mirza Altintaş, K. Uğur, A. E. Boncukcuoğlu, B. Karaalioglu, G. Akkuzu, D. S. Ozgur, F. Yildirim, C. Erzik, C. Bes
|
|
2025 OP0125
|
TARGETING NLRP3 INFLAMMASOME ACTIVATION AND INFLAMMATION IN GOUT WITH NEK7 MOLECULAR GLUE DEGRADERS: A NOVEL THERAPEUTIC STRATEGY,
D. Wible, Q. Chen, S. Nguyen, M. Schillo, V. Verdine, K. Gosala, A. Trouilloud, H. Farine, V. Strande, D. Bonenfant, C. King, K. Meier, C. Komishane, M. Cabanski, A. Kostikova, L. McAllister, E. Krishnan, F. Janku, M. Walter, E. Liardo, A. Paterson, A. Iracheta-Vellve
|
|
2025 OP0126
|
IDENTIFICATION OF METABOLITE PROFILES DURING GOUT FLARE IN A PROSPECTIVE GOUT COHORT: GLUTAMINE AND HISTIDINE AS ANTI-INFLAMMATORY METABOLITES,
C. Leroy, N. Pham, C. Caradeuc, A. L. Nguyen, F. Brial, B. Kischkel, G. Jayat, N. Giraud, F. Fenaille, L. Joosten, A. Latourte, P. Richette, F. Castelli, G. Bertho, H. K. Ea
|
|
2025 OP0297
|
INDUCTION OF GC-FREE REMISSION BY THE BISPECIFIC CD19xCD3 T CELL ENGAGER BLINATUMOMAB IN PATIENTS WITH SEVERE, THERAPY-REFRACTORY ANTI-SYNTHETASE SYNDROME,
C. Duesing, A. Stütz, A. H. Györfi, L. M. Lahu, F. S. Deicher, G. Chehab, J. G. Richter, M. C. van Saan, B. S. Tuemerdem, A. E. Matei, B. Buehring, R. Grieshaber-Bouyer, M. Hagen, G. Schett, W. Merkt, J. Distler
|
|
2025 POS0014
|
Repository corticotropin injection (RCI) attenuates inflammatory response in a pre-clinical murine collagen induced arthritis model,
M. Corr, A. Place, G. Hsueh, N. Lane
|
|
2025 POS0328
|
EFFICACY AND SAFETY OF AVACOPAN FOR TREATMENT OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS RECEIVING CYCLOPHOSPHAMIDE,
D. Geetha, T. Neumann, A. Karras, M. C. Cid, P. A. Merkel, S. Bray, A. M. Bozeman, D. R. W. Jayne
|
|
2025 POS0332
|
GLUCOCORTICOID FREE REMISSION IN MAINTENANCE TREATMENT OF ANCA ASSOCIATED VASCULITIS (AAV) AFTER DISCONTINUATION OF AVACOPAN—A UNICENTRE NON-INTERVENTIONAL PROSPECTIVE OBSERVATIONAL STUDY OF 34 PATIENTS OVER 18 MONTHS,
G. Assmann, E. Wiebke, T. Ryszard, B. Alina, S. Claus, R. Joerg
|
|
2025 POS0368
|
AURANOFIN ALLEVIATES GOUT INFLAMMATION BY SUPPRESSING MIGRATION OF NEUTROPHIL VIA IL-33/ST2 DEPENDENT PATHWAY.,
H. Yoo, A. Choi, J. Yang, J. Lee
|
|
2025 POS0446
|
THREE YEARS OF AVACOPAN TREATMENT IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS,
J. R. van Leeuwen, L. Quartuccio, I. Gunnarsson, B. Sprangers, Y. K. O. Teng
|
|
2025 POS0460
|
Pediatric ANCA-Associated Vasculitis Study of Avacopan Efficacy, Pharmacokinetics, and Safety: A Phase 3 Trial in Progress,
F. Barbar-Smiley, E. Wu, S. Gagne, P. Quartier, M. Twilt, T. Renson, K. Morishita, Z. Zhang, R. K. Oberoi, H. Amouzadeh, R. Yeung
|
|
2025 POS0687
|
USE AND TREND OF OPIOID, NON-OPIOID AND GABAPENTINOID ANALGESICS IN PEOPLE WITH MUSCULOSKELETAL PAIN: DATA FROM THE CONSTANCES COHORT,
F. Bailly, B. Granger, V. Foltz, S. Kab, A. Petit, F. Tubach, B. Fautrel
|
|
2025 POS0697
|
EGL-003: AN OPTIMIZED IL-2 MUTEIN DESIGNED TO EXPAND REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES,
C. Orvain, M. Dubois, C. Janot-Sardet, E. Russo, E. Lheriteau, K. Bailly, P. Soulard, C. Muller, P. Caudana, M. Tkach, I. Mamedov, Y. Courbebaisse, J. Denizeau, A. Meola, F. Rey, P. Guardado-Calvo, A. Lladser, C. Sedlik, R. Winter, E. Piaggio, J. Bach, B. Vanhove, F. Kotsias
|
|
2025 POS0794
|
THE ORAL IRAK4-INHIBITORS ZABEDOSERTIB (BAY1834845) AND BAY1830839 SUPPRESS IMMUNE COMPLEX INDUCED INTERFERON-A PRODUCTION BY PLASMACYTOID DENDRITIC CELLS IN A DOSE DEPENDENT MANNER,
S. Jodl, R. Dahmen, A. Wagenfeld, M. L. Eloranta, L. Ronnblom
|
|
2025 POS0807
|
TARGETING NEUTROPHILS AND INTERFERON TO ACHIEVE LONG-TERM REMISSION IN ACTIVE LUPUS: COMBINING CXCL5 WITH METHYLPREDNISOLONE AND CYCLOPHOSPHAMIDE THERAPY,
C. J. Pua, A. Law, D. Guo, C. T. Ng, A. Low, J. Thumboo, X. Fan
|
|
2025 POS0966
|
OBINUTUZUMAB SHOWS PROMISE IN LUPUS NEPHRITIS REGARDLESS OF BASELINE SEROLOGICAL BIOMARKERS: AN EXPLORATORY POST HOC ANALYSIS OF THE PHASE II NOBILITY STUDY,
E. M. Vital, B. Vargas, J. Rae, T. Wang, J. Hackney, C. M. Looney, W. F.III Pendergraft, L. Lightstone, B. H. Rovin, R. A. Furie, H. Raghu
|
|
2025 POS1135
|
Discovery and Characterization of Novel Oral TNF-Alpha Inhibitors as Potential Treatments for Autoimmune Diseases,
J. Chen, J. Yu, J. Du, P. Shi, X. Wang
|
|
2025 POS1143
|
The NAD+ Metabolome Pathway is Profoundly Altered in Chronic Inflammatory Rheumatic Diseases, Modulated by anti-TNF, and Modified by NAD+ Boosters,
B. Vellón-García, G. D. García-Delgado, A. Llamas-Urbano, Y. Hanaee, P. Ortiz-Buitrago, C. Merlo, M. D. C. Abalos-Aguilera, J. M. Martínez-Moreno, M. Á. Puche-Larrubia, I. Arias-de la Rosa, M. D. López Montilla, R. Ortega-Castro, J. Calvo-Gutiérrez, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, E. Collantes-Estevez, A. Escudero-Contreras, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2025 POS1165
|
INDUCTION OF CURE IN EARLY ARTHRITIS (I CEA): RESULTS OF A RANDOMIZED SINGLE BLIND CLINICAL TRIAL TO COMPARE THREE TREATMENT STRATEGIES IN RECENT ONSET UNDIFFERENTIATED ARTHRITIS,
I. Nevins, J. van der Pol, L. van Ouwerkerk, G. Helmich, R. Bos, Y. Goekoop-Ruiterman, H. E. Vonkeman, J. Bijsterbosch, P. H. P. de Jong, M. Güler-Yüksel, S. Böhringer, T. Huizinga, F. van Gaalen, S. A. Bergstra
|
|
2025 POS1181
|
IMPACT OF IMMUNOSUPPRESSIVE MEDICATIONS ON LUPUS-RELATED DAMAGE: A PROPENSITY SCORE ANALYSIS OF THE BIRMINGHAM LUPUS COHORT,
A. Saleh, C. Gordon, J. Reynolds
|
|
2025 POS1352
|
MYELOID CELL-SPECIFIC DELETION OF EP2 PROTECTS AGAINST OSTEOARTHRITIS IN MICE BY METABOLIC REPROGRAMMING OF PROINFLAMMATORY MACROPHAGES,
C. Wang, P. Sheng, L. Zheng
|
|
2025 POS1409
|
EFFICACY OF A NOVEL CXCR7 AGONIST IN COLLAGEN-INDUCED ARTHRITIS (CIA) MOUSE MODEL,
Y. Kim, Y. Lee, E. H. Chae
|
|
2025 POS1432
|
MECHANISMS OF CD45RChigh T AND B CELL DEPLETION BY AN ANTI-CD45RC mAb IN EXPERIMENTAL RHEUMATOID ARTHRITIS,
C. Bergua, M. Besnard, G. Ahmil, L. H. Ouisse, N. Vimond, E. Brisebard, F. Blanchard, T. Larcher, R. Van Brempt, B. Le Goff, I. Anegon, C. Guillonneau
|
|
2025 POS1445-HPR
|
INVESTIGATION OF THE SYNERGISTIC BENEFITS OF COMBINING TOPICAL DICLOFENAC WITH STRUCTURED EXERCISE IN KNEE OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
S. Karaborklu Argut, A. Erekdağ, D. Celik, A. Kaya
|
|
|
[104]
|
Artificial Intelligence
|
|
|
| 2025 |
|
2025 ABS0032
|
BIOMIX INTEGRATED MULTI-OMICS ANALYSIS OF PRECISESADS DATA REVEALS KEY METABOLIC PATHWAY ALTERATIONS IN B LYMPHOCYTES, IMMUNE CELLS, AND THEIR MICROENVIRONMENT IN SJÖGREN’S DISEASE,
C. IPERI, A. Fernández-Ochoa, J. O. Pers, G. Barturen, M. Alarcon-Riquelme, R. Quirantes-Piné, I. Borrás-Linares, A. Segura-Carretero, V. Devauchelle-Pensec, D. Cornec, A. Bordron, C. Jamin
|
|
2025 ABS0034
|
APPLICATION OF CLUSTERING TECHNIQUES FOR PATIENT STRATIFICATION IN RHEUMATIC DISEASES,
A. García-Alija, B. P. Magallares, H. S. Park, G. Verdaguer, A. Laiz, P. Moya, A. Casals Urquiza, C. Díaz-Torné, L. Sainz Comas, I. Castellví, S. P. Fernandez-Sanchez, J. Bernardez, H. Codes, J. L. Tandaipan, C. Pitarch, C. Marco Pascual, A. Garcia Guillen, N. Fernández-Verdés, L. Úbeda, M. À. Melchor, M. Sihuro, S. Ros, H. Corominas
|
|
2025 ABS0036
|
UNDERSTANDING SLEDAI SCORE VARIABILITY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
C. Tozzi, A. Taylor, C. Donoghue, S. HOTEE, G. Wong, S. chen
|
|
2025 ABS0037
|
FUNCTIONAL INVESTIGATION AND EXPERIMENTAL VALIDATION OF DISULFIDPTOSIS-RELATED SUBTYPES AND IMMUNE LANDSCAPES IN RHEUMATOID ARTHRITIS,
P. Zhang
|
|
2025 ABS0075
|
PREDICTING HYPERTENSION AND DISEASE ACTIVITY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS: A MACHINE LEARNING APPROACH,
A. Alsaber, A. A. A. H. Al-Herz, B. Alawadhi, G. Aldabie, H. Khraiss, J. Pan, P. Setiya, K. S. M. E. M. Mohammed, A. Alawadhi, E. Hasan, W. Al-Kandari, A. Ghanem, Y. M. A. H. G. A. A. Ghadanfar, H. Tarakma, A. Al-Sultan, A. Abdullah, A. Albuloushi, S. L. Palliam, I. Abu Doush
|
|
2025 ABS0156
|
AI-BASED CLASSIFICATION OF SPONDYLOARTHRITIDES USING THE TURKISH PATIENTS OF ASAS perSpA DATASET: INSIGHTS ON CLINICAL FEATURES AND PATIENT OUTCOMES,
T. Duruöz, A. Madayen, E. N. Saruhan, R. Houshyar Zarnaghi, H. H. Gezer, I. Aktas, S. Akar, N. Sahin, Ö. Akgül, S. Hizmetli, M. Alkan Melikoglu, U. Kalyoncu, E. Capkin, F. G. Ural, F. Yilmaz, Ş. Ataman, I. Sezer, K. Pekkan
|
|
2025 ABS0163
|
PREDICTION OF RHEUMATOLOGICAL DISEASES USING MACHINE LEARNING MODELS AND NATURAL LANGUAGE PROCESSING TECHNIQUES ON PHYSICIAN NOTES,
A. C. Genç, F. Turkoglu, E. Bilgin, E. Gönüllü
|
|
2025 ABS0209
|
ASSESSMENT OF SEX BIAS IN MACHINE LEARNING RESEARCH IN RHEUMATOID ARTHRITIS,
A. Talwar, S. Turner, C. Maw, G. Quayle, T. Watt, S. Gohil, E. Duckworth, C. Ciurtin
|
|
2025 ABS0246
|
DISSECTING PATIENT HETEROGENEITY IN OSTEOARTHRITIS: APPLICATION OF MACHINE-LEARNING APPROACHES TO HIGH-DIMENSIONAL IMMUNE CYTOMIC DATA,
A. Chia, G. Ang, A. Lajam, M. Wasser, E. Petretto, Y. Y. Leung, S. Albani
|
|
2025 ABS0274
|
CAUSAL EFFECT OF GLUCOCORTICOID ON HEALTHCARE COSTS IN SLE: A FLEXIBLE INSTRUMENTS-FREE APPROACH,
K. Zhao, Y. Qian, H. Xie
|
|
2025 ABS0320
|
COMPUTER-AIDED HRCT ANALYSIS: IDENTIFYING NOVEL BIOMARKERS FOR THE ASSESSMENT AND OUTCOME PREDICTION OF SJÖGREN’S DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE,
G. La Rocca, F. Ferro, V. Uggenti, B. Dei, G. Fulvio, I. C. Navarro García, M. Mosca, C. Romei, C. Baldini
|
|
2025 ABS0413
|
LET’S ASK THE PATIENT: DISEASE PREDICTION BASED ON FREE-TEXT SYMPTOM DESCRIPTIONS,
I. Pérez - Sancristóbal, N. Steinz, L. Qin, T. D. Maarseveen, F. Zegers, B. Bislawska Axnäs, L. Rodriguez Rodriguez, R. Knevel
|
|
2025 ABS0415
|
ESTIMATION OF DAS28-ESR SCORE FROM A SINGLE ACCELEROMETER SIGNAL USING BAYESIAN REGULARIZED NEURAL NETWORKS,
P. Mielnik, A. Myhre Hjelle, A. Traseth, M. Fojcik, K. Tokarz
|
|
2025 ABS0450
|
WEARABLE-BASED ACCELEROMETRY FEATURES AS A POTENTIAL DIGITAL BIOMARKER FOR IDENTIFYING FIBROMYALGIA PATIENTS THROUGH STATIC BALANCE ASSESSMENT IN DUAL-TASK CONDITIONS,
Z. Veličković, N. Trajković, M. Novičić, N. Šuljagić, M. Janković, G. Radunovic
|
|
2025 ABS0506
|
ESTABLISHING A PREDICTION MODEL OF GOUT IN PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA BASED ON A COMMON DATA MODEL PLUS MACHINE LEARNING ALGORITHMS,
M. J. Kim, S. M. Lee, J. S. Kim, B. Ryu, K. Shin
|
|
2025 ABS0559
|
WEARABLE-BASED ACCELEROMETRY FEATURES AS A POTENTIAL DIGITAL BIOMARKER FOR IDENTIFYING FIBROMYALGIA PATIENTS THROUGH GAIT ASSESSMENT IN DUAL-TASK CONDITIONS,
Z. Veličković, N. Trajković, M. Novičić, N. Šuljagić, M. Janković, G. Radunovic
|
|
2025 ABS0573
|
RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN,
V. Venerito, C. Nani, A. Manfredi, M. Fornaro, G. Lopalco, F. Iannone, C. Burattini, M. Sebastiani
|
|
2025 ABS0689
|
ENHANCING MORTALITY RISK PREDICTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: INSIGHTS FROM A MACHINE LEARNING STACKING ENSEMBLE MODEL,
Z. Chen, Y. Dai, Y. Wu, F. Gao
|
|
2025 ABS0718
|
AGE AS THE MAIN PREDICTOR FOR RHEUMATOID ARTHRITIS INITIAL TREATMENT: A MACHINE LEARNING ANALYSIS USING DATA FROM METEOR REGISTRY,
D. Vega-Morales, S. A. Bergstra, A. Chopra, W. M. Orzua-de la Fuente, P. Machado, E. Vieira-Sousa, N. Govind
|
|
2025 ABS0746
|
Predicting interstitial lung disease severity in patients with connective tissue diseases: The role of clinical parameters and artificial intelligence quantified pulmonary high-resolution computed tomography,
T. Hoffmann, U. Teichgräber, B. Lassen-Schmidt, D. Renz, L. B. Brüheim, M. Krämer, J. Böttcher, F. Güttler, G. Wolf, A. Pfeil
|
|
2025 ABS0753
|
DISEASE PHENOTYPES IN A BEHçET’S SYNDROME MONOCENTRIC COHORT - A NEURAL NETWORK ANALYSIS,
F. Di Cianni, A. Sulis, D. Marinello, V. Lorenzoni, R. Talarico, M. Mosca
|
|
2025 ABS0864
|
EVALUATING THE USABILITY OF AN ARTIFICIAL INTELLIGENCE-BASED CHAT APPLICATION FOR SHARED DECISION-MAKING IN RHEUMATOID ARTHRITIS PATIENTS,
S. R. Choi, S. B. Lee, H. R. Park, H. R. Ko, Y. S. Jung, E. Nam, S. Yoon, S. K. Cho, Y. K. Sung
|
|
2025 ABS0866
|
CAN WE EXPLAIN HOW IMAGE-BASED AI MODELS COME TO THEIR MEDICAL DECISIONS IN RHEUMATIC DISEASES A LITERATURE REVIEW AND OWN CRITICAL APPRAISAL,
J. Nicolaes, T. Hügle
|
|
2025 ABS0881
|
A MACHINE LEARNING ALGORITHM BASED ON A 15-AUTOANTIBODY PROFILE BY A NOVEL FULLY AUTOMATED MULTIPLEXED MICROARRAY IMMUNOASSAY FOR THE DIAGNOSIS OF AUTOIMMUNE CONNECTIVE TISSUE DISEASES,
G. Gomez, Y. Cheng, K. Nita, M. Hausmann, C. Fischer, Y. Ataman-Önal
|
|
2025 ABS0885
|
COMPLEMENT CONSUMPTION PATTERNS AS AN EARLY PREDICTOR OF SYSTEMIC SJÖGREN DISEASE: GENERATIVE ARTIFICIAL INTELLIGENCE-ASSISTED ANALYSIS USING STRATIFIED CROSS-VALIDATION GENERALIZABILITY MODELS,
P. Brito-Zerón, A. Flores-Chávez, L. T. Delgado Garcia, I. F. Horváth, R. Priori, H. Bootsma, B. Armagan, V. Manfrè, S. Praprotnik, G. Hernandez-Molina, R Pereira da Costa, R. Gerli, M. Rischmueller, Y. Suzuki, R. Solans-Laqué, S. Pasoto, E. Skoglund, I. Sanchez-Berna, A. Alunno, V. Fernandes Moça Trevisani, V. Valim, S. Melchor Díaz, B. Maure Noia, E. Fonseca-Aizpuru, H. Nakamura, L. D. Miguel, M. Vázquez, M. Akasbi Montalvo, G. Policarpo-Torres, B. De Miguel-Campo, A. Szántó, A. Gattamelata, A. Vissink, L. Quartuccio, L. Kiliç, K. Perdan-Pirkmajer, V. C Romão, E. Bartoloni, S. Downie-Doyle, Y. Fujisawa, M. Ramos-Casals
|
|
2025 ABS0910
|
DEVELOPMENT OF A DEEP LEARNING-BASED ARTIFICIAL INTELLIGENCE TOOL FOR AUTOMATED mSASSS CALCULATION IN ANKYLOSING SPONDYLITIS,
K. Abacar, Ş. Çolakoğlu Özkaya, E. Biyikli, O. Buğdayci, A. Denizli, B. Koçak, M. B. Çöteli, D. Akdoğan, A. Gökduman, P. Atagündüz
|
|
2025 ABS0912
|
EVALUATING ChatGPT’s PERFORMANCE IN DIAGNOSING LOW BACK PAIN: A COMPARISON WITH CLINICIANS AND IMPACT OF PROMPTED SPECIALTIES,
A. Nack, X. Michelena, P. Maymo Paituvi, C. Calomarde-Gómez, D. Lobo, A. García-Alija, R. Ugena-García, M. Aparicio-Espinar, P. Vidal-Montal, D. Benavent
|
|
2025 ABS0922
|
AUTOMATED EXTRACTION OF PATIENT-REPORTED PAIN OUTCOMES IN OSTEOARTHRITIS USING PROMPT ENGINEERING OF LARGE LANGUAGE MODELS,
J. Doshi, S. Batter, Y. Wu, A. Santilli, S. S. Kannayiram, S. M. Goodman, B. Mehta
|
|
2025 ABS0949
|
SURFACE ELECTROMYOGRAPHY (s-EMG) ANALYSIS AND MACHINE LEARNING FOR DISEASE ACTIVITY EVALUATION IN ANKYLOSING SPONDYLITIS (AS),
C. Sun, X. Wang, N. Fei, Z. Xie, L. Tu, Z. Lin
|
|
2025 ABS0950
|
ARTIFICIAL INTELLIGENCE ANALYSIS OF HRCT IMAGES REFLECTS PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE,
L. Thornton, E. De Lorenzis, S. Di Donato, M. Minerba, L. A. Bissell, P. George, F. Del Galdo
|
|
2025 ABS0964
|
EVALUATION OF THE ACCURACY OF ARTIFICIAL INTELLIGENCE TOOLS IN THE DETECTION OF DRUG INTERACTIONS IN RHEUMATOLOGY,
R. Mazzucchelli, C. Sanz Sanchez, M. Prada Bou, P. Turrado Crespí, G. M. Silva Riadigos, N. Crespí Villarías, E. Pérez-Fernández, C. Pijoán-Moratalla, M. Pavo Blanco, P. Zarco-Montejo, R. Almodóvar, P. Sanmartin Fenollera
|
|
2025 ABS0972
|
LUNG ULTRASOUND AND HR CHEST COMPUTED TOMOGRAPHY: COMPARISON AMONG DIFFERENT ILD TOMOGRAPHIC PATTERNS IN A MIXED COHORT OF PATIENTS WITH RHEUMATIC DISEASES WITH NEW PERSPECTIVE OF ARTIFICIAL INTELLIGENCE. A MONOCENTRIC STUDY,
G. Busto, C. Rotondo, V. Rella, R. Barile, F. P. Cantatore, A. Corrado
|
|
2025 ABS0983
|
COMPARISON OF THE EXTENSION OF DIFFERENT TOMOGRAPHIC PATTERNS OF CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE AMONG DIFFERENT ANTIBODY SPECIFICITIES USING ARTIFICIAL INTELLIGENCE APPLICATION: A SINGLE-CENTER PILOT STUDY.,
R. Barile, C. Rotondo, B. Capuano, R. Colia, V. Rella, G. Carabellese, G. Giancaspro, F. P. Cantatore, A. Corrado
|
|
2025 ABS1032
|
TWO DECADES OF RHEUMATOLOGY RESEARCH (2000-2023): A DYNAMIC TOPIC MODELING PERSPECTIVE,
A. Madrid García, D. Freites, B. Merino, I. Pérez - Sancristóbal, L. Rodriguez Rodriguez
|
|
2025 ABS1033
|
RHEUMATOLOGY ON REDDIT: A DESCRIPTIVE AND SENTIMENT ANALYSIS,
A. Madrid García, B. Merino
|
|
2025 ABS1077
|
CLINICAL PHENOTYPING AND STRATIFICATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-NUCLEOSOME ANTIBODIES: A MACHINE LEARNING APPROACH,
A. García-Alija, B. P. Magallares, A. Hernández, G. Verdaguer, A. Calvet, A. Laiz, P. Moya, A. Casals Urquiza, C. Díaz-Torné, L. Sainz Comas, I. Castellví, S. P. Fernandez-Sanchez, J. Bernardez, H. Codes, J. L. Tandaipan, C. Pitarch, C. Marco Pascual, A. Garcia Guillen, M. À. Melchor, M. Sihuro, S. Ros, L. Úbeda, N. Fernández-Verdés, H. Corominas
|
|
2025 ABS1176-HPR
|
FIVE YEARS OF THE DIGITAL RHEUMATOLOGY NETWORK: ACHIEVEMENTS, INSIGHTS, AND FUTURE DIRECTIONS,
T. Hügle, L. Gupta, A. Chan, B. van den Bemt, V. Venerito, J. Richter, M. Blanchard, J. M. van Laar, M. Krusche, D. Hans, J. Knitza
|
|
2025 ABS1220-HPR
|
DEVELOPMENT OF THE PEDIATRIC PHYSICAL ACTIVITY TRACKING PLATFORM (PEDI@CTIVITY) AND SMARTWATCH-BASED BIG DATA ANALYSIS: A DIGITAL HEALTH APPLICATION IN SOCIETY 5.0,
N. Arman, T. Çakar, S. Güllü, N. Aktay Ayaz, A. Yekdaneh, A. Albayrak
|
|
2025 ABS1252-PARE
|
ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY HELATH CARE: A BIBLIOGRAPHIC ANALYSIS,
F. Cosan
|
|
2025 OP0036
|
Artificial Intelligence Reinforced Social Robotics in Patient Communication for Patients with Rheumatic Diseases,
D. van Gorssel, M. Hegeman, D. Gerritsen, J. W van ‘t Klooster, H. E. Vonkeman
|
|
2025 OP0050
|
Clinical Validation of Large Language Models for Osteoporosis Risk Assessment: A Case-Based Analayis,
P. Vij, S del Vescovo, C. Casteleyn, I. Coskun Benlidayi, M. Jasim, T. Adizie, H. Sapkota, S. Venkatachalam, V. Venerito, L. Gupta
|
|
2025 OP0082
|
Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148),
C. Campochiaro, D. Mongin, D. S. Courvoisier, G. De Luca, P. Carreira Delgado, J. K. de Vries-Bouwstra, G. Kumánovics, R. Bečvář, O. Distler, A. Balbir-Gurman, E. Selvi, A. Cauli, S. Rednic, F. Del Galdo, M. Di Battista, I. Litinsky, M. Matucci-Cerinic, M. Iudici, Y. Allanore
|
|
2025 OP0083
|
The 1-year progression of systemic sclerosis-associated interstitial lung disease is predicted applying artificial intelligence tools but not visual quantification of pulmonary CT scans,
F. Motta, A. Tonutti, F. Catapano, G. Sellaro, A. Bognanni, F. Amati, A. Stainer, C. Messana, S. Aliberti, M. Francone, C. Selmi, M. De Santis
|
|
2025 OP0111
|
Digital Biomarkers in Rheumatoid Arthritis: Single-Camera Motion Capture Meets Computer Vision. External validation of the Mefisto study,
V. Venerito, T Manigold, M. Capodiferro, D Markham, M Blanchard, F Iannone, T Hügle
|
|
2025 OP0155
|
RA RISK GENES ARE DIFFERENTIALLY EXPRESSED BETWEEN (PEAC) PATHOTYPES IN SYNOVIUM WITH A CLEAR ENRICHMENT IN THE LYMPHOID-RICH PATHOTYPE,
I. C. den Hond, M. J. T. Reinders, M. Lewis, C. Pitzalis, R. Knevel, E. B. van den Akker
|
|
2025 OP0220
|
RISK FACTORS FOR CANCER IN SYSTEMIC SCLEROSIS, IMPACT ON DISEASE PHENOTYPE AND PROGNOSIS, AND PROPOSAL OF MACHINE LEARNING-BASED PERSONALIZED SCREENING STRATEGIES: INSIGHTS FROM AN EUSTAR STUDY,
A. Tonutti, F. Motta, S. Erba, B. Granel, B. Maurer, C. Sieiro Santos, D. Temiz Karadağ, E. Rezus, E. Zanatta, F. Atzeni, F. Benvenuti, G. Kumánovics, G. Szucs, G. Moroncini, G. Boleto, L. Caillault, M. Kuwana, M. Limonta, M. Cutolo, M. Bordoy Pastor, O. Distler, R. Bečvář, R. Giacomelli, R. De Angelis, S. Guiducci, S. Blaise, S. Stano, V. Riccieri, Y. El Miedany, C. Selmi, M. De Santis
|
|
2025 OP0244
|
INTEGRATIVE MULTI-OMICS PHENOTYPING IN BLOOD REVEALS DISTINCT IMMUNE AND METABOLIC SIGNATURES BETWEEN ACPA-NEGATIVE AND ACPA-POSITIVE RHEUMATOID ARTHRITIS,
J. Sung, B. Hur, V. Gupta, M. Oh, H. Zeng, C. S. Crowson, K. J. Warrington, E. Myasoedova, V. L. Kronzer, J. M.III Davis
|
|
2025 OP0255
|
SPATIAL AND QUANTITATIVE SEMIAUTOMATED IMAGE ANALYSIS OF SYNOVIAL BIOPSIES STUDIED USING A NOVEL HIGH-PLEX IMMUNOFLUORESCENCE PLATFORM,
L. A. Peñaranda-Bolaño, A. Arora, J. Murillo-Saich, E. Lo, T. George, D. Tanoeihusada, S. McArdle, M. Guma, E. Quesada Masachs
|
|
2025 OP0275
|
POTENTIAL DRUG TARGETS FOR CHRONIC WIDESPREAD PAIN: A PROTEOME-WIDE MENDELIAN RANDOMIZATION AND DRUG REPURPOSING ANALYSIS,
L. Chen, J. xie, D. Prieto-Alhambra
|
|
2025 OP0304
|
AN OMERACT STUDY FOR THE DEVELOPMENT OF AN ALGORITHM FOR AUTOMATIC IDENTIFICATION OF CALCIUM PYROPHOSPHATE DEPOSITION BY ULTRASOUND: THE CRYSTAL ARTIFICIAL INTELLIGENCE MONITORING (CLAIM) STUDY,
G. Filippou, D. Cirillo, T. Bassani, S. Sirotti, S. Gitto, A. Adinolfi, E. Cipolletta, L. Coronel, M. Diaz, A. Di Matteo, E. Filippucci, H. B. Hammer, D. MacCarter, I. Möller, E. Naredo, F. Porta, O. M. Olivas Vergara, G. Sakellariou, W. Schmidt, O. Aitisha Tabesh, G. Tamborrini, P. Todorov, M. Arese, R. Fabbri, A. Lucia, A. Varvaro, P. Sarzi-Puttini, M. A. D’Agostino, P. Mandl, C. Pineda, H. Keen, L. M. Sconfienza, L. Terslev
|
|
2025 OP0307
|
ARTIFICIAL INTELLIGENCE IN AXIAL SPONDYLOARTHRITIS DIAGNOSIS: INTEGRATING STRUCTURAL AND INFLAMMATORY LESIONS FROM SACRUM MRI,
H. S. Cha, Y. Kim, S. Kang, M. J. Chung, H. Kim, J. Lee, H. Yoo, S. Lee
|
|
2025 OP0311
|
NOVEL MRI-BASED SYNTHETIC CT AND LOW-DOSE CT FOR THE ASSESSMENT OF SYNDESMOPHYTES AND OSTEOPHYTES IN THE SPINE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, RHEUMATOID ARTHRITIS, AND HEALTHY CONTROLS,
S. T. Willesen, J. Møllenbach Møller, K. K. Gosvig, A. E. F. Hadsbjerg, S. Georgiadis, S. J. Pedersen, M. Østergaard
|
|
2025 OP0328
|
DISTINCT JOINT PATTERNS IN TREATMENT-NAÏVE RA ALSO CORRESPOND TO HISTOLOGICAL VARIATIONS,
T. D. Maarseveen, L. A. Coletto, S. Perniola, D. Bruno, L. Petricca, M. R. Gigante, V. A. Pacucci, C. Di Mario, D. Campobasso, B. Tolusso, R. Benvenuto, M. M. Lizzio, E. Gremese, M. A. D’Agostino, M. Gessi, T. Huizinga, E. B van den Akker, S. Alivernini, R. Knevel
|
|
2025 OP0343
|
THE CLAUDICAITIO MODEL: ULTRASOUND IMAGE CLASSIFICATION IN GIANT CELL ARTERITIS BY APPLICATION OF ARTIFICIAL INTELLIGENCE,
C. J. Bauer, S. Schaab, S. Albarqouni, V. S. Schäfer
|
|
2025 POS0018
|
Identification of Clinical Phenotypes in Behçet’s Syndrome Using Latent Class Analysis,
S. Chadli, R. Abouqal, H. Khibri, M. Bourkia, N. Moatassim, W. Ammouri, M. Maamar, H. Harmouche, Z. Tazi Mezalek
|
|
2025 POS0044
|
DEEP-LEARNING ANALYSIS OF HRCT IMAGES PREDICTS PULMONARY PROGRESSION AND MORTALITY IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE,
E. De Lorenzis, R. D’Abronzo, P. G. Cerasuolo, L. Calandriello, G. Cicchetti, G. Natalello, B. Iovene, F. Varone, G. Sgalla, L. Richeldi, A. R. Larici, M. A. D’ Agostino, S. L. Bosello
|
|
2025 POS0092
|
A VISION TRANSFORMER BASED APPLICATION FOR THE COMBINED DETECTION AND GRADING OF OSTEOARTHRITIS, CPPD AND RHEUMATOID ARTHRITIS ON HAND RADIOGRAPHS,
T. Hügle, D. Markham, C. Lechtenboehmer, L. Caratsch, E. Rosoux, U. A. Walker, F. Becce, T. Manigold
|
|
2025 POS0124
|
FAST AND ACCURATE DETECTION OF SACROILIITIS: THE ROLE OF THE MACHINE LEARNING METHOD YOLOv7 IN IDENTIFYING BONE MARROW EDEMA,
S. Tekeoglu, A. Gocoglu
|
|
2025 POS0141
|
APPLICATION OF ARTIFICIAL INTELLIGENCE TOOLS IN AXIAL SPONDYLOARTHRITIS IMAGING ASSESSMENT: A SYSTEMATIC LITERATURE REVIEW EVALUATING THE PERFORMANCES ACROSS MRI, CT, AND RADIOGRAPHY,
D. Rosillon, M. de Hooge, G. Varkas, E. Gvozdenovic
|
|
2025 POS0143
|
PREDICTION OF THE LACK OF IMPROVEMENT IN TOTAL HIP AND FEMORAL NECK BONE MINERAL DENSITY WITH ROMOSOZUMAB: A MACHINE LEARNING MODEL FOR PATIENTS WITH OSTEOPOROSIS,
D. Velasco, M. A. Ramírez Huaranga, L. Jiménez Rodríguez, A. I. Martín-Albo López, A. López-Menchero Mora, D. Castro-Corredor, M. D. Mínguez Sánchez, M. Paulino Huertas, J. Anino-Fernández, E. Revuelta-Evrad, V. Salas Manzanedo, L. Martin-Sierra
|
|
2025 POS0144
|
PREDICTING INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC AND TARGETED SYNTHETIC DMARDS: A MACHINE LEARNING APPROACH,
K. Peng, D. Yang, J. Wang, C. Y. Shen, M. C. Y. Cheng, S. C. W. Chan, I. Y. K. Tang, Q. Zhang, E. C. Lai, N. L. Pratt, C. S. Lau, X. Li
|
|
2025 POS0186
|
DIAGNOSTIC PERFORMANCE OF ROBOTIC ULTRASONOGRAPHY IN RHEUMATOID ARTHRITIS: – RESULTS FROM THE CONTROLLED ARTHUR TRIAL,
M. Ammitzbøll-Danielsen, M. Østergaard, H. P. L. Tam, L. Terslev
|
|
2025 POS0208
|
PROTEOMIC SIGNATURES IN CHRONIC WIDESPREAD PAIN,
L. Chen, J. Xie, D. Prieto-Alhambra
|
|
2025 POS0212
|
MACHINE LEARNING MODELS FOR PREDICTING OPIOID-RELATED HOSPITALISATION IN NEW OPIOID USERS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES,
C. R. Ramirez Medina, J. Benitez-Aurioles, M. Lunt, D. Jenkins, W. Dixon, N. Peek, M. Jani
|
|
2025 POS0234
|
MACHINE LEARNING AND PROTEOMICS FOR PREDICTING ANTI-TNFα RESPONSE IN PSORIATIC ARTHRITIS: IDENTIFICATION OF DRUG MODULATED PROTEINS,
E. Martin-Salazar, I. Arias-de la Rosa, L. Cuesta-López, M. Ruiz-Ponce, A. M. Barranco, M. Á. Puche-Larrubia, C. Perez-Sanchez, R. Ortega-Castro, J. Calvo-Gutiérrez, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, N. Barbarroja
|
|
2025 POS0275
|
EVALUATION OF A LARGE LANGUAGE MODEL’S PERFORMANCE IN SCORING CUTANEOUS MANIFESTATIONS IN DERMATOMYOSITIS: A COMPARISON WITH EXPERT ASSESSORS,
M. Fornaro, S. Panigrahi, S. Sabbagh, F. Iannone, V. Venerito, L. Gupta
|
|
2025 POS0301
|
DEVELOPING AND EXTERNALLY VALIDATING A MULTIVARIABLE PREDICTION MODEL TO PREDICT THE RISK OF DEVELOPING PSORIATIC ARTHRITIS IN ADULTS NEWLY DIAGNOSED WITH PSORIASIS IN PRIMARY CARE: AN OBSERVATIONAL COHORT STUDY,
A. Vivekanantham, M. Pineda-Moncusí, E. Burn, S. Khalid, D. Prieto-Alhambra, L. C. Coates
|
|
2025 POS0302
|
DEVELOPMENT AND EVALUATION OF A MACHINE LEARNING MODEL FOR THE EARLY IDENTIFICATION OF PSORIATIC ARTHRITIS IN THE COMMUNITY,
M. Dreyfuss, D. Riesel, G. Shalev, D. White, O. Ramni, B. Getz, D. Underberger, S. Steinberg-Koch, E. Myasoedova
|
|
2025 POS0311
|
SARCOIDOSIS AS A SYSTEMIC DISEASE: IDENTIFYING PATTERNS OF MULTIORGAN-SPECIFIC INVOLVEMENT AND EPIDEMIOLOGICAL PROFILING THROUGH GENERATIVE ARTIFICIAL INTELLIGENCE-DRIVEN CLUSTERING,
P. Brito-Zerón, A. Flores-Chávez, C. Feijoo-Masso, G. Policarpo-Torres, R. Gómez de la Torre, B. Escalante, J. M. Lopez-Dupla, C. Soler-i-Ferrer, E. Fonseca-Aizpuru, A. González-García, J. C. Herranz-Pérez, S. GARCÍA MORILLO, A. Alguacil, Á. Robles Marhuenda, M. Bonet, M. V. Villalba-García, A. J. Chamorro, B. De Miguel-Campo, M. G. CRUZ CAPARROS, M. Akasbi Montalvo, A. Mayer-Fuentes, M. Ramos-Casals
|
|
2025 POS0317
|
THE IMMUNE MAP OF LUPUS NEPHRITIS: A SPATIALLY-RESOLVED KIDNEY PROTEOMIC APPROACH,
C. Y. Lee, M. C. Marlin, X. Yang, V. Morkotinis, A. I. Celia, J. Buyon, R. A. Furie, D. L Kamen, J. Hodgin, C. Putterman, J. Barnas, K. C. Kalunian, P. Izmirly, B. Diamond, A. Davidson T. Accelerating Medicines Partnership in RA/SLE, J. A. James, M. Petri, J. M. Guthridge, A. Rosenberg, A. Fava
|
|
2025 POS0318
|
MACHINE LEARNING IDENTIFIES DISTINCT TRAJECTORIES OF CLINICAL RESPONSE TO RITUXIMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND OFFERS A MORE MEANINGFUL ASSESSMENT THAN CONVENTIONAL LANDMARK ANALYSIS,
M. Rodziewicz, S. Shoop-Worrall, S. Dyball, E. Sutton, J. Reynolds, B. Parker, I. Bruce
|
|
2025 POS0336-HPR
|
CO-DESIGN AND EARLY EVALUATION OF A REMOTE MONITORING MOBILE APP BASED ON SELF-IMAGING FOR PATIENTS WITH INFLAMMATORY ARTHRITIS: FOCUS GROUP INSIGHTS,
L. Russo, M. Blanchard, J. Maglione, P. Hermann, C. Koller, T. Hügle
|
|
2025 POS0338-HPR
|
A USER-CENTERED MULTIMODAL ELECTRONIC HEALTH RECORD SIDECAR APPLICATION TO MONITOR INFLAMMATORY ARTHRITIS: DEVELOPMENT AND IMPLEMENTATION IN CLINICAL PRACTICE,
L. Russo, M. Blanchard, J. Maglione, P. Hermann, C. Koller, T. Hügle
|
|
2025 POS0488
|
AI-POWERED SCREENING FOR PSORIATIC ARTHRITIS: A COMPARATIVE STUDY WITH EXISTING TOOLS,
U. Bakay, Ö. S Karstarli Bakay, T. Izci Duran, Z. Dündar
|
|
2025 POS0526
|
Association of Chondrocalcinosis with disease activity and drug response in Rheumatoid Arthritis: Baseline characteristics of the Swiss Rheumatoid Arthritis Outcomes cohort,
T. Manigold, N. Bodmer, E. Rosoux, G. Fahrni, D. Markham, R. Micheroli, L. M. Bachmann, J. Brändli, F. Becce, T. Hügle
|
|
2025 POS0562
|
Evaluation of Small bowel Involvement in Systemic Sclerosis Using Morpho-Functional Image Analysis Assisted by Artificial Intelligence,
L. G. Alcala-gonzalez, L. Hui, P. Gilabert, A. Guillen-Del-Castillo, A. Aguilar, C. Barber, C. Codina, L. Triginer, J. Serra, E. Monclus, S. Segui, C. P. Simeón-Aznar, C. Malagelada
|
|
2025 POS0601
|
DATA-DRIVEN METRICS FOR EVALUATING RHEUMATOID ARTHRITIS THERAPY RESPONSE,
A. Wong, S. Guardiano, V. Akmaev, L. Zhang
|
|
2025 POS0607
|
QUANTIFYING TISSUE MICROSTRUCTURAL CHANGES IN SCLERODERMA SKIN USING A NOVEL, POINT-OF-CARE, HIGH-FREQUENCY-ULTRASOUND INSTRUMENT,
K. Lakin, C. Hoerig, J. Gordon, E. Ghahramani, S. Liu, M. Diaz, R. Spiera, D. Orange, J. Mamou
|
|
2025 POS0678
|
A MACHINE LEARNING MODEL FOR THE EARLY IDENTIFICATION OF RHEUMATOID ARTHRITIS: DEVELOPMENT AND VALIDATION,
M. Dreyfuss, Y. Jenudi, D. Riesel, O. Ramni, D. Underberger, B. Getz, S. Steinberg-Koch, D. White, E. Myasoedova
|
|
2025 POS0707
|
MAPPING DIETARY BIOACTIVE PROFILES IN RHEUMATOID AND OSTEOARTHRITIS: A NOVEL ANALYTICAL APPROACH USING UK BIOBANK DATA,
P. Cardenas Canto, M. H. Traka, A. MacGregor, M. Defernez, J. Dainty, M. Yates, M. Brandner, K. Kemsley, L. Zhang, L. Bardon, P. Pratyasha
|
|
2025 POS0716
|
DYSREGULATED LIPID AND METABOLIC PATHWAYS MAY CONTRIBUTE TO UNDERLYING DISEASE MECHANISMS IN PATIENTS WITH HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,
A. Oppong, G. Robinson, A. Holloway, R. Wilson, T. McDonnell, B. Carpenter, E. Jury, J. Manson
|
|
2025 POS0721
|
INTERPRETATION OF ANTI-NUCLEAR ANTIBODY INDIRECT IMMUNOFLUORESCENCE PATTERNS USING ARTIFICIAL INTELLIGENCE,
H. Jain, K. Sivasami, R. Kutum, G. Ahuja, S. Adhikari, S. J., A. Kumar, V. Vasdev
|
|
2025 POS0748
|
CAN ROBOTIC ULTRASONOGRAPHY REPLACE STANDARD ULTRASONOGRAPHY IN RHEUMATOID ARTHRITIS – RESULTS FROM THE CONTROLLED ARTHUR TRIAL,
M. Ammitzbøll-Danielsen, M. Østergaard, H. P. L. Tam, L. Terslev
|
|
2025 POS0772
|
PREDICTION OF CLINICAL RELAPSES AT 12 MONTHS IN PATIENTS WITH TAKAYASU ARTERITIS USING [18F]FDG PET AND CONVOLUTIONAL NEURAL NETWORKS,
A. Tomelleri, C. Bezzi, S. Resta, C. Campochiaro, F. Fallanca, E. Baldissera, S. Ghezzo, N. Farina, A. Chiti, P. Mapelli, M. Matucci-Cerinic, M. Picchio, L. Dagna
|
|
2025 POS0786
|
OPTIMIZING SYSTEMIC LUPUS ERYTHEMATOSUS CARE WITH ARTIFICIAL INTELLIGENCE: A SYSTEMATIC REVIEW OF CLINICAL APPLICATIONS,
J. Sarmiento-Monroy, D. Benavent, L. Arnaud, J. A. Gómez-Puerta
|
|
2025 POS0808-PARE
|
A GENERATIVE AI-POWERED CHATBOT FOR PATIENT SUPPORT AND EDUCATION IN RARE DISEASES,
D. O’Regan, C. Coady, C. Armstrong, J. Power, V. Beattie, T. Whymark, J. Kelly, T. Treacy
|
|
2025 POS0883
|
OPTIMIZING RHEUMATOLOGY CONSULTATIONS WITH ARTIFICIAL INTELLIGENCE: INSIGHTS FROM THE ReumAI PILOT STUDY,
A. Gómez-Centeno, M. Sabaris-Vilas, F. Garcia-Sancho, J. Segura-Sanchez
|
|
2025 POS0885
|
UNDERSTANDING THE RHEUMATOLOGY UNSTRUCTURED EHR CLINICAL NOTES: A COMPARATIVE ANALYSIS OF NATURAL LANGUAGE PROCESSING TOPIC MODELLING TECHNIQUES,
X. Michelena, M. Almirall, M. Barceló, J. Cortés-Hernández, J. J. De Agustin, A. Erra, M. A. López Lasanta, H. Borrell Paños, G. Carot-Sans, Y. Cossio-Gil, J. Piera-Jiménez, S. Marsal Barril
|
|
2025 POS0926
|
FINE-TUNING AND PRE-TRAINING IMPROVE THE PREDICTIVE ACCURACY OF LARGE LANGUAGE MODELS FOR ASSESSING RHEUMATOID ARTHRITIS DISEASE ACTIVITY,
S. Honda, K. Ikari, M. Fujisaki, E. Tanaka, M. Harigai
|
|
2025 POS0930
|
A METABOLOMICS APPROACH TO CLASSIFY CARDIOVASCULAR DISEASE ABNORMALITY IN VERY EARLY RHEUMATOID ARTHRITIS,
A. Millar-Wilson, B. Erhayiem, G. Fent, S. Plein, N. Nair, J. Bowes, M. Buch, D. Plant
|
|
2025 POS0994
|
PREDICTING ONE-YEAR DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS USING MACHINE LEARNING AND EXPLAINABLE AI,
A. Ortolan, S. L. Bosello, L. Lilli, L. Antenucci, C. Masciocchi, M. Gorini, G. Castellino, L. Petricca, M. R. Gigante, V. A. Pacucci, L. Lanzo, C. Gavotti, F. Cristiano, P. Cerasuolo, J. Lenkowicz, A. Cesario, S. Patarnello, M. A. D’ Agostino
|
|
2025 POS1088
|
Improved Machine Learning Models for Predicting Colchicine Resistance in Familial Mediterrenean Fever,
A. Ozturk, M. Kucur, L. Yagci, B. Kilic, S. Ugurlu
|
|
2025 POS1091
|
Development and Validation of ‘Rheumatic ‘ - A Digital Symptom Checker for Confirmation and Prediction of Rheumatic Diseases: A Large-Scale Prospective Study,
L. Qin, D. Selani, F. Zegers, J. Desai, B. Bislawska Axnäs, C Baatenburg de Jong, H. K. Glas, L. M. Verhoef, C. Aulin, L. Rodriguez Rodriguez, J. Askling, R. Bos, Y. Goekoop-Ruiterman, A van Tubergen, T. Huizinga, E. Steyerberg, L. Klareskog, M. J. T. Reinders, S. Le Cessie, E. B van den Akker, R. Knevel
|
|
2025 POS1092
|
Clinical Prediction Models Predicting For Medication Adverse Events In Patients With Rheumatic And Musculoskeletal Conditions: A Systematic Literature Review,
C. Diomatari, G. Martin, D. Jenkins, M. Jani
|
|
2025 POS1168
|
MACHINE LEARNING-BASED PREDICTION FOR GOUT USING PRS AND CLINICAL VARIABLES: A KOREAN COHORT STUDY,
D. H. Kwak, H. Kim, S. S. Choi, K. W. MOON
|
|
2025 POS1192
|
RISK STRATIFICATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: IMPROVING THE PERFORMANCES OF A PREDICTION MODEL,
S. L. Bosello, A. Ortolan, L. Lilli, L. Antenucci, C. Masciocchi, M. Gorini, G. Castellino, L. Petricca, M. R. Gigante, V. A. Pacucci, L. Lanzo, P. Rizzuti, R. Ventura, S. Piunno, J. Lenkowic, A. Cesario, S. Patarnello, M. A. D’ Agostino
|
|
2025 POS1277
|
AUTOMATED ULTRASOUND SYSTEM ASSESSMENT - AN IMPORTANT ADJUNCT TO THE CLINICAL EVALUATION OF HANDS OF PATIENTS WITH ARTHRALGIA,
A. Colic, H. D. Hansen, A. Colic, M. Szkudlarek
|
|
2025 POS1316
|
THREE SYSTEMIC LUPUS ERYTHEMATOSUS PHENOTYPES ACCORDING TO CLUSTER ANALYSIS OF CLINICAL AND IMMUNOLOGICAL CLASSIFICATION CRITERIA: A MULTICENTRE STUDY OF 773 PATIENTS,
A. González-García, M. Fabregate, C. Feijoo-Masso, F. Mitjavila, D. Paredes, G. Espinosa, S. Parra, M. A. Bahamonde-García, L. Sáez-Comet, B. D. C. Gracia Tello, M. V. Villalba-García, Á. Robles Marhuenda, B. Frutos Perez, F. Lirola, E. Fonseca-Aizpuru, J. A. Todoli, J. M. Lopez-Dupla, B. De Miguel-Campo, J. L. Callejas, R. Ríos-Garcés, C. Martinez-Caballero, N. Navarrete, M. López-Veloso, I. Les Bujanda, O. Araujo Loperena, I. García-Sanchez, A. Jerez-Lienas, R. Coto-Hernández, S. García Morillo, E. Calvo Begueria, J. M. Gómez-Verdú, F. J. García Hernández, G. Daroca-Bengoa, G. Ruiz-Irastorza, I. Cusacovich
|
|
2025 POS1322
|
DEVELOPMENT OF A DEEP LEARNING-BASED TOOL FOR THE AUTOMATED GRADING OF SYNOVITIS AND CLASSIFICATION OF ARTHRITIS USING ULTRASOUND IMAGING,
M. Schlereth, R. Noversa de Sousa, G. Corte, C. Tur, I. Minopoulou, M. Yalcin Mutlu, A. Temiz, S. Bayat, D. Simon, G. Schett, A. Kleyer, K. Breininger, F. Fagni
|
|
2025 POS1351
|
EARLY PREDICTION OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS USING MACHINE LEARNING APPROACH,
J. Baloun, L. Andrés Cerezo, T. Kropackova, A. Prokopcova, K. Brabnikova Maresova, H. Mann, J. Vencovský, K. Pavelka, L. Šenolt
|
|
2025 POS1370
|
TOWARDS REVOLUTIONIZING RHEUMATOID ARTHRITIS CARE USING GENETIC INFORMATION VIA A NOVEL EXOMIC TRANSFORMER,
S. Ayanian, C. Osborne, G. Venkatesh, V. Pondenkandath, B. Kanakiya, M. Blasi, C. Molnar, M. Redlon, N. Vassilieva, E. Klee, K. Lazaridis, E. Myasoedova
|
|
2025 POS1448-HPR
|
EFFICIENCY OF MOBILE-BASED AI-PERSONALIZED EXERCISE PROGRAM VERSUS SUPERVISED AI-PERSONALIZED EXERCISE PROGRAM IN JUVENILE IDIOPATHIC ARTHRITIS: A PILOT STUDY,
A. Yekdaneh, N. Arman, N. Aktay Ayaz
|
|
2025 POS1481-HPR
|
EXPLORING THE FEASIBILITY OF USING DIGITAL TECHNOLOGIES TO MEASURE FREE-LIVING PHYSICAL ACTIVITY AND REAL-TIME SYMPTOMS IN PEOPLE LIVING WITH RHEUMATOID ARTHRITIS,
R. Baynham, J Veldhuijzen van Zanten, A. Doherty, S. Fenton
|
|
2025 POS1490-HPR
|
CAN KNEE OSTEOARTHRITIS BE PREDICTED USING MACHINE LEARNING WITH PEDOBAROGRAPHIC DATA,
N. B. Cigercioglu, Y. Y. Pilavci, H. Guney-Deniz
|
|
|
[55]
|
Atherosclerosis
|
|
|
| 2025 |
|
2025 ABS0002
|
LONG-TERM PLATELET P-SELECTIN PREDICTIVE ROLE FOR THROMBOSIS IN CONNECTIVE TISSUE DISEASES AND SYSTEMIC VASCULITIS,
G. A. Ramirez, E. Allegrini, C. Campochiaro, L. Moroni, A. Tomelleri, E. Baldissera, G. De Luca, M. Matucci-Cerinic, L. Dagna, A. Manfredi, N. Maugeri
|
|
2025 ABS0082
|
IDENTIFICATION OF CORONARY MORPHOLOGICAL DAMAGE IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHROPATHIES,
A. Torres-Roselló, E. Heras-Recuero, J. A. Martinez Lopez, T. Blázquez-Sánchez, M. Garbayo-Bugeda, A. Castrillo-Capilla, J. Tuñón-Fernández, M. Á. González-Gay
|
|
2025 ABS0086
|
HOW DISEASE ACTIVITY AFFECTS ULTRASONOGRAPHIC MARKERS OF ARTERIAL STIFFNESS IN RA PATIENTS TREATED WITH TNF INHIBITORS AND JAK INHIBITORS,
G. Gerganov, M. Dimova-Mileva, M. Markov, S. Bogdanova-Petrova, S. Hristova, S. Dimitrov, R. Moraliyska, Z. Dimova, D. Simeonova, T. Georgiev
|
|
2025 ABS0116
|
COMMON PROTEOMIC BIOMARKERS OF VASCULAR AND MYOCARDIAL TISSUE ABNORMALITIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS,
R. R. Shukla, A. I. Mohammed, R. Dumitru, L. A. Bissell, B. Erhayiem, G. Fent, C. Miller, F. Del Galdo, S. Plein, D. Plant, M. Buch
|
|
2025 ABS0198
|
MOLECULAR LANDSCAPE AND CO-EXPRESSED PATHWAYS IN RHEUMATOID ARTHRITIS COMPLICATED BY ATHEROSCLEROSIS: INSIGHTS FROM INTEGRATIVE BIOINFORMATIC TRANSCRIPTOMICS,
R. Martinez-Canales, A. Montoya-Rosales, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 ABS0227
|
DECREASED GPR55 EXPRESSION LINKS B-CELL ACTIVATION AND VASCULAR REMODELLING IN ATHEROSCLEROSIS IN EARLY RHEUMATOID ARTHRITIS PATIENTS,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2025 ABS0295
|
ACCURACY OF THE INTIMA-MEDIA THICKNESS BY ULTRASOUND FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS: A SYSTEMATIC REVIEW,
C. Pitasi, F. Lamarca, V. Vilela, A. B. Vargas-Santos, M. Aschwanden, S. Imfeld, D. Staub, T. Daikeler
|
|
2025 ABS0318
|
CARDIOVASCULAR RISK IN EARLY ARTHRITIS: A LOWER SCORE IS NOT ALWAYS BETTER,
A. Lo Gullo, A. Toscano, G. Mandraffino
|
|
2025 ABS0346
|
ACTIVE SKIN INVOLVEMENT IS ASSOCIATED WITH ALTERATIONS IN LEFT VENTRICULAR GEOMETRY IN PATIENTS WITH PSORIATIC ARTHRITIS,
O. A. Garza-Flores, A. Gonzalez-Melendez, R. L. Polina-Lugo, I. Hernández-Velázquez, C. E. Cantú-Moreno, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, D. A. Salcedo-Almanza, V. M. Fraga-Enriquez
|
|
2025 ABS0348
|
ANTIPHOSPHOLIPID ANTIBODIES ARE ASSOCIATED WITH SUBCLINICAL CARDIAC DYSFUNCTION IN SLE PATIENTS,
O. A. Garza-Flores, R. L. Polina-Lugo, A. Gonzalez-Melendez, F. M. Garcia-Garcia, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. M. Fraga-Enriquez
|
|
2025 ABS0355
|
IMPACT OF DISEASE ACTIVITY ON QUALITY OF LIFE AND CAROTID PLAQUE PREVALENCE IN PATIENTIS WITH PSORIATIC ARTHRITIS,
A. Gonzalez-Melendez, R. L. Polina-Lugo, O. A. Garza-Flores, R. I. De la Rosa-Vazquez, F. M. Garcia-Garcia, M. I. Gonzalez-Loperena, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, D. A. Salcedo-Almanza
|
|
2025 ABS0380
|
SCORE2 IS MORE USEFUL THAN THE FRAMINGHAM SCORE IN IDENTIFYING HIGH RISK ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS, OSTEOARTHRITIS AND FIBROMYALGIA,
G. Tade, N. Dlongolo, M. Seboka, A. Woodiwiss, U. Mariani, M. Dzikinu, P. Dessein
|
|
2025 ABS0385
|
MENOPAUSE AS A CARDIOVASCULAR RISK FACTOR IN RHEUMATOID ARTHRITIS: INSIGHTS AND IMPLICATION,
A. Gonzalez-Melendez, R. L. Polina-Lugo, O. A. Garza-Flores, A. Domínguez-Guerra, R. I. De la Rosa-Vazquez, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, V. M. Fraga-Enriquez, D. A. Salcedo-Almanza
|
|
2025 ABS0408
|
HYPERURICEMIA AS CARDIOVASCULAR RISK FACTOR: A STUDY IN PATIENTS WITH RHEUMATIC DISEASES,
A. Mayo-Juanatey, J. Lacasa-Molina, M. Robustillo-Villarino, L. Montolio-Chiva, C. Valera-Ribera, P. A. Mencio-Viana, P. León-Torralba, P. Andújar-Brazal, A. Taberner-Cortés, I. Vázquez-Gómez, E. Valls-Pascual, À. Martínez-Ferrer, D. Ybáñez-García, J. J. Alegre Sancho
|
|
2025 ABS0531
|
SUSTAINED CARDIOVASCULAR RISK FACTOR TARGET ACHIEVEMENT AND ATHEROSCLEROTIC PLAQUE PROGRESSION OVER A 10-YEAR FOLLOW-UP PREDICT NON-ALCOHOLIC FATTY LIVER DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
V. Poulia, N. Papazoglou, E. Michailidou, G. V. Papatheodoridis, P. P. Sfikakis, M. G. Tektonidou
|
|
2025 ABS0536
|
ASSESSING ACCURACY OF DIFFERENT MODIFICATIONS OF SCORE IN ESTIMATION OF CARDIVASCULAR RISK IN SYSTEMIC SCLEROSIS,
S. Oreska, A. Prokopcova, H. Štorkánová, J. Kudlicka, V. Tuka, O. Mikeš, Z. Krupičková, M. Satny, E. Chytilova, J. Kvasnicka, M. Špiritović, B. Heřmánková, P. Cesak, M. Rybar, K. Pavelka, L. Šenolt, R. Bečvář, J. Vencovský, M. Vrablik, M. Tomčík
|
|
2025 ABS0540
|
STUDY OF 97 PATIENTS WITH CARDIOVASCULAR SURGERY DUE TO ANEURYSMS AND/OR AORTIC DISSECTION: UNDERLYNG DISEASES AND PATHOLOGICAL FINDINGS,
A. Martín-Gutiérrez, J. Loricera, J. M. Gómez-Ortega, A. Ucelay, R. Blanco
|
|
2025 ABS0599
|
THE COMPARISON OF CAROTID INTIMA-MEDIA THICKNESS BETWEEN THE PATIENTS WITH CHRONIC DISEASE HISTORY AND GOUT USING COLCHICINE AND THE PATIENTS WITH CARDIOVASCULAR RISK FACTORS,
E. Yilmaz, K. Halli Akay
|
|
2025 ABS0619
|
CORONARY ARTERY CALCIFICATION IN PATIENTS WITH r-axSpA: A COMPARATIVE STUDY WITH MATCHED CONTROLS IN SOUTHWESTERN SWEDEN,
E. Hulander, A. Deminger, S. Enegren, M. Hallström, C. Feldthusen, E. Fagman, O. Angerås, T. Zverkova Sandstrom, M. Geijer, H. Forsblad-d’Elia
|
|
2025 ABS0674
|
OSCILLOMETRIC, GREYSCALE, AND NOVEL COLOR-DOPPLER ULTRASOUND MARKERS OF MACROVASCULAR DAMAGE IN SJÖGREN’S SYNDROME: FINDINGS FROM THE SICARD COHORT STUDY,
K. Triantafyllias, M. Bach, S. Boegel, M. Muthuraman, G. K. Bertsias, D. Boumpas, R. Bergner, M. Schepers, A. Schwarting
|
|
2025 ABS0702
|
TRIGLYCERIDE-GLUCOSE-BMI INDEX AS A SEROLOGICAL BIOMARKER OF CAROTID PLAQUE AND CARDIAC FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS,
R. L. Polina-Lugo, A. Gonzalez-Melendez, O. A. Garza-Flores, F. M. Garcia-Carrillo, J. A. Cardenas-de la Garza, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, R. I. Arvizu-Rivera, V. M. Fraga-Enriquez, D. A. Salcedo-Almanza
|
|
2025 ABS0724
|
ANTI-BETA-2-GLYCOPROTEIN-1 IgA ANTIBODIES FACILITATE MACROPHAGE CHOLESTEROL LOADING AND INFLUENCE CORONARY ATHEROSCLEROSIS PROGRESSION IN A DOSE-DEPENDENT MANNER IN RHEUMATOID ARTHRITIS,
G. Karpouzas, B. Papotti, S. Ormseth, M. Palumbo, M. Budoff, N. Ronda
|
|
2025 ABS0727
|
THE EFFECT OF ASSOCIATED SJÖGREN’S DISEASE ON CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS,
N. BayraM Akinci, M. Erdogan, B. Aksoy, G. Mumcu, N. Inanc
|
|
2025 ABS0775
|
NON-HDL CHOLESTEROL LEVELS AND CAROTID PLAQUE IN PATIENTS WITH PSORIATIC ARTHRITIS,
R. L. Polina-Lugo, A. Gonzalez-Melendez, O. A. Garza-Flores, J. A. Cardenas-de la Garza, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, D. A. Galarza-Delgado, R. I. Arvizu-Rivera
|
|
2025 ABS0786
|
ACHIEVING A GOOD RESPONSE REFLECTS REGRESSION OF CAROTID ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TARGETED THERAPIES,
J. W. Kim, J. S. Yoon, H. Lee, S. H. Park, S. K. Kim, J. Y. Choe
|
|
2025 ABS0804
|
NON-INVASIVE VASCULAR BIOMARKERS IDENTIFY PARTLY REVERSIBLE DISEASE-RELATED ARTERIAL DAMAGE AT LARGE VESSEL VASCULITIS DIAGNOSIS,
O. D. Argyropoulou, A. A. Argyris, E. K. Aissopou, D. Mouziouras, G. Charalampopoulos, C. P. Mavragani, N. Tentolouris, P. P. Sfikakis, M. N. Manoussakis, C. D. Anagnostopoulos, P. G. Vlachoyiannopoulos, A. D. Protogerou
|
|
2025 ABS0839
|
CARDIOVASCULAR OUTCOMES AND MORTALITY ASSOCIATED WITH GLP-1 RECEPTOR AGONISTS IN INFLAMMATORY MYOSITIS AND NECROTIZING MYOPATHY: A RETROSPECTIVE COHORT STUDY,
R. Ali, H. Akbari, B. Subedi, I. Tan, S. Abdollahi, F. Rodriguez, A. Lau
|
|
2025 ABS0870
|
INTIMA/MEDIA THICKNESS IN RHEUMATOID ARTHRITIS -CLINICAL AND IMMUNOLOGICAL IMPLICATIONS,
D. Elena, L. Andries, N. Ciobanu, R. Eugeniu, N. Alesea, M. Curchi, L. Groppa
|
|
2025 ABS0970
|
COMPARISON OF THE PERFORMANCE OF CARDIOVASCULAR RISK SCORES AND RISK EVOLUTION IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS),
R. Ben Chehida, S. Ben Jemaa, A. Feki, R. Akrout, Z. Gassara, M. H. Kallel, S. Baklouti, H. Fourati
|
|
2025 ABS0971
|
RISK ESTIMATION FOR SUBCLINICAL HEART FAILURE USING THE PREVENT CALCULATOR IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES,
V. Gonzalez-Gonzalez, O. A. Garza-Flores, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera
|
|
2025 ABS0996
|
HYPERHOMOCYSTEINEMIA AND CARDIOVASCULAR RISK ASSESSED BY THE QRISK3 SCORE IN PATIENTS WITH SPONDYLOARTHRITIS,
R. Dhahri, I. Fenniche, L. Ben Ammar, B. A. Hiba, A. Ba, M. Ayoub, M. Slouma, C. Mazigh, I. Gharsallah
|
|
2025 ABS1045
|
ORGAN CALCIFICATIONS DETECTED BY THORACIC COMPUTED TOMOGRAPHY IMAGING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
A. H. Zinglersen, L. K. Winberg, K. Fuglsang Kofoed, A. Fuchs, S. Jacobsen
|
|
2025 OP0072
|
Does the amount of genetic predisposition to RA influence the risk of myocardial infarction,
H. Westerlind, L. Padyukov, A. Sysojev Öberg, S. B. G., S. Saevarsdottir, J. Askling
|
|
2025 OP0164
|
AN UNUSUAL PRESENTATION OF IGG4-RELATED DISEASE: PROGRESSIVE CORONARY ARTERY STENOSIS,
L. Yagci, B. Kilic, A. Ozturk, S. Kaymaz, D. Raimoglou, B. Kilickiran Avci, S. Batur, S. Ugurlu
|
|
2025 POS0025
|
Evaluating Macroangiopathy in Small Vessel Vasculitides Using Cardiovascular and Cerebrovascular Surrogates: The VASCARD Cohort Study.,
K. Triantafyllias, J. Keil, L. E. Thiele, A. Schwarting
|
|
2025 POS0455
|
Is there a difference in the incidence of major adverse cardiovascular events in rheumatoid arthritis diagnosed since 2000 compared with osteoarthritis,
C. M. A. Lin, H. Tabaqchali, A. G. Pratt, J. D. Isaacs, F. A. Cooles
|
|
2025 POS0469
|
Nailfold capillaroscopy as predictor of cardiovascular events and SCORE2 risk adjustment in systemic sclerosis,
C. Valera-Ribera, F. J. Narváez Garcia, J. Lacasa-Molina, M. Robustillo-Villarino, A. Mayo-Juanatey, P. Mencio-Viana, P. León-Torralba, P. Andújar-Brazal, A. Taberner-Cortés, I. Vázquez-Gómez, E. Valls-Pascual, À. Martínez-Ferrer, D. Ybáñez-García, J. J. Alegre-Sancho
|
|
2025 POS0642
|
INTIMA-MEDIA THICKNESS OF CAROTID ARTERIES IN SYSTEMIC SCLEROSIS: AN UPDATED META-ANALYSIS,
T. Beirão, C. Rua, C. Silva, R. Vieira, A. Aleixo, P. Pinto, F. Campos Costa, A. S. Pinto, D. Fonseca, M. Tiago, T. Videira
|
|
2025 POS0698
|
CHARACTERIZATION OF THE ALDH4A1/ANTI-ALDH4A1 AXIS AS A NEW PLAYER FOR ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS: BASIC, CLINICAL AND THERAPEUTIC EVIDENCE,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2025 POS0712
|
CLINICAL IMPACT AND MOLECULAR CHANGES IN THE CARDIOVASCULAR PROFILE OF BARICITINIB ON BIOLOGIC-NAÏVE RHEUMATOID ARTHRITIS PATIENTS: COMPARATIVE ANALYSIS WITH TNF INHIBITORS AND cDMARDs,
L. Muñoz-Barrera, C. Perez-Sanchez, R. Ortega-Castro, S. Corrales-Díaz Flores, J. Calvo-Gutiérrez, C. Aranda-Valera, M. L. Ladehesa-Pineda, F. U. Pilar, I. Sanchez-Pareja, E. Moreno-Caño, M. C. Ábalos-Aguilera, C. Merlo-Ruiz, M. Á. Aguirre-Zamorano, P. Seguí Azpilcueta, T. Cerdó, N. Barbarroja, R. González-Conejero, C. Martínez, C. Lopez-Pedrera, A. Escudero-Contreras
|
|
2025 POS0782
|
INCREMENTAL PROGNOSTIC VALUE OF EPICARDIAL ADIPOSE TISSUE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. D. Azoulay, N. Kachenoura, S. Boussouar, E. Charpentier, N. Pasi, L. A. Nguyen, T. Broussaud, A. Giron, L. Parker, J. Leite, S. Hatem, R. Lhote, M. Pha, M. Hié, A. Mathian, M. Pineton de Chambrun, M. Papo, F. Cohen, J. Haroche, Z. Amoura, A. Redheuil
|
|
2025 POS0792
|
THE ASSOCIATION OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS,
C. Y. Wu, W. L. Fan, L. C. Hsieh, J. L. Huang
|
|
2025 POS0797
|
UNIQUE IMMUNOLOGICAL CELL PROFILES AND KEY PATHWAYS ASSOCIATED WITH ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Martinez-Canales, A. Montoya-Rosales, G. Figueroa-Parra, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2025 POS0853
|
DESCRIPTIVE STUDY OF DIETARY AND PHYSICAL ACTIVITY HABITS WITHIN A COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
N. Gensous, G. Rescoussier, E. Lazaro, C. Richez, S. Skopinski, P. Blanco, T. Martin, E. Hachulla, S. Jousse-Joulin, T. Barnetche, A. Kabala, P. Duffau
|
|
2025 POS0937
|
ASSOCIATIONS BETWEEN SERUM OXYLIPIN SIGNATURES AND ATHEROSCLEROSIS DURING THE EARLIEST STAGES OF ARTHRITIS: A MULTI-OMIC STUDY,
J. Rodríguez-Carrio, R. Coras, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. M. Armando, O. Quehenberger, A. Suárez, M. Guma
|
|
2025 POS0938
|
UCP1 AND ATPIF1 CORRELATE WITH CARDIOVASCULAR AND THERAPEUTIC OUTCOMES IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS: THE EMERGING ROLE OF MITOCHONDRIAL TARGETS,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez, J. Rodríguez-Carrio
|
|
2025 POS1032
|
IMPACT OF STATIN DISCONTINUATION ON LIPID PROFILE IN PATIENTS WITH IMMUNE-MEDIATED NECROTIZING MYOPATHY ASSOCIATED WITH ANTI-HMG-CoA REDUCTASE ANTIBODIES,
L. Molinero, A. Pascual, I. Aldecoa-Ansorregui, J. Padrosa, J. Milisenda, A. Matas-García
|
|
2025 POS1041
|
COMPARING JAK INHIBITORS AND STANDARD THERAPIES IN REFRACTORY MYOPATHIES: IMPACT ON CARDIOVASCULAR, MALIGNANCY, AND DISEASE ACTIVITY OUTCOMES,
H. Akbari, R. Ali, S. Abdollahi
|
|
2025 POS1048
|
REDUCING CARDIOVASCULAR RISK IN MYOSITIS: A FOCUS ON LIPID-LOWERING THERAPY,
K. Szabó, D. Szinay, H. Molnár, T. G. Béldi, V. Bencs, H. Lőrincz, M. Harangi, M. Nagy-Vincze, Z. Griger
|
|
2025 POS1175
|
SYSTEMIC LUPUS ERYTHEMATOSUS: EVALUATION OF CARDIOVASCULAR RISK SCORES INCLUDING CAROTID ULTRASOUND,
C. Zamora Ramos, A. Bartolomé Sanchez, N. García-Arenzana Les, J. Avila Robustillo, M. I. Pena Yáñez, E. Alvarez Andres, P. Collado
|
|
2025 POS1180
|
MYOCARDIAL INFARCTION CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH AND WITHOUT INFLAMMATORY JOINT DISEASES: ARE THEY REALLY DIFFERENT,
E. Ikdahl, A. Kerola, P. L. Myhre, E. Sollerud, A. G. Semb
|
|
2025 POS1197
|
COMPARATIVE ANALYSIS OF ARTERIAL AGE AND CAROTID ATHEROMA PLAQUES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS,
A. Belmonte Mora, N. Molina Osorio, M. Álvarez Castaño, Ú. Torres Parejo, I. F. Aomar-Millán, J. Salvatierra
|
|
2025 POS1241
|
ASSOCIATION BETWEEN CUTANEOUS MANIFESTATIONS AND CARDIOVASCULAR RISK ESTIMATED BY THE PREVENT CALCULATOR IN PATIENTS WITH PSORIATIC ARTHRITIS,
O. A. Garza-Flores, R. L. Polina-Lugo, A. Gonzalez-Melendez, F. M. Garcia-Garcia, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera
|
|
2025 POS1311
|
VASCULAR EFFECTS OF ACHIEVING LOW DISEASE ACTIVITY IN AXIAL SPONDYLARTHRITIS - A 2-YEAR PROSPECTIVE COHORT STUDY,
H. Meng, S. L. Lau, I. T. Cheng, B. P. Yan, A. P. W. Lee, H. So, L. S. Tam
|
|
2025 POS1343
|
IMPACT OF HYDROXYCHLOROQUINE BLOOD LEVELS ON LIPOPROTEIN PROFILES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS,
F. A. Reyes Neira, N. Aikawa, E. F. Borba, S. Pasoto, C. A. Silva, V. Balbi, E. Bonfa, C. Goldenstein Schainberg
|
|
